Disentangling the Role of CHOP in Mitochondrial Dysfunction by Kaspar, Sophie Melissa
   
vorgelegt von 
Sophie Melissa Kaspar 
aus München 
 
Köln, 2019 
 
Inaugural-Dissertation 
 
zur 
Erlangung des Doktorgrades 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Universität zu Köln 
 
 
 
Disentangling the Role of CHOP in  
Mitochondrial Dysfunction 
  
Berichterstatter:  Prof. Dr. Aleksandra Trifunovic  
 Prof. Dr. Rudolf Wiesner 
 
Tag der mündlichen Prüfung: 13. Februar 2020 
  
III 
Table of Contents 
TABLE OF CONTENTS ............................................................................................................... III 
LIST OF FIGURES .................................................................................................................... VII 
LIST OF TABLES ........................................................................................................................ IX 
ABBREVIATIONS ....................................................................................................................... X 
ABSTRACT ............................................................................................................................. XV 
ZUSAMMENFASSUNG ......................................................................................................... XVII 
1 INTRODUCTION ................................................................................................................. 1 
1.1 MITOCHONDRIAL STRUCTURE AND FUNCTION ........................................................................ 2 
1.1.1 Replication, transcription and translation of the mammalian mitochondrial genome
 3 
1.1.1.1 Replication .............................................................................................................................. 4 
1.1.1.2 Transcription ........................................................................................................................... 5 
1.1.1.3 Translation .............................................................................................................................. 5 
1.1.2 OXPHOS ................................................................................................................ 7 
1.1.3 Mitochondrial genetics in the context of diseases ................................................. 9 
1.1.3.1 Aminoacyl-tRNA synthetase-related diseases ..........................................................................11 
1.2 MITOCHONDRIAL STRESS SIGNALLING ................................................................................. 13 
1.2.1 Mitochondrial unfolded protein response (UPRmt) ............................................... 13 
1.2.1.1 The UPRmt in C.elegans ...........................................................................................................14 
1.2.1.2 The mammalian UPRmt............................................................................................................15 
1.3 INTEGRATED STRESS RESPONSE (ISR) ................................................................................. 17 
1.3.1 Initiation, progression and termination of the ISR ............................................... 18 
1.3.1.1 The four eIF2α kinases ............................................................................................................19 
1.3.1.2 eIF2α phosphorylation represents the core event of the ISR ....................................................19 
1.3.1.3 Activating transcription factor 4 (ATF4) ...................................................................................21 
1.3.1.4 eIF2α de-phosphorylation terminates the ISR ..........................................................................21 
1.3.2 Outcome of the ISR ............................................................................................. 22 
1.3.3 CCAAT/enhancer-binding protein family (C/EBP) ................................................. 23 
1.3.3.1 C/EBP-homologous protein (CHOP) .........................................................................................23 
1.4 OBJECTIVES .................................................................................................................. 24 
2 MATERIALS AND METHODS ............................................................................................. 26 
2.1 MOUSE EXPERIMENTS ..................................................................................................... 26 
2.1.1 Animal care and breeding ................................................................................... 26 
  
IV 
2.1.2 Experimental mouse models ............................................................................... 27 
2.1.3 Phenotyping ....................................................................................................... 28 
2.1.3.1 Sampling ................................................................................................................................28 
2.1.3.2 Body weight determination ....................................................................................................28 
2.1.3.3 Blood glucose measurement ...................................................................................................28 
2.1.3.4 In vivo protein translation assessment ....................................................................................28 
2.2 CELL CULTURE............................................................................................................... 29 
2.2.1 Maintenance of cultured cells ............................................................................. 29 
2.2.2 Cryopreservation ................................................................................................ 29 
2.2.3 Cellular treatments ............................................................................................. 30 
2.2.4 Transfection and selection of stably-transfected cells .......................................... 30 
2.3 MOLECULAR BIOLOGY ..................................................................................................... 30 
2.3.1 Isolation of genomic DNA.................................................................................... 30 
2.3.1.1 Isolation of crude DNA ............................................................................................................30 
2.3.1.2 Isolation of purified DNA.........................................................................................................31 
2.3.2 Isolation of total RNA .......................................................................................... 31 
2.3.3 Quantification of nucleic acids ............................................................................ 32 
2.3.4 Polymerase chain reaction (PCR) ......................................................................... 32 
2.3.4.1 Genotyping PCR ......................................................................................................................32 
2.3.4.2 Reverse transcriptase PCR (RT-PCR) ........................................................................................33 
2.3.4.3 Quantitative real-time PCR (qPCR) ..........................................................................................34 
2.3.4.4 mtDNA quantification .............................................................................................................35 
2.3.5 Transformation of chemically compentent E. coli .............................................. 35 
2.3.6   Preparative and analytical scale plasmid DNA purification from E. coli .............. 36 
2.3.7   Agarose gel electrophoresis .............................................................................. 36 
2.3.8   DNA gel extraction ............................................................................................ 36 
2.3.9   DNA sequencing ................................................................................................ 37 
2.3.10 Q5 site directed mutagenesis ............................................................................ 37 
2.3.11 Northern blot analysis for mitochondrial mRNA quantification .......................... 37 
2.4 BIOCHEMISTRY .............................................................................................................. 38 
2.4.1 Isolation of proteins ............................................................................................ 38 
2.4.1.1 Protein extraction from cardiac tissue .....................................................................................38 
2.4.1.2 RIPA lysis of cultured cells .......................................................................................................38 
2.4.2 SDS polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot ................ 38 
2.4.3 Isolation of cardiac mitochondria ........................................................................ 41 
2.4.4 Mitochondrial respiration ................................................................................... 41 
2.4.5 Blue native polyacrylamide gel electrophoresis (BN-PAGE) .................................. 41 
  
V 
2.4.6 In organello translation....................................................................................... 42 
2.5 HISTOLOGY .................................................................................................................. 43 
2.5.1 Cryostat sections ................................................................................................ 43 
2.5.2 Hematoxilin and eosin (H&E) staining ................................................................. 43 
2.5.3 COX/ SDH staining .............................................................................................. 43 
2.5.4 Transmission electron microscopy ....................................................................... 44 
2.6 OMIC ANALYSES ............................................................................................................ 44 
2.6.1 Label-free quantification of the cardiac proteome ............................................... 44 
2.6.2 CHOP co-immunoprecipitation (co-IP) and subsequent mass-spectrometrical 
quantification of purified proteins................................................................................... 45 
2.6.3 RNA sequencing (RNAseq) of cardiac total mRNA ................................................ 46 
2.6.4 Amino acid quantification ................................................................................... 46 
2.6.5 Metabolomics ..................................................................................................... 46 
2.7 SOFTWARE ................................................................................................................... 47 
2.8 NOMENCLATURE ........................................................................................................... 47 
2.9 CHEMICALS .................................................................................................................. 47 
3 RESULTS ........................................................................................................................... 53 
3.1.1 Generation of DARS2/CHOP double knock-out mice ............................................ 53 
3.1.2 Phenotypic changes caused by deletion of dars2 develop prematurely upon loss of 
CHOP  ........................................................................................................................... 55 
3.1.3 Mitochondrial and cellular stress responses activated in DARS2 KO and DKOL mice . 
  ........................................................................................................................... 67 
3.1.3.1 Omics analyses showcase transcriptional and translational changes of ATF4 targets as a central 
aspect of the response to mitochondrial dysfunction in DARS2 KO and DKO mice ....................................67 
3.1.3.2 ISR activation in DKOL exceeds the degree of activation in age-matched DARS2 KO mice ..........70 
3.1.3.3 The ISR is the earliest detected activated stress pathway in DKO animals .................................73 
3.1.3.4 UPRmt and ISR show different degrees of activation during the terminal stages of DARS2 KO and 
DKOL animals, respectively .....................................................................................................................75 
3.1.3.5 Activation of the ISR results in inhibition of cytoplasmic protein synthesis in DKOE mice ...........78 
3.1.3.6 Re-initiation of cytoplasmic protein synthesis in DKOL animals coincides with further reinforced 
pathological changes ..............................................................................................................................79 
3.1.3.7 Despite CHOP deficiency the negative feedback loop of the ISR is activated in DKOL mice ........82 
3.1.3.8 Assessment of further potentially relevant, stress-related pathways ........................................83 
3.1.4 C/EBPβ is the only identified transcription factor interacting with CHOP in DARS2 
KO animals ..................................................................................................................... 88 
3.2 INVESTIGATING THE MITO-SPECIFIC MODULATION OF THE ISR IN VITRO ...................................... 89 
  
VI 
3.2.1 Cellular models of mitochondrial dysfunction and physiological impact of CHOP 
upon ISR activation ......................................................................................................... 89 
3.2.2 CHOP deficiency modulates the protein levels of C/EBPβ isoforms ....................... 92 
3.2.3 LIP and LAP act as functional antagonists for transcriptional regulation of atf4 .. 94 
4 DISCUSSION ..................................................................................................................... 97 
4.1 DARS2 KO MICE AS AN APPROPRIATE TOOL TO INVESTIGATE GENERAL STRESS RESPONSES INDUCED BY 
MITOCHONDRIAL DYSFUNCTION ................................................................................................. 98 
4.2 CHOP DEFICIENCY RESULTS IN SEVERE DEREGULATION OF THE ISR CHARACTERISED BY ATF4 OVER-
ACTIVATION ........................................................................................................................... 99 
4.3 FIRST IN VIVO EVIDENCE FOR A TRANSLATIONAL SWITCH FROM ACUTE TO CHRONIC ISR ............... 100 
4.4 PUTATIVE SIGNALS UPSTREAM OF EIF2Α PHOSPHORYLATION ................................................. 101 
4.5 CHOP IS NOT REQUIRED FOR IN VIVO ACTIVATION OF UPRMT MARKERS ................................... 103 
4.6 MITOCHONDRIAL DEFICIENCY INDUCED BY LOSS OF DARS2 ENTAILS CONSIDERABLE CHANGES IN CARDIAC 
METABOLISM THAT OCCUR PREMATURELY UPON CHOP DEFICIENCY ................................................. 104 
4.6.1 General pathological changes associated with mitochondrial dysfunction in the 
myocardium ................................................................................................................. 104 
4.6.2 ATF4-specific metabolic alterations induced by the activation of the ISR ........... 106 
4.7 THE INTERPLAY BETWEEN LIP AND CHOP IS ESSENTIAL FOR ADJUSTED TRANSCRIPTIONAL REGULATION 
OF ATF4 DURING SEVERE MITOCHONDRIAL DYSFUNCTION .............................................................. 107 
4.8 SUMMARY ................................................................................................................. 110 
REFERENCES ......................................................................................................................... 112 
ERKLÄRUNG ......................................................................................................................... 133 
  
VII 
List of Figures 
Figure 1.1: Organisation of the human mtDNA. ......................................................................... 3 
Figure 1.2: Replication of human mtDNA according to the strand displacement model (SDM). .. 5 
Figure 1.3: Mitochondrial translation in humans. ...................................................................... 7 
Figure 1.4: The mitochondrial OXPHOS system. ......................................................................... 8 
Figure 1.5: Heteroplasmy, the threshold effect and the genetic bottleneck. ............................. 10 
Figure 1.6: Reported mutations of mitochondrial aminoacyl-tRNA synthetase-encoding genes in 
humans and the corresponding organ system affected by the respective mutations.... 12 
Figure 1.7: Mitochondrial dysfunction in C.elegans induces cytoplasmic accumulation and 
subsequent nuclear translocation of ATFS-1 resulting in activation of UPRmt target genes.
................................................................................................................................... 15 
Figure 1.8: The four axes of mammalian UPRmt. ...................................................................... 16 
Figure 1.9: The ISR - a retrograde signalling cascade. .............................................................. 18 
Figure 1.10: Translation initiation on murine atf4 mRNA under regular conditions (upper part) or 
during eIF2B inhibition (lower part). ........................................................................... 20 
Figure 3.1: Breeding scheme for generation of WT, DARS2 KO, CHOP KO and DKO mice. ......... 54 
Figure 3.2: Genotypic validation of WT, CHOP KO, DARS2 KO and DKO mice. ........................... 54 
Figure 3.3: Phenotypic characterisation of DKO animals. ......................................................... 56 
Figure 3.4: DARS2 KO and DKOL hearts display pathological changes. ..................................... 58 
Figure 3.5: GO term analysis revealed strong enrichment of amino acid-related categories in 
DKOL mice................................................................................................................... 59 
Figure 3.6: Metabolic alterations induced by loss of DARS2 and CHOP result in overall elevated 
amino acid levels in DKOL mice. .................................................................................. 60 
Figure 3.7: Lack of CHOP in DARS2-deficient hearts promotes loss of the respiratory chain. ..... 62 
Figure 3.8: Mitochondrial translation defect in DKOL results in a respiratory defect at the 
organelle level. ........................................................................................................... 64 
Figure 3.9: DKOL mice accumulate high levels of citrate in cardiac tissue. ................................ 66 
Figure 3.10: RNAseq analysis suggests ATF4-like regulation of DARS2 KO and DKOL transcripts.
................................................................................................................................... 68 
Figure 3.11: Enhanced ATF4-like regulation of the DKOL proteome. ......................................... 69 
Figure 3.12: Distinct ISR activation in DARS2 KO mice is tremendously enhanced upon loss of 
CHOP. ......................................................................................................................... 72 
Figure 3.13: At p6 DKO animals provide first indications for ISR activation. ............................. 74 
Figure 3.14: DARS2 KO mice display upregulation of UPRmt markers at six weeks of age. ......... 75 
  
VIII 
Figure 3.15:  Loss of CHOP precedes ISR activation caused by DARS2 deficiency from six to less 
than three weeks of age. ............................................................................................ 77 
Figure 3.16: DKOE animals exhibit inhibition of protein synthesis and up-regulation of gadd34 
mRNA levels, two hallmarks of the ISR. ....................................................................... 78 
Figure 3.17: In contrast to the current model of the ISR, protein synthesis in DKOL mice is re-
initiated during the ISR. .............................................................................................. 80 
Figure 3.18: Mitochondrial translation and RC complex assembly of DKOE mice is comparable to 
WT mice. .................................................................................................................... 81 
Figure 3.19: CHOP deficiency in DARS2 KO mice does not affect the GADD34-mediated negative 
feedback loop of the ISR. ............................................................................................ 82 
Figure 3.20: GLUT4, 4EBP1 and p-4EBP1 protein levels are increased in DKOL mice.................. 84 
Figure 3.21: DKOL mice exhibit increased p62 protein levels..................................................... 85 
Figure 3.22: Neither DARS2 KO nor DKOL mice display signs of altered apoptotic cell death. .... 86 
Figure 3.23: DKOL mice increase protein folding capacity of the ER lumen by augmented BiP 
protein levels. ............................................................................................................. 87 
Figure 3.24: Mitochondrial dysfunction-induced ATF4 up-regulation is fully attributable to ISR 
activation. .................................................................................................................. 90 
Figure 3.25: Inhibition of the ISR induced by mitochondrial dysfunction is beneficial under 
conditions of CHOP deficiency. .................................................................................... 92 
Figure 3.26: CHOP-deficient cells exhibit an altered response to mitochondrial dysfunction on the 
level of the C/EBPβ isoforms. ...................................................................................... 93 
Figure 3.27:  Nuclear retention of LIP represses transcriptional activation of ATF4................... 95 
Figure 4.1: Model of CHOP-mediated nuclear retention of LIP, exerting repressive effects on the 
Atf4 promoter. ......................................................................................................... 109 
Figure 4.2: Events contributing DKO mice pathology. ............................................................ 110 
 
 
 
 
 
 
 
  
IX 
List of Tables 
Table 2.1: Primers used for qPCR ............................................................................................. 34 
Table 2.2: Primers used for mtDNA quantification ................................................................... 35 
Table 2.3: Antibodies, suppliers and catalogue numbers of antibodies used for Western blot .. 40 
Table 3.1: RNAseq data suggest activation of the UPRmt in DKOL mice. .................................... 70 
Table 3.2: Significantly changed proteins (q<0.05) determined by label-free quantitative 
proteomics of cardiac samples at p6 in DKO vs. WT mice. ........................................... 73 
Table 3.3: Significantly enriched proteins (p<0.05, FC>2) isolated by CHOP co-
immunoprecipitation and identified by subsequent mass spectrometry....................... 88 
  
X 
Abbreviations 
°C  Degree Celcius  
35S-met Radioactive methionine isotope 
A Adenosine 
ADP  Adenosine diphosphate  
AFG3L2 AFG3-like protein 2 
AKT RAC-alpha serine/threonine-protein kinase 
AMP  Adenosine monophosphate  
AMPK 5'-AMP-activated protein kinase 
APS Ammonium persulfate 
ASNS Asparagine synthetase 
ATF Activating transcription factor 
ATFS-1 Stress activated transcription factor 1 (C.elegans) 
ATP  Adenosine triphosphate  
BiP Binding-immunoglobulin protein 
BN Blue native 
bp Base pairs 
BSA  Bovine serum albumin  
C Cytosine 
CI Complex I 
CII Complex II 
CIII Complex III 
CIV Complex IV 
CV Complex V 
C/EBP CCAAT-enhancer-binding protein 
CAA  Chloroacetamide  
cAMP Cyclic AMP 
cDNA  Complementary DNA  
CHOP C/EBP-homologous protein 
Ci Curie 
Ckmm Muscle creatine kinase 
CLPP Caseinolytic mitochondrial matrix peptidase proteolytic subunit 
clpp-1  Caseinolytic mitochondrial matrix peptidase proteolytic subunit (C.elegans) 
COX Cytochrome c oxidase 
Cre  Bacteriophage P1 derived site-specific recombinase  
Cyt Cytochrome 
DARS2 Mitochondrial aspartyl-tRNA synthetase 
DBD DNA binding domain 
(d)dH2O (Double) distilled Water 
DKO Double knock-out 
  
XI 
DMSO Dimethyl sulfoxide 
DNA       Deoxyribonucleic acid  
DNase Deoxyribonuclease 
dNTP     Desoxy-ribonucleoside triphosphate  
dsRNA Double-stranded ribonucleic acid 
DTT       Dithiothreitol  
e.g. Exempli gratia 
ECL Enhanced chemiluminescence 
EDTA    Ethylenediaminetetraacetic acid  
EGTA Ethylene glycol tetraacetic acid 
eIF2α α subunit of the eukaryotic initiation factor 2 
ER Endoplasmatic reticulum 
EtBr Ethidiumbromide 
ETC Electron transport chain 
EtOH     Ethanol  
ETS Electron transfer system 
FAO       Fatty acid oxidation  
FC Fold change 
FCCP     Carbonylcyanide p-(trifluoromethoxy)phenylhydrazone  
Fe-S Iron-sulfur 
fl             Floxed, loxP flanked  
FMN Flavin mononucleotide 
G Gunanine 
g  Gravitational acceleration (9.81m/s2)  
GBP5 Guanylate-binding protein 5 
GCN2 general control non-derepressible protein 2 
h Hour 
H&E       Hematoxylin and eosin  
H2O2        Hydrogen peroxide  
HCl         Hydrogen chloride  
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HRI Heme-regulated inhibitor 
HRP       Horseradish peroxidase  
HSP Heavy strand promoter 
IAA        Iodoacetamide  
IMM Inner mitochondrial membrane 
IMS Intermembrane space 
IRE1a Inositol-requiring protein 1 
ISR Integrated stress response 
KCl Potassium chloride 
KCN       Potassium cyanide  
  
XII 
kDa        Kilo Dalton  
KO          Knock-out  
LONP-1 Lon protease homolog, mitochondrial (C.elegans) 
LONP1 Lon protease homolog, mitochondrial 
LSP Light strand promoter 
M            Molar (g/mol) 
MEFs Mouse embryonic fibroblasts 
MeOH    Methanol  
mA Milli-Ampere 
mg            Milli-gram 
MgCl2    Magnesium chloride  
min Minute 
ml              Milli-litre  
mM Milli-molar  
mRNA  (Messenger) ribonucleic acid  
mt Mitochondrial 
mtARS Mitochondrial aminoacyl-tRNA synthetase 
mtDNA  Mitochondrial DNA  
mtEF Mitochondrial elongation factor 
MTHFD2 Mitochondrial methylenetetrahydofolate dehydrogenase 
mtIF Mitochondrial initiation factor 
mtLSU Mitochondrial large ribosomal subunit 
mTOR Mammalian target of rapamycin 
mtRF Mitochondrial release factor 
mtRRF1 Mitochondrial ribosomal release factor 1 
MTS Mitochondrial targeting sequence 
mtSSB Mitochondrial single strand binding protein 
mtSSU Mitochondrial small ribosomal subunit 
NaCl       Sodium chloride  
NAD+     Nicotinamide adenine dinucleotide (oxidised)  
NADH    Nicotinamide adenine dinucleotide (reduced)  
NADP+  Nicotinamide adenine dinucleotide phosphate (oxidised)  
NADPH  Nicotinamide adenine dinucleotide phosphate (reduced)  
NaF        Sodium fluoride  
NaH2PO4 Monosodium phosphate 
NaN3      Sodium azide  
NaOH    Sodium hydroxide  
nDNA Nuclear DNA 
NES Nuclear export sequence 
ng Nano-gram 
NLRP3 NACHT, LRR and PYD domains-containing protein 3 
  
XIII 
NLS Nuclear localisation signal 
O2            Molecular oxygen  
OMM Outer mitochondrial membrane 
ORF Open reading frame 
OXPHOS  Oxidative phosphorylation  
p Postnatal day 
PAGE     Polyacrylamide gel electrophoresis  
PARP protein poly-ADP-ribosyltransferase 
PBS(T)  Phosphate buffered saline (with Tween)  
PCR        Polymerase chain reaction  
PERK PKR-like ER kinase 
PKR Double-stranded RNA-dependent protein kinase 
POLG DNA polymerase gamma 
POLRMT DNA-directed RNA polymerase, mitochondrial 
PYCR1 Pyrroline-5-carboxylate reductase 
qPCR Quantitative polymerase chain reaction 
RC Respiratory chain 
RNase Ribonuclease 
ROS Reactive oxygen species 
rpm       Revolutions per minute  
rRNA Ribosomal ribonucleic acid 
RT          Room temperature  
RT-PCR Reverse transcription polymerase chain reaction 
SD  Standard deviation  
SDH Succinate dehydrogenase 
SDS Sodium dodecyl sulfate 
sec Second 
SHMT2 Mitochondrial serine hydroxymethyltransferase 
SU Subunit 
TAD Transactivation domain 
TBE        Tris borate EDTA  
TBS(T) Tris buffered saline (with Tween) 
TCA Tircarboxylic acid cycle, citrate cycle, Krebs cycle 
TE Tri-EDTA buffer 
TEAB     Triethylammonium bicarbonate  
TEFM Transcription elongation factor of mitochondria 
TEFM Transcription elongation factor, mitochondrial 
TEM       Transmission electron microscopy  
TEMED  Tetramethylethylenediamine  
TES        [Tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid  
TF Transcription factor 
  
XIV 
TFAM transcription factor A, mitochondrial 
TFB2M Mitochondrial transcription factor B2 
tg Transgene 
Tris        Trisaminomethane  
tRNA Transfer ribonucleic acid 
Tween  Polyethylene glycol sorbitan monolaurate  
U             Units  
uORF Upstream open reading frame 
UPR       Unfolded protein response  
V Volt 
v/v Volume per volume 
w/v Weight per volume 
WT         Wild type  
ΔOTC Truncated ornithine transcarbamylase 
µg Micro-gram 
µL Micro-litre 
µM Micro-molar 
 
  
  
XV 
Abstract 
Maintenance of mitochondrial homeostasis is essential for a broad spectrum of 
signalling, metabolic and energetic processes. Consequently, mitochondrial dysfunction 
is linked to the development of a wide range of myopathies and many common diseases, 
including type 2 diabetes, Parkinson's and Alzheimer's diseases.  
In response to disturbed mitochondrial proteostasis, an organelle-specific stress 
response is initiated, which results in an adaptive transcriptional response partially 
sharing the signature of the integrated stress response (ISR).  
However, the exact sequence of events of the signalling cascade resulting in the 
activation of a nuclear response remains elusive. CHOP was one of the first transcription 
factors (TFs) proposed to play a role in response to impaired mitochondrial proteostasis. 
Although - due to the lack of a functional DNA-binding domain - CHOP needs to form 
heterodimers with other TFs in order to activate or suppresses respective target genes.  
The present study aims to investigate the molecular aspects and in vivo functions of 
CHOP in a murine model of mitochondrial dysfunction. Therefore, DARS2/CHOP double-
deficient mice, from now referred to as double knock-out (DKO) mice, were generated. 
Disruption of mitochondrial translation by heart and skeletal muscle-specific knock-out 
of the mitochondrial aspartyl-tRNA synthetase Dars2 (DARS2 KO) results in severe 
mitochondrial dysfunction and causes the death of the animals with approximately seven 
weeks of age. Additional deletion of Chop even further reduces the lifespan to less than 
three weeks, suggesting an existential role of the TF within the initiated stress-signalling 
pathway. Our data indicate that CHOP's impact arises from the regulation of another TF: 
ATF4. The analysis of transcriptomic data uncovered excessive transcriptional activation 
of ATF4 targets in DKO mice. Those massive changes were further confirmed on the 
protein level and coincide with the rapid deterioration of the animal's health status. 
Co-immunoprecipitation experiments revealed the TF C/EBPβ as the most abundant 
CHOP interactor in hearts of DARS2 KO mice. Further experiments in cell culture 
showed that under normal conditions, mitochondrial dysfunction triggers CHOP and 
C/EBPβ protein expression. C/EBPβ has three isoforms: LAP*, LAP and LIP. In 
comparison to the isoforms LAP* and LAP, LIP exhibited a disproportionate increase 
under conditions of mitochondrial dysfunction. Our experiments confirmed opposite 
effects of LAP and LIP on Atf4 transcription. Whereas LAP promoted Atf4 transcription, 
LIP acted as a transcriptional repressor of Atf4. Notably, CHOP deficiency in the context 
of mitochondrial dysfunction resulted in an impaired response of LIP in particular, which 
failed to increase on the protein level as observed under wild type-like conditions. Hence 
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we propose, that the impairment of LIP accumulation upon mitochondrial dysfunction in 
a CHOP-deficient background results in loss of negative regulation of Atf4 transcription 
in DKO animals. As a result, ATF4 is exceedingly active and causes an anabolic 
overstress of the mice. We propose to complement the current ISR model by a 
supplementary CHOP and LIP-driven regulatory layer, contributing to the transcriptional 
control of Atf4 in the context of mitochondrial dysfunction. 
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Zusammenfassung 
Zahlreiche zelluläre Kommunikations-, Stoffwechsel- und Energiebereitstellungs-
Prozesse sind stark von der Aufrechterhaltung der mitochondriellen Homöostase 
abhängig. Folglich sind mitochondrielle Dysfunktionen eng mit einem weiten Spektrum 
an Erkrankungen, unter anderem vielen Myopathien aber auch allgemeineren 
Krankheiten (z.B. Typ 2 Diabetes, Parkinson und Alzheimer), verknüpft. 
Die Störung der mitochondriellen Proteostase induziert eine Organellen-spezifische 
Stressantwort. Es folgt die Aktivierung einer adaptiven, transkriptionellen Antwort, 
welche über eine große Schnittmenge mit der sogenannten Integrierten Stressantwort 
(ISA) verfügt. 
Allerdings ist der genaue Ablauf der Signalkaskade, die in die Aktivierung der nuklearen 
Antwort mündet, nur ansatzweise bekannt. Einer der ersten Transkriptionsfaktoren (TF), 
welcher mit der nuklearen Antwort infolge von einer gestörten mitochondriellen 
Proteostase in Verbindung gebracht wurde, ist CHOP. Aufgrund einer defizitären DNA-
Bindungsdomäne von CHOP ist zu beachten, dass dieser TF für die Repression bzw. 
Aktivierung von Ziel-Genen auf die Bildung von Heterodimeren angewiesen ist.  
Ziel der vorliegenden Studie ist die Untersuchung der molekularen Aspekte sowie in vivo 
Funktionen von CHOP in einem Mausmodell mit bestehender mitochondrieller 
Dysfunktion. Für diesen Zweck wurde eine DARS2/CHOP doppel-defizitäre Mauslinie 
generiert, welche nachfolgend als Doppel-Knockout (DKO)-Mauslinie bezeichnet wird. 
Die Herz- und Skelettmuskel-spezifische Deletion der mitochondriellen aspartyl-tRNA-
Synthetase Dars2 (DARS2 KO) resultiert in einer schweren mitochondriellen Dysfunktion 
und führt im Alter von etwa sieben Wochen zum Tod der Mäuse. Eine zusätzliche 
Deletion von Chop führt zu einer weiteren Verkürzung der Lebenserwartung auf weniger 
als drei Wochen, was auf eine essenzielle Funktion von CHOP im Rahmen der 
induzierten Stressantwort hindeutet. Unseren Daten zufolge hat die Wirkung von CHOP 
ihren Ursprung in der Regulation eines weiteren TFs: ATF4. Die Auswertung der 
Transkriptom-Daten offenbarte eine exzessive, transkriptionelle Aktivierung von ATF4 
Ziel-Genen in DKO-Mäusen. Diese massiven Veränderungen wurden ebenfalls auf 
Proteinebene bestätigt und gingen einher mit einer rapiden Verschlechterung des 
Allgemeinzustands der Tiere. 
 
Der TF C/EBPβ wurde mittels Co-Immunpräzipitation als der am häufigsten auftretende 
Interaktionspartner von CHOP in Herzen von DARS2 KO-Mäusen identifiziert. 
Weiterführende Versuche auf Zellkulturebene zeigten, dass unter normalen Umständen 
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mitochondrielle Dysfunktion die Expression der Proteine CHOP und C/EBPβ induziert. 
C/EBPβ tritt in drei Isoformen auf: LAP*, LAP und LIP. Bei vorliegender mitochondrieller 
Dysfunktion wies LIP, im Gegensatz zu den beiden anderen Isoformen LAP* und LAP, 
einen überproportional starken Anstieg auf Proteinebene auf. Unsere Versuche 
bestätigten gegensätzliche Effekte von LAP und LIP auf die Atf4-Transkription. Während 
LAP sich positiv auf die Atf4-Transkription auswirkte, agierte LIP als trankriptioneller 
Atf4-Repressor. Bemerkenswerterweise resultierte die CHOP-Defizienz im Kontext 
mitochondrieller Dysfunktion in einer beeinträchtigten Antwort von LIP. Der auf 
Proteinebene beobachteter Anstieg des TFs LIP im Wildtyp versagte bei CHOP-
Defizienz. Daraus leiten wir den Verlust der negativen Regulation der Atf4-Transkription 
aufgrund eines fehlenden Anstiegs von LIP auf Proteinebene bei Abwesenheit von 
CHOP als Ursache für den beobachteten Phänotyp in DKO-Tieren ab. Die resultierende 
übermäßige Aktivierung von ATF4 führt zu einer anabolischen Überlastung der Mäuse. 
Aufbauend darauf schlagen wir eine Erweiterung des gegenwärtigen Modells der ISA 
um eine zusätzliche CHOP- und LIP-gesteuerte regulatorische Ebene vor, welche zur 
transkriptionellen Kontrolle von Atf4 im Kontext mitochondrieller Dysfunktion beiträgt. 
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1 Introduction 
The major difference between eukaryotic and prokaryotic cells is a distinct nuclear 
compartment separated by a double membrane from the cytoplasm. The high degree of 
compartmentalisation provided by the endomembrane system in eukaryotic cells eases 
a spatial separation and thereby allows the simultaneous operation of cellular processes 
requiring different micro-environments. Mitochondria represent one of the oldest 
endomembrane systems in eukaryotes. They are the product of a long chain of 
evolutionary steps that started approximately 1.5 billion years ago when the 
atmosphere’s oxygen levels dramatically increased. The seminal event of this 
evolutionary process was the engulfment of an aerobic α-proteobacterium by an 
ancestral eukaryotic cell, followed by a plethora of incidents comprising major events 
such as endosymbiotic gene transfer and the acquisition of additional metabolic functions 
beyond aerobic synthesis of ATP by mitochondria (Friedman and Nunnari, 2014; John 
and Whatley, 1975; Kurland and Andersson, 2000; Margulis, 1970; Timmis et al., 2004). 
According to the hypothesis proposed by Nick Lane and William Martin the complexity 
of eukaryotic life has its origin in the acquisition of mitochondria, enabling organisms to 
overcome the bioenergetic limitation of the prokaryotic genome size (Lane and Martin, 
2010). 
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1.1 Mitochondrial structure and function 
The outer appearance of mitochondria is subject to a certain variability reaching from a 
tubular network to spherical bodies, as reflected by the greek words for thread (“mitos”) 
and granule (“chondros”) from which the organelle’s name was derived. Whether the 
complex mitochondrial reticulum tends towards the one or the other is determined by the 
dynamic balance of fusion and fission events (Ernster and Schatz, 1981; Friedman and 
Nunnari, 2014; Westermann, 2010). Two membranes, the outer and inner mitochondrial 
membrane (OMM and IMM, respectively), separate the mitochondrial compartments, the 
intermembrane space (IMS) and the matrix, from the cytoplasm. Both membranes clearly 
distinguish from each other regarding features such as surface area/topology, lipid 
composition, membrane-embedded protein complexes or ion permeability. Whereas the 
OMM surrounds the organelle, the IMM is structured into the inner boundary and the 
cristae membrane. Cristae are infoldings of the IMM that are stabilized by the MICOS 
complex at cristae junctions, the interface of cristae and inner boundary membrane as 
well as a contact site between IMM and OMM (Ernster and Schatz, 1981; Rampelt et al., 
2017). 
The mitochondrial matrix harbours multiple copies of the circular, polycistronic 
mitochondrial genome (mtDNA) as well as the whole mitochondrial genetic system 
ensuring maintenance, replication and transcription of mtDNA as well as the subsequent 
translation of mtDNA-encoded proteins (Jacobs and Holt, 1998). The outreach of the 
endosymbiotic gene transfer mentioned earlier becomes apparent from the ratio of 
nuclear DNA (nDNA) to mtDNA-encoded proteins: In mammalian cells, only 13 out of 
approximately 1500 mitochondrial proteins are encoded by the mtDNA, along with 22 
tRNAs and two rRNAs. MtDNA-encoded proteins are unanimously part of the IMM-
embedded oxidative phosphorylation system (OXPHOS), converting NADH and FADH2 
generated in the matrix to a proton gradient across the IMM and subsequently to ATP 
(Anderson et al., 1981; Lodish et al., 2008; Lopez et al., 2000). 
Mitochondria house many metabolic pathways. Most central for energy metabolism is 
the TCA cycle, oxidising acetyl-CoA moieties to CO2, thereby feeding NADH and FADH2 
to complex (C) I and CII, respectively. Acetyl-CoA is provided either by (i) carbohydrate 
breakdown through cytoplasmic glycolysis, (ii) β-oxidation of fatty acids in the matrix or 
(iii) mitochondrial ketone body oxidation and branched-chain amino acid (BCAA) 
catabolism (Akram, 2014; Spinelli and Haigis, 2018). Apart from its catabolic role, the 
TCA cycle fulfils also many anabolic functions as it provides numerous precursors for 
e.g. fatty acid, amino acid or heme synthesis (Owen et al., 2002). Consequently, 
mitochondria are biosynthetic hubs and, in addition to the before-mentioned synthetic 
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pathways, are also involved in essential processes such as iron-sulphur cluster and 
nucleotide synthesis. Aside from bioenergetics and biosynthesis, mitochondria make an 
important contribution to detoxification, as they ensure the conversion of toxic ammonia 
generated by amino acid catabolism into urea for excretion by means of the urea cycle 
(Spinelli and Haigis, 2018). Furthermore, mitochondria are known as signalling 
organelles, communicating for instance via reactive oxygen species (ROS), Ca2+ or 
acetyl-CoA, and are involved in cell fate-determining processes such as apoptosis 
(Chandel, 2015; Wang and Youle, 2009). 
1.1.1 Replication, transcription and translation of the 
mammalian mitochondrial genome 
MtDNA is a polycistronic organised, circular genome of 16.6 kb in mammals, present in 
100 to 10.000 copies per cell (Figure 1.1). It consists of a guanine-rich heavy (H) strand, 
encoding the vast majority of transcripts, and a complement cytosine-rich light (L) strand. 
With 93% of coding sequences in total and entirely devoid of introns, mtDNA exhibit an 
extremely high gene density in comparison to nDNA. However, there is also a large non-
coding region (NCR) with an approximate length of 1kb. The NCR contains several 
regulatory elements, such as the L-strand promoter (LSP), H-strand promoter (HSP) or 
the origin of replication of the H-strand (OH) as well as the displacement loop (D-loop) 
region. The origin of replication of the L-strand (OL) is located approximately 11 kb 
downstream of the OH (Anderson et al., 1981; Andrews et al., 1999). 
 
Figure 1.1: Organisation of the human mtDNA. 
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The vast majority of transcripts (twelve mRNAs, two rRNAs [marked in green] and 14 tRNAs 
[marked in blue]) is encoded on the H-strand of mtDNA. Consequently, the L-strand encodes one 
mRNA and eight tRNAs. Among the 13 proteins of the respiratory chain (RC) encoded by the 
mitochondrial genome are seven subunits (SUs) of CI [marked in red], one SU of CIII [marked in 
orange], three SUs of CIV [marked in violet] and two SUs of CV [marked in yellow]. CII is the only 
complex of the RC fully encoded by the nuclear genome. Non-coding regions are shown in white. 
The large NCR of about 1 kb comprises the HSP, LSP, OH and the D loop. Reprinted from (Schon 
et al., 2012). 
1.1.1.1 Replication 
The mitochondrial genome is organised in nucleoids of ~100nm in diameter, with mtDNA 
and TFAM (transcription factor A, mitochondrial) as major components of these 
nucleoprotein complexes (Bogenhagen, 2012; Kukat et al., 2011). MtDNA in nucleoids 
can be stored, but also actively replicated. It has been shown, that mitochondrial division 
occurs at ER-mito contact points and that actively replicating nucleoids localize to those 
regions of future division, allowing coordination of mtDNA synthesis and mitochondrial 
division (Lewis et al., 2016). 
Although other models were suggested in-between, the currently most widely accepted 
model of mtDNA replication is the strand displacement model (SDM) already proposed 
in the early 1970ies. The SDM is characterized by continuous synthesis of both, OH and 
OL (Robberson et al., 1972). POLRMT (DNA-directed RNA polymerase, mitochondrial) 
is required for the synthesis of short RNA sequences at OH and OL, in order to prime the 
respective strands for subsequently POLγ (DNA polymerase gamma)-mediated 
synthesis of mtDNA (Wanrooij et al., 2008). The Twinkle DNA helicase performs 
unwinding of the double-stranded mtDNA. DNA synthesis of the H-strand starts at OH 
and progresses continuously until OL is reached. Until then the L-strand is not 
synthesized, therefore the parental H-strand is bound by mtSSB (mitochondrial single-
strand binding protein) to prevent random initiation of transcription by POLRMT (Miralles 
Fuste et al., 2014). Hence, the SDM represents an asynchronous mode of replication. 
As soon as OL is passed, the synthesis of the L-strand is initiated, too. Ribonuclease H1 
most probably carries out primer removal. After termination of replication DNA ligase III 
ensures ligation of the newly synthesized strands and separation of both resulting 
daughter molecules mechanically linked via a hemi-catenane structure after termination 
of replication requires the enzymatic activity of topoisomerase 3α (Falkenberg, 2018). 
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Figure 1.2: Replication of human mtDNA according to the strand displacement model 
(SDM). 
The minimal human mitochondrial replisome is constituted of POLγ, Twinkle DNA helicase and 
mtSSB (Korhonen et al., 2004). POLRMT is required for primer synthesis. Reprinted from 
(Falkenberg, 2018). 
1.1.1.2 Transcription 
Besides its role in mtDNA packaging the DNA-binding protein TFAM was also shown to 
be a core component of the mitochondrial transcription machinery, allowing the 
recruitment of POLRMT during transcription initiation by inducing a sharp bend of the 
DNA upstream of the transcription start site at LSP and HSP (Morozov et al., 2014; Shi 
et al., 2012).  Subsequent binding of TFB2M (mitochondrial transcription factor B2) 
induces promoter melting and facilitates the formation of the open initiation complex 
(Posse and Gustafsson, 2017). The elongation process is launched by release of TFAM 
and TFB2M followed by recruitment of TEFM (transcription elongation factor, 
mitochondrial), that enhances the processivity of POLRMT, leading to synthesis of one 
single polycistronic precursor mRNA molecule for each strand. The synthesis of the 
replication priming short RNA sequences is most probably induced by absence of TEFM 
resulting in premature termination after initiation of transcription (Agaronyan et al., 2015; 
Minczuk et al., 2011). 
1.1.1.3 Translation  
Even though the mitochondrial translation machinery still carries traits recalling its 
bacterial ancestry as illustrated by the susceptibility of mitochondrial translation to 
antibiotics such as aminoglycosides or tetracyclines, it harbours several 
mitochondria-specific characteristics neither present in conventional prokaryotic or 
cytoplasmic eukaryotic translation (Hutchin et al., 1993; van den Bogert and Kroon, 
1981). This includes the high protein content of the 55S mitoribosome (formed by two 
Introduction 6 
mtDNA-encoded rRNAs and approximately 80 nDNA-encoded proteins), a codon usage 
deviant form the universal code (e.g. the stop codon UGA encodes for Trp in 
mitochondria) or the usage of one single tRNAMet for both, initiation and elongation, for 
example (Amunts et al., 2015; Chrzanowska-Lightowlers et al., 2011; Mikelsaar, 1983). 
Translation initiation (Figure 1.3) begins with the recruitment of the mRNA to the small 
subunit of the mitochondrial ribosome (mtSSU). During this phase mtSSU-bound mtIF 
(mitochondrial initiation factor) 3 prevents the premature association of the mtSSU with 
the large subunit of the mitochondrial ribosome (mtLSU) (Gaur et al., 2008; Haque and 
Spremulli, 2008; Mai et al., 2017). Subsequently, f-Met-tRNAMet is recruited by 
mtIF2:GTP to the start codon. Upon stable codon:anticondon interaction the formation 
of the monosome by interaction of the mtSSU with the mtLSU occurs, inducing hydrolysis 
of GTP and mtIF2/3 release in parallel. Elongation (Figure 1.3) requires the formation of 
a ternary complex comprising mtEF-Tu (mitochondrial elongation factor Tu), GTP and 
an aminoacylated tRNA (Mai et al., 2017; Tucker et al., 2011). As soon as a stable 
codon:anticondon interaction at the A-site of the ribosome forms, GTP hydrolysis allows 
peptide bond formation and release of mtEF-Tu. As a result, the ribosomal A-site 
contains a dipeptidyl tRNA and the P-site is occupied by an uncharged tRNA. A 
conformational change induced by mtEF-G results in release of the uncharged tRNA as 
well as the translocation of the dipeptidyl tRNA to the P-site (Cai et al., 2000). When the 
termination codon reaches the A-site, the protein mtRF1a induces the GTP-catalyzed 
release of the polypeptide chain from the mitoribosome in humans. The recycling of the 
mitoribosome for a new cycle of translation depends on mtRRF1(mitochondrial ribosomal 
recycling factor 1)  and mtEF-G2 triggering the dissociation of mtSSU and mtLSU (Figure 
1.3) (Rorbach et al., 2008; Soleimanpour-Lichaei et al., 2007; Tsuboi et al., 2009). 
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Figure 1.3: Mitochondrial translation in humans. 
Main components of the translation complex in the three respective translational stages: initiation, 
elongation and termination. E, P and A mark the mito-ribosomal E (exit), P (peptidyl) and A 
(aminoacyl)-sites. Reprinted from (Jhas, 2012). 
1.1.2 OXPHOS 
The OXPHOS system is composed of the complexes I-IV and the two electron carriers 
coenzyme Q and cytochrome c, forming the electron transport chain (ETC) and building 
up a proton gradient in the IMS, as well as CV, utilising the proton motive force generated 
by the ETC to synthesise ATP (Figure 1.4). Except for the water-soluble cytochrome c 
located in the IMS, all components of the OXPHOS system are embedded in the IMM 
(Papa et al., 2012). CV (also known as F1F0 ATP synthase) is organised in dimer rows 
and thereby induces the membrane curvature at the cristae ridges required for cristae 
formation. The ETC complexes are located in the cristae on both sides of the CV dimer 
rows (Arnold et al., 1998; Davies et al., 2012; Gilkerson et al., 2003).  
Briefly, the OXPHOS system has two entry points for electrons in the ETC: (i) CI, the 
NADH dehydrogenase, and (ii) CII, the succinate dehydrogenase. As indicated by the 
respective names, CI is fuelled by NADH whereas CII oxidises succinate to fumarate, 
using FADH2 as co-factor for the electron transfer. CI subsequently transfers two 
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electrons from NADH to coenzyme Q. The electron transfer is coupled to the 
translocation of four protons (H+) from the matrix to the IMS via four individual channels 
in CI. The oxidation of succinate by CII yields two more electrons. However, the transfer 
of those electrons from FADH2 to coenzyme Q is not releasing comparable amounts of 
energy as it is the case for NADH. Therefore no protons are translocated by CII 
(Baradaran et al., 2013; Rutter et al., 2010). Following the electron transfer from CI or II, 
coenzyme Q is oxidised by CIII through a series of subsequent reactions called the ‘Q’-
cycle, culminating in reduction of cytochrome c (Al-Attar and de Vries, 2013; Mitchell, 
1976). Finally, CIV (also known as the cytochrome c oxidase) oxidises four cytochrome 
c molecules utilising one oxygen molecule as the final electron acceptor. Per electron 
transferred by CIII and IV, both complexes pump one proton each into the IMS 
(Fontanesi et al., 2006; Kuhlbrandt, 2015). The electrochemical gradient resulting from 
the coupling of electron transfer and proton translocation by the ETC complexes is used 
for the rotatory catalysis of ATP by CV (Jonckheere et al., 2012). 
 
Figure 1.4: The mitochondrial OXPHOS system. 
Fuelled by the TCA cycle products NADH and FADH2, electron transport complexes I to IV 
generate an electrochemical gradient driving ATP synthesis by CV. UQ: ubiquinone (coenzyme 
Q). Reprinted from (Kuhlbrandt, 2015). 
The assembly of multi-enzyme complexes I-V is an intricate process requiring the 
synergistic cooperation of the nuclear and mitochondrial genome. As discussed earlier, 
all 13 mtDNA-encoded proteins are subunits (SUs) of the respiratory chain (RC) 
complexes I, III, IV and V and synthesised in the mitochondrial matrix. CI-V, however, 
consist of approximately 80 additional SUs encoded by the nDNA. Those proteins are 
synthesised in the cytosol and subsequently imported in mitochondria, where the 
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assembly of the RC, promoted by numerous assembly proteins, occurs (Falkenberg et 
al., 2007; Ghezzi and Zeviani, 2012).  
Various supra-molecular assemblies of the ETC complexes, so-called supercomplexes, 
have been observed. The largest one is the respirasome, constituted of one CIII dimer 
(III2) along with CI and up to four copies of CIV. The close proximity of the complexes 
might promote an economic electron transfer. Furthermore, the dynamic 
supra-molecular organisation of the ETC components could support an adapted 
oxidation depending on the substrates used to fuel the TCA cycle, since the ratio of 
generated NADH to FADH2 varies as a function of the TCA cycle-feeding upstream 
pathway (e.g. β-oxidation of fatty acids vs. glycolysis) (Lapuente-Brun et al., 2013; 
Schagger and Pfeiffer, 2000). 
1.1.3 Mitochondrial genetics in the context of diseases 
Mitochondrial disorders belong to the most common genetic disorders caused by 
mutations of mitochondrial genes. However, for several reasons, the diagnosis is highly 
challenging. First, the clinical symptoms emerge as extremely heterogeneous with 
regard to the affected tissues (isolated organs vs. multisystem disorders), the precise 
tissue-specific symptoms or the age of manifestation (neonatal phase, childhood or 
adulthood). Second, the phenotype-genotype correlation is very weak. Third, there is no 
limitation regarding the inheritance pattern: possible inheritance mechanisms comprise 
non-mendelian (maternal inheritance via mtDNA) and mendelian (X-linked, autosomal 
recessive or autosomal dominant) inheritance. Furthermore, de novo occurrence of 
mutations also need to be considered (Craven et al., 2017; Gorman et al., 2016; Schon 
et al., 2012; Vafai and Mootha, 2012). 
Mutations in mitochondrial genes are either localised in the nuclear or the mitochondrial 
genome. The former group of mutations typically affect the stability of mtDNA, comprise 
mutations in structural SUs or assembly factors of the respiratory chain, impact on 
mitochondrial translation or has other implications for instance on the mitochondrial 
network dynamics (Chinnery, 1993). The latter can be divided into two classes of mtDNA 
mutation variants: First, mtDNA rearrangements (e.g. deletions or inversions) most often 
resulting from replication errors or inefficient mtDNA repair machinery. Second, mtDNA 
point mutations representing either (i) neutral, non-pathogenic variations of the ancestral 
“mitochondrial Eve’s” mtDNA that gave rise to distinct mitochondrial haplogroups 
common in the population, or (ii) rare, pathogenic mtDNA mutations primarily in protein-
coding or tRNA genes (Chinnery, 1993; Schon et al., 2012). 
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Regarding pathologic mtDNA mutations, a further degree of complexity is added by the 
possible co-existence of two or more mtDNA genotypes within a mitochondrion, cell, 
tissue or organism, termed heteroplasmy (Figure 1.5a). In conclusion, the proportion of 
mutated mtDNA copies can vary from 0% to 100%, whereby both extremes correspond 
to a homoplasmic and all possible interjacent ratios to a heteroplasmic status (Craven et 
al., 2017; Larsson, 2010; Schon et al., 2012; Stefano et al., 2017). The phenotypic 
threshold effect describes the positive correlation between the percentage of mutated 
mtDNA and the severity of clinical symptoms observed up to a certain extent. Most often, 
low levels of mutations do not entail clinical symptoms. However, upon passing a certain 
threshold (usually 60-80% of heteroplasmy), the disease manifests as a mild disorder at 
an intermediate mutation level or as a severe disease at high mutation level (Figure 1.5a) 
(Larsson, 2010; Rossignol et al., 2003).  
 
Figure 1.5: Heteroplasmy, the threshold effect and the genetic bottleneck. 
(a) Disease-causing mtDNA mutations are predominantly heteroplasmic. Exceeding a certain 
tissue and mutation-specific threshold results in manifestation of the disease phenotype. (b) 
During oogenesis, only a fraction of mitochondria originating from the primary oocyte is 
transmitted to the mature oocyte possibly resulting, together with the subsequent mitochondrial 
biogenesis in the mature oocyte, in marked differences of heteroplasmy levels when comparing 
primary and mature oocyte. Reprinted from (Craven et al., 2017). 
Furthermore, random segregation of mitochondria upon cell division, as well as mitotic 
or post-mitotic nature of different tissues, can result in a variation of heteroplasmy levels 
over time. Random segregation results inter alia in a phenomenon called the “genetic 
bottleneck”, where the transmission of only a fraction of the mitochondria from the 
primary to the mature oocyte and the subsequent amplification of those respective 
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mitochondria can lead to significantly different heteroplasmy levels in the mature vs. the 
primary oocyte (Figure 1.5b) (Gorman et al., 2016; Stewart and Larsson, 2014).  
1.1.3.1 Aminoacyl-tRNA synthetase-related diseases 
The cluster of mitochondrial aminoacyl-tRNA synthetase-related diseases exemplarily 
reflects clinical heterogeneity of mitochondrial diseases. Phenotypes resulting from 
mutations in aminoacyl-tRNA synthetases range, among other things, from ovarian 
dysfunction over hearing loss to cardiomyopathies (Nunnari 2012). 
The canonical function of aminoacyl-tRNA synthetases (in the abbreviated form: ARSes 
or aaRSes) and a major prerequisite for protein synthesis is the charging of tRNAs with 
cognate amino acid residues. In the cytoplasm, one ARS per amino acid residue ensures 
tRNA aminoacylation for translation. Those 20 ARSes comprise two bi-functional 
synthetases, KARS (alternative terminology: LysRS) and GARS (GlyRS), showing dual 
localisation in both, cytoplasm and mitochondria. In addition to KARS and GARS, 17 
mito-specific aminoacyl-tRNA synthetases (in the abbreviated form: ARS2es or mt-
aaRSes) enable mitochondrial translation (Antonellis and green 2008). One worthy detail 
to note is that mitochondria appeared to lack the equivalent to cytoplasmic QARS 
(GlnRS), charging the tRNAGln. Instead, EARS2 (mt-GluRS) mischarges mt-tRNAGln with 
glutamic acid that is subsequently converted to glutamine by tRNA-dependent 
aminotransferases (Nagao 2009). 
Intriguingly, despite the essential canonical role in protein synthesis and the ubiquitous 
expression across all tissues, disease-causing mutations of distinct ARS-encoding 
genes exhibit a striking tissue-specificity (Figure 1.6).  
Introduction 12 
 
Figure 1.6: Reported mutations of mitochondrial aminoacyl-tRNA synthetase-encoding 
genes in humans and the corresponding organ system affected by the respective 
mutations. 
The dashed line functions as a placeholder for the lacking mitochondrial counterpart of the 
cytosolic QARS (GlnRS). Modified from (Sissler et al., 2017). 
ARS-mediated genetic diseases may be categorised in (i) dominant mutations, 
characterised by late-onset and a predominant impairment at the level of the central 
nervous system, and (ii) recessive, primarily loss-of-function mutations, characterised by 
early-onset and severe pathology affecting a wide range of tissues (Meyer-Schuman 
2017). With regard to the protein architecture of ARSes, mutations either affect (i) one of 
the substrate-binding sites (ATP, amino acid or tRNA terminal -CCA binding site) usually 
resulting in impaired or disrupted catalysis, (ii) the binding interface (concerns amino acid 
residues essential for specific binding of the ARS to the cognate tRNA or oligomer 
formation essential for the activity of certain ARSes) usually resulting in mischarging of 
tRNAs or misfolding of ARSes leading to inactive particles/ aggregates, or (iii) regions 
distant from known key functional regions (Sissler 2017). The first publication 
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characterising mutations in mitochondrial aminoacyl-tRNA synthetases described the 
autosomal recessive disease LBSL (leukoencephalopathy with brain stem and spinal 
cord involvement and lactate elevation) caused by DARS2-deficiency (Scheper 2007). 
1.2 Mitochondrial stress signalling  
As one of the first mitochondrial stress signalling pathways the concept of the retrograde 
response was born around 30 years ago. Pioneering work of the Butow laboratory on S. 
cerevisiae provided first evidence for the influence of nuclear gene expression by the 
functional state of mitochondria (Liao and Butow, 1993; Parikh et al., 1989; Parikh et al., 
1987). The retrograde response is a mitochondria-to-nucleus signalling pathway initiated 
in response to mitochondrial dysfunction by metabolic cues or straighter routes. It results 
in mostly adaptive rewiring of cellular metabolism or stress-related pathways, thereby 
representing a cellular adjustment orchestrated by the nucleus to the altered 
mitochondrial state in order to restore mitochondrial homeostasis (Butow and Avadhani, 
2004; Giannattasio et al., 2005).  
Following up on these fundamental findings, different types of retrograde communication 
pathways were also described in the mammalian system. One of the most 
straightforward examples is the signalling cascade initiated by energy deprivation. 
Briefly, the increase of AMP/ATP ratio activates AMPK, which in turn increases ATP 
production via several direct and indirect routes. Core events of AMPK signalling result 
in induction of mitochondrial biogenesis, and inhibition of mTOR signalling leading to 
reduced cell growth, lipid and protein synthesis (Bolster et al., 2002; Jäger et al., 2007). 
Other examples of retrograde signalling in mammals are the mitochondrial unfolded 
protein response (UPRmt) and in a wider definition, also the integrated stress response 
(ISR).  
1.2.1 Mitochondrial unfolded protein response (UPRmt) 
Roughly two decades ago first experiments described transcriptional activation of the 
mitochondrial chaperones HSP10 and HSP60 by retrograde mitochondria-to-nucleus 
communication upon induction of protein folding stress in mammalian cells via loss of 
mtDNA (Martinus et al., 1996; Yoneda et al., 2004) or accumulation of protein aggregates 
in the mitochondrial compartment (Papa and Germain, 2014; Zhao et al., 2002). In 
analogy to the conceptually similar UPRER activated by endoplasmatic reticulum (ER)-
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specific perturbation of proteostasis, the stress response was named the UPRmt (Yoneda 
2004, Horibe 2007).  
Remarkable progress in decipherment of the UPRmt was made in C.elegans. Precise 
shaping of this pathway in the mammalian system, however, still challenges numerous 
research groups. To name but one example, the mere definition of the pathway used in 
the field is still very heterogenous. This is illustrated by two recent reviews on the UPRmt 
either limiting the definition to primary involvement of mitochondrial protein misfolding as 
causative agent (Münch, 2018) or extending it to a transcriptional response activated by 
multiple forms of mitochondrial dysfunction (Shpilka and Haynes, 2017). 
The effects of the UPRmt are not only limited to recovery of mitochondrial proteostasis by 
transcriptional activation of mitochondrial chaperones and proteases. In addition, it is 
commonly accepted that the UPRmt also exerts an important role in inducing profound 
metabolic adaptations representing a cellular adjustment to the altered mitochondrial 
state (Jovaisaite and Auwerx, 2015; Lin and Haynes, 2016; Topf et al., 2019). 
1.2.1.1 The UPRmt in C.elegans 
Over the years numerous methods triggering the UPRmt in C. elegans were established, 
reaching from OXPHOS impairment (e.g. knockdown or mutation of RC subunits) to 
disruption of the protein quality control system consisting of mitochondrial chaperones 
and proteases (e.g. knockdown of chaperones hsp-6 or hsp-60), among others (Baker 
et al., 2012; Durieux et al., 2011; Lin et al., 2016; Yoneda et al., 2004). All mentioned 
conditions finally culminate in the accumulation of unfolded proteins in the mitochondrial 
matrix that are subsequently degraded in short peptides by one of the two matrix 
proteases: ClpP-1 (ATP-dependent Clp protease proteolytic subunit 1, mitochondrial). 
Thereafter, the IMM ABC transporter HAF-1 is required for the active export of the 
generated peptides, presumably inhibiting the mitochondrial import of the TF ATFS-1 
(stress-activated transcription factor 1). ATFS-1 is characterised by a dual localisation 
signal, as it harbours a nuclear localisation sequence (NLS) as well as a mitochondrial 
targeting sequence (MTS). Under normal conditions, the MTS of the TF predominates 
the signal of the NLS. This results in preferential import of the protein into mitochondria, 
followed by ATFS-1 degradation mediated by the second matrix protease LONP-1 (Lon 
protease homolog, mitochondrial) (Harbauer et al., 2014; Haynes et al., 2007; Haynes 
et al., 2010; Nargund et al., 2012). As mentioned before, this process is prevented by 
the activation of the UPRmt and thus allows the NLS of ATFS-1 to take effect. ATFS-1-
mediated transcriptional activation was previously related to OXPHOS recovery, 
restoration of mitochondrial proteostasis, ROS detoxification and mitochondrial protein 
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import (Figure 1.7) (Arnould et al., 2015; Shpilka and Haynes, 2017). Besides ATFS-1 
another TF complex composed of DVE-1 (Homeobox domain-containing protein) and 
UBL-5 (Ubiquitin-like protein 5) was shown to be involved in the transcriptional regulation 
of the UPRmt in C.elegans (Haynes et al., 2007). 
 
Figure 1.7: Mitochondrial dysfunction in C.elegans induces cytoplasmic accumulation and 
subsequent nuclear translocation of ATFS-1 resulting in activation of UPRmt target genes.  
Reprinted from (Shpilka and Haynes, 2017). 
1.2.1.2 The mammalian UPRmt 
In mammals, the situation appears to be less clear (especially regarding the upstream 
signalling events of the stress response) and more complicated as it is the case in the 
before-mentioned nematode model system. A recent review proposed the subdivision of 
the mammalian UPRmt into four different axes (Figure 1.8): (i) The canonical UPRmt, that 
will be discussed in greater detail below. (ii) The UPRmt sirtuin axis promoting antioxidant 
activity. (ii) The UPRIMS/ERα axis, specifically activated by accumulated proteins in the 
IMS. (iii) The UPRmt translational axis, a local response to accumulation of unfolded 
proteins in the mitochondrial matrix resulting in reduced mRNA processing and thereby 
decreased mitochondrial protein translation (Münch, 2018). 
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Figure 1.8: The four axes of mammalian UPRmt. 
Reprinted from (Münch, 2018). 
Major findings of the canonical UPRmt were generated by the Hoogenraad laboratory 
using either ρ0 rat hepatoma H4 cells or simian kidney-derived COS-7 cells 
overexpressing a truncated version of the mitochondrial matrix protein ornithine 
carbamoyltransferase (ΔOTC) to induce the stress pathway (Martinus et al., 1996; Zhao 
et al., 2002). Core events of the mammalian UPRmt comprise the JNK2-dependent 
phosphorylation of the TF c-Jun, promoting mRNA expression of the TF CHOP (C/EBP 
homologous protein) (Aldridge et al., 2007; Horibe and Hoogenraad, 2007). The latter 
one appeared to exert – in association with the TF C/EBPβ (CCAAT/enhancer-binding 
protein beta) – an essential role for the transcriptional activation of the chaperones 
HSP10 and HSP60 (Aldridge et al., 2007; Zhao et al., 2002). In the course of their work, 
Hoogenraad and co-workers established an extensive list of UPRmt target genes, 
including chaperones, proteases and other mitochondrial proteins such as components 
of the mitochondrial import machinery (Horibe and Hoogenraad, 2007). However, only a 
mere fraction of these candidates mainly generated by reporter assays was confirmed 
as endogenous targets in the following years (Arnould et al., 2015). Still, CHOP proved 
to be a constant factor throughout the work of several research groups on retrograde 
signalling induced by mitochondrial dysfunction (Dogan et al., 2014; Forsstrom et al., 
2019; Horibe and Hoogenraad, 2007; Michel et al., 2015). Nonetheless it became 
apparent, that the induction of mitochondrial dysfunction by other types of stress such 
as neuron-specific DRP1 (Dynamin-1-like protein) deletion, depletion of mtDNA, 
Introduction 17 
inhibition of mitochondrial protein import, interference with mitochondrial translation or 
inhibition of the RC rather carry essential features of another stress response: the ISR 
(Ishikawa et al., 2009; Michel et al., 2015; Quirós et al., 2017; Restelli et al., 2018). Most 
likely, UPRmt and ISR at least partially overlap and participate in a complicated crosstalk.  
One of the first publications suggesting a possible interconnection of UPRmt and ISR 
analysed a murine model of intestinal bowel disease, where the ISR was shown to 
mediate the UPRmt via JNK phosphorylation by the ISR effector kinase PKR (Interferon-
induced, double-stranded RNA-activated protein kinase) (Rath et al., 2012). Notably, 
activation of the ISR preceding the UPRmt was also proposed in a model of arsenite-
mediated inhibition of the OXPHOS system (Rainbolt et al., 2013) as well as in a recently 
published stress response model termed the integrated mitochondrial stress response 
(ISRmt). In mammalian muscle, the ISRmt is characterised by sequential induction of 
distinct stages transcriptionally mediated by the TFs ATF5, ATF3 and ATF4 and followed 
by mild UPRmt activation during the terminal state (Forsstrom et al., 2019; Suomalainen 
and Battersby, 2017).  
1.3 Integrated stress response (ISR) 
Activation of the ISR can occur in response to a multitude of physiological and 
pathological conditions. Therefore, this pathway could be considered as an all-purpose 
response to stress aiming to aid cell survival, cell recovery and ‒ in cases of persisting 
stress ‒ execute apoptotic cell death. Extrinsic triggers are viral infection, glucose 
deprivation or hypoxia, among other things (Pakos‐Zebrucka et al., 2016). Intrinsically 
the ISR is, for instance, activated by mitochondrial dysfunction or ER protein folding 
stress (Harding et al., 1999; Quirós et al., 2017). The specific outcome with regard to the 
initiating stressors is regulated inter alia at the level of (i) duration and intensity of eIF2α 
(eukaryotic translation initiation factor 2A) phosphorylation or (ii) the translation of ATF4 
(activating transcription factor 4) and other bZIP transcription factors (Guan et al., 2014; 
Novoa et al., 2003; Scheuner et al., 2006). The key events of ISR signalling are 
summarised below (Figure 1.9). 
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Figure 1.9: The ISR - a retrograde signalling cascade. 
Integration of stress signals originating from different cellular compartments into one stress 
pathway is achieved via a set of four kinases at the regulatory level. The ISR core event is the 
phosphorylation of eIF2α, leading to inhibition of global protein synthesis and translation of stress-
responsive proteins like the key effector of the ISR: ATF4. Reprinted from (Pakos‐Zebrucka et 
al., 2016). 
1.3.1 Initiation, progression and termination of the ISR 
In mammals, ISR triggering events are sensed and processed by a set of four eIF2α 
kinases phosphorylating eIF2α at S51 (Ron, 2002). Each kinase detects a specific set of 
stress signals; however it was already shown for multiple conditions that the functions of 
these kinases partially overlap and a cooperative mode of action allows fine-tuning of 
the cellular response to a variety of stressors (Pakos‐Zebrucka et al., 2016).  All four 
kinases are characterised by a considerable homology of the catalytic domain and similar 
requirements (dimerisation followed by auto-phosphorylation) to achieve full activation  
(Donnelly et al., 2013).  
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1.3.1.1 The four eIF2α kinases 
PERK (PKR-like ER kinase) is the only membrane-embedded eIF2α kinase. It senses 
explicitly stress in the ER lumen that can be caused e.g. by perturbations of Ca2+ 
homeostasis or accumulation of unfolded proteins (Korennykh and Walter, 2012; Wang 
and Kaufman, 2016). The activation mechanism resulting in kinase dimerisation is still a 
matter of research as currently two models are proposed. First, dissociation of the under 
normal conditions PERK-bound ER chaperone BiP (binding-immunoglobulin protein) 
was proposed as the activating signal (Bertolotti et al., 2000; Carrara et al., 2015). 
Second, the direct binding of unfolded proteins to the luminal domain of PERK might 
cause the activation of the kinase (Gardner and Walter, 2011). 
PKR (double-stranded (ds) RNA-dependent protein kinase) differentiates from the other 
three kinases via its two N-terminal dsRNA binding domains (Saunders and Barber, 
2003). Those DSDBs allows PKR to sense dsRNA, e.g. originating from viral infections 
or released by mitochondria (Kim et al., 2018; Lemaire et al., 2008). 
HRI (heme-regulated inhibitor) exhibits a relative tissue-specific expression pattern as it 
is mainly expressed in erythroid cells (Han et al., 2001). Its primary function consists in 
the detection of iron deficiency by sensing heme levels via two heme-binding domains 
(Rafie-Kolpin et al., 2000). In case of low heme availability HRI inhibits the translation of 
globin mRNA by activation of the ISR and thereby prevents the accumulation of toxic 
globin aggregates in erythroid cells (Chefalo et al., 1998; Han et al., 2001). Other HRI-
activating signals are NO or arsenite-induced oxidative stress (Ill-Raga et al., 2015; 
McEwen et al., 2005). 
GCN2 (general control non-derepressible protein 2) is activated upon accumulation of 
uncharged tRNAs that the kinase detects via an histidyl-tRNA synthetase-related domain 
(Wek et al., 1995). Besides amino acid starvation, glucose deprivation and UV light are 
known to activate GCN2 (Deng et al., 2002; Ye et al., 2010). 
1.3.1.2 eIF2α phosphorylation represents the core event of the ISR 
As mentioned earlier, the activation of each eIF2α kinase cumulates in phosphorylation 
of eIF2α, the central hub of the ISR. As a consequence, global cytoplasmic protein 
synthesis is attenuated, while specific stress-responsive mRNAs are preferentially 
translated (Pakos-Zebrucka et al., 2016). What are the underlying mechanisms of 
action?  
Inhibition of cytoplasmic protein synthesis is based on prevention of ternary complex 
(TC) assembly. The ternary complex consists of (i) the eIF2α-containing eIF2 complex, 
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(ii) GTP and (iii) tRNAiMet. Together with the 40S subunit of the ribosome as well as eIF1A 
and eIF1 it is forming the 43S pre-initiation complex (PIC) recognising the AUG start 
codon on the respective mRNA to be translated. Binding of tRNAiMet to AUG triggers 
hydrolysis of GTP, resulting in the release of eIF2-GDP. Exchange of GDP for GTP is a 
prerequisite for recycling eIF2-GDP to form a new TC together with tRNAiMet. 
Phosphorylated eIF2α, however, is a competitive inhibitor of the guanine exchange factor 
(GEF) eIF2B required for the recycling step and thereby prevents TC formation (Figure 
1.10) (Jackson et al., 2010; Lomakin and Steitz, 2013; Pain, 1996).  
 
Figure 1.10: Translation initiation on murine atf4 mRNA under regular conditions (upper 
part) or during eIF2B inhibition (lower part). 
CDS: coding DNA sequence. Reprinted from (Pakos-Zebrucka et al., 2016). 
The mechanism behind preferential translation is based on specific structural elements 
characterising stress-responsive mRNAs: the occurrence of inhibitory upstream open 
reading frames (uORFs) in the 5’ untranslated region (UTR). For example ATF4, the key 
effector of the ISR, is encoded by a transcript harbouring two uORFs in mice (three uORF 
in humans) (Figure 1.10) (Harding et al., 2000). Under un-stressed conditions, the 
ribosome scanning the atf4 mRNA would initiate translation at uORF1 generating only a 
short peptide as translation re-initiates at uORF2. Translation starting at uORF2 (uORF3 
in humans, respectively) overlaps with the ATF4 coding sequence but the generation of 
ATF4 is prevented, as the overlap is out-of-frame. As a result, ATF4 is not synthesised 
under these conditions (Pakos-Zebrucka et al., 2016). In contrast to this, the re-initiation 
of translation at uORF2 in mice fails increasingly with decreased TC availability. This 
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results in an augmenting number of ribosomes correctly initiating translation at the AUG 
of the coding sequence and therefore augmenting ATF4 protein levels (Donnelly 2013).  
1.3.1.3 Activating transcription factor 4 (ATF4) 
ATF4 is the central effector of the ISR regulating gene expression either as a homodimer 
or in cooperation with other TFs as a heterodimer. Like CHOP and C/EBPβ it is a bZIP 
TF and belongs to the ATF family.  Heterodimers of ATF4 and C/EBP family members 
recognise a consensus sequence called the C/EBP-ATF response element (CARE) 
(Ameri and Harris, 2008; Dey et al., 2010; Fawcett et al., 1999; Kilberg et al., 2009; 
Pakos-Zebrucka et al., 2016). ATF4 targets are subjected to a dynamic mode of 
regulation as the following example illustrates: During amino acid deprivation, a 
heterodimer consisting of C/EBPβ and ATF4 induces transcription of Asns (asparagine 
synthetase). Later during the stress response, however, the heterodimer bound to the 
Asns promoter sequence remodels and ATF4 is replaced by ATF3, followed by 
decreased Asns gene expression (Chen et al., 2004).  
As a stress-responsive protein, it is characterised by an extremely short half-life and is 
tightly regulated on the transcriptional, translational and post-translational level as well 
as by dimerisation partners (Dey et al., 2010; Pakos-Zebrucka et al., 2016; Rutkowski et 
al., 2006).  ATF4 mainly acts as an activator of transcription, among other things for 
genes involved in amino acid import and metabolism, mitochondrial 1-C metabolism or 
protection from oxidative stress (Harding et al., 2003; Kilberg et al., 2012; Krug et al., 
2014; Nikkanen et al., 2016). 
1.3.1.4 eIF2α de-phosphorylation terminates the ISR 
The ISR comprises a GADD34 (growth arrest and DNA damage-inducible protein 
34)-mediated negative feedback mechanism responsible for the termination of the stress 
response upon resolution of stress. Transcriptional activation of Gadd34 occurs 
downstream of the eIF2α-ATF4-CHOP signalling cascade and is essential for the 
formation of the GADD34-containing PP1 (protein phosphatase 1) complex (Connor et 
al., 2001; Marciniak et al., 2004; Novoa et al., 2001). This complex includes GADD34 as 
regulatory SU as well as the catalytical SU PP1c and executes the de-phosphorylation 
of eIF2α that is essential for re-initiation of cytoplasmic CAP-dependent protein synthesis 
(Novoa et al., 2001). However, it is interesting to note that the PP1 complex also ensures 
the maintenance of low eIF2α phosphorylation levels under un-stressed conditions. In 
this context, a second regulatory SU, CReP (constitutive repressor of eIF2α 
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phosphorylation), supplements GADD34 for the formation of the PP1 complex together 
with PP1c (Jousse et al., 2003). 
1.3.2 Outcome of the ISR 
Under optimal conditions, the ISR is active only for a limited time and represents an 
adaptive and pro-survival response. The inhibition of protein synthesis in the cytoplasm 
can reduce the protein load under conditions of increased protein folding stress, as it is 
the case during activation of the UPRER. Reduction of protein synthesis is ultimately 
reducing the number of proteins entering the ER, thereby allowing the organelle to 
process the currently present proteins first. Furthermore, beside re-routing metabolic 
flows in accordance to the specific condition, stress-responsive translation also provides 
the cell with the necessary tools to increase protein folding capacity, for instance by 
increased chaperone and protease levels (Ron, 2002). Another condition under which 
the cell benefits from temporary inhibition of translation is infection by viral particles, as 
the replication and propagation of viral particles requires the cellular protein synthesis 
machinery (Balachandran et al., 2000). 
Should the ISR not successfully alleviate cellular stress and be active over a prolonged 
period, apoptotic cell death signalling is initiated. Apoptosis can be activated via several 
pathways; the best-studied however is the ATF4-mediated activation of CHOP. As a TF, 
CHOP has several possibilities to promote apoptosis: For instance it is a known regulator 
of the BCL2 (B cell lymphoma 2) family, harbouring pro- and anti-apoptotic proteins 
(Iurlaro and Muñoz-Pinedo, 2016; McCullough et al., 2001). Furthermore, CHOP acts as 
an activator of DR5 (death receptor 5), the latter promoting the assembly of the death-
inducing signalling complex (DISC) necessary for initiation of the caspase cleavage 
cascade starting with cleavage of pro-caspase 8 (Lu et al., 2014). In addition, CHOP 
indirectly facilitates apoptosis by increasing Ero1α transcription. ERO1α (endoplasmic 
reticulum oxidoreductase alpha) mediates di-sulfide bond formation in the ER and 
produces ROS as a by-product of the reaction, thereby destabilising the oxidising 
environment of this cellular compartment by promoting hyper-oxidation (Marciniak et al., 
2004).  
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1.3.3 CCAAT/enhancer-binding protein family (C/EBP) 
The C/EBP family consists of six distinct members, C/EBPα, β, γ, δ, ε, and ζ (Cao et al., 
1991). Structurally, a highly conserved C-terminal bZIP domain characterises the C/EBP 
family. The bZIP domain comprises a basic (b) DNA-binding domain (DBD) and a leucine 
zipper (ZIP) multimerisation domain. In order to bind target DNA sequences, C/EBP 
family members form Y-shaped homo- or homotypic hetero-dimers. The coiled-coil 
association of the respective bZIP domains stabilises the interaction of the DBDs on 
opposite sides of the major groove of the DNA double helix (Glover and Harrison, 1995; 
Landschulz et al., 1989; Miller et al., 2003). Heterodimerisation occurs predominantly 
within the C/EBP family or alternatively with members of the ATF (activation transcription 
factor) family, thereby resulting in a considerable expansion of the repertoire of DNA-
binding specificities. Furthermore, four out of six C/EBP family members harbour N-
terminal trans-activation domains (TAD) (Tsukada et al., 2011). 
1.3.3.1 C/EBP-homologous protein (CHOP) 
CHOP (C/EBPζ according to the nomenclature of the C/EBP family) is a 
stress-responsive TF induced by pathways such as the UPRER, UPRmt or the ISR 
(Oyadomari and Mori, 2004; Shpilka and Haynes, 2017). Other common names for the 
protein are GADD153 (growth arrest and damage associated protein 153) or DDIT3 
(DNA damage-inducible transcript 3). Its stress-specific relevance is emphasised by the 
fact that CHOP-deficient mice do not display substantial phenotypes under stress-free 
conditions. Upon activation, this multifunctional TF regulates major cellular processes 
ranging from inflammation, via differentiation to apoptosis (Yang et al., 2017). In the 
context of disorders, the major functional association of CHOP seems to be apoptosis. 
As an example, β-cell apoptosis – a hallmark of type 2 diabetes – was proven to depend 
on the expression of CHOP (Song et al., 2008). On the other hand, several new 
preclinical models of cancer treatment aim to selectively activate CHOP-mediated 
apoptosis in malignant cells (Fribley et al., 2015; He et al., 2016a; Rosilio et al., 2015). 
From a structural point of view, CHOP is by far the most uncommon TF within the C/EBP 
family. First, it is fully devoid of a TAD. Second, CHOP exhibits a disrupted helical 
structure in the DBD due to several substitutions of conserved residues for the helix 
destabilising residues Pro and Gly. In addition to the resulting defective NLS that is 
localised in the DBD of bZIP TFs, those structural particularities result in obligatory 
heterodimer formation for CHOP. As a consequence of the divergent characteristics of 
the CHOP DBD, CHOP-containing heterodimers with other C/EBP family members do 
not recognise the classical palindromic C/EBP consensus sequence (Ron and Habener, 
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1992; Williams et al., 1997). Among the C/EBP TFs, CHOP preferentially associates with 
LIP (liver inhibitory protein), the inhibitory C/EBPβ isoform (Hattori et al., 2003).  
 
1.4 Objectives 
Maintenance of mitochondrial homeostasis is essential for a broad spectrum of 
signalling, metabolic and energetic processes. To maintain mitochondrial function under 
conditions of disturbed organelle homeostasis, an elaborated network of stress pathways 
signalling the dysfunction and inducing adaptive nuclear responses evolved (Arnould et 
al., 2015; Bohovych and Khalimonchuk, 2016; Spinelli and Haigis, 2018).  
One of the most contentious mammalian mitochondrial stress pathways of the past two 
decades is the UPRmt. The scientific community struggles for a precise definition of the 
conditions under which this stress pathway is activated. Another current matter of debate 
is the relationship between the UPRmt with one of the cell’s global responses to stress: 
the ISR. Both stress responses can be activated by mitochondrial dysfunction and show 
a certain degree of overlap, e.g. regarding the set of TFs activated downstream of the 
respective signalling cascades (Forsstrom et al., 2019; Münch, 2018; Shpilka and 
Haynes, 2017). 
Our research group previously described a murine model of severe mitochondrial 
dysfunction induced by heart and skeletal muscle-specific deletion of Dars2 (DARS2 
KO). The deficiency caused (with increasing severity of mitochondrial dysfunction) up-
regulation of bona fide UPRmt markers (Dogan et al., 2014). However, this up-regulation 
was preceded by the increase of several TFs (ATF4, ATF5 and CHOP) previously 
associated with both, the UPRmt and the ISR (Fiorese et al., 2016; Horibe and 
Hoogenraad, 2007; Pakos-Zebrucka et al., 2016; Quirós et al., 2017; Shpilka and 
Haynes, 2017). 
Since CHOP was the first TF proposed to play a fundamental role in the UPRmt and due 
to the fact that CHOP is an important effector of the ISR (Horibe and Hoogenraad, 2007; 
Oyadomari and Mori, 2004; Zinszner et al., 1998), the TF was selected as the leverage 
point of the present study to further disentangle the stress signalling cascades triggered 
by mitochondrial dysfunction in the previously described DARS2 KO mouse (Dogan et 
al., 2014).  
The following three research aims were defined: First, to assess whether the activation 
of CHOP has a beneficial or detrimental impact on the pathological changes induced by 
Introduction 25 
mitochondrial dysfunction. Second, to identify the pathway CHOP is operating in under 
the given conditions. Third, to understand the function CHOP exerts within the pathway. 
In order to address the before-mentioned research aims a newly generated mouse model 
deficient for DARS2 (heart and skeletal-muscle specific) and CHOP (whole-body) along 
with well-directed cell-cultural treatments were combined in a targeted approach.    
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2 Materials and Methods 
2.1 Mouse experiments 
2.1.1 Animal care and breeding 
All mice (C57BL/6N) analysed during the course of this study were bred and raised in 
the CECAD in vivo research facility. Housing of the animals was carried out in individually 
ventilated cages (IVC) under the following conditions:  
• Ambient temperature: 22-24°C 
• 12h light/dark cycle, the light cycle starting at 6am 
• Ad libitum access to water and normal chow diet (R/M-H-V1554, sniff 
Spezialdiäten GmbH) 
• Specific pathogen-free (SPF) 
For breeding one male was housed with 1-2 females of a similar age, 8 weeks of age 
being the earliest time point to start a mating. After weaning animals were kept in groups 
of three to five animals of the same sex. Sacrifice of animals until 10 days of age was 
carried out by decapitation with sharp scissors. Older animals were sacrificed by cervical 
dislocation. Housing conditions and experimental procedures were consistent with NIH 
guidelines and conducted following protocols approved by the local governmental 
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authorities (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen, 
LANUV). 
2.1.2 Experimental mouse models 
Aiming to investigate the in vivo function of the stress-responsive transcription factor 
CHOP in the context of the heart and skeletal muscle-specific DARS2 KO, following 
mouse strains were used: 
Chop-/- 
B6.129S(Cg)-Ddit3tm2.1Dron/J mice were obtained from The Jackson Laboratory. Those 
mice are characterzied by a Chop::LacZ knock-out allele, resulting in the whole body 
knock-out of Chop.  
 Dars2fl/fl 
Dars2 conditional gene targeting was performed within the framework of the International 
Knockout Mouse Consortium (KOMP). Dars2fl/fl animals were generated as previously 
reported (Dogan et al., 2014). 
CkmmCretg/+ 
Heterozygous CkmmCre transgenic mice were provided by Prof. Dr. Nils Larson (Wang 
et al., 1999). Those animals harbour one copy of the Cre-recombinase under control of 
the striated muscle creatine kinase (Ckmm) promoter, the latter getting activated after 
embryonic day 13.0 (E13.0) (Lyons et al., 1991).  
 
Heart and skeletal muscle-specific DARS2-deficient mice (CkmmCretg/+, Dars2fl/fl; as 
from now referred to as DARS2 KO) resulted from inter-crossing of Dars2fl/fl mice with 
CkmmCretg/+ mice. CkmmCretg/+, Dars2fl/+ mice generated from this first breeding were 
then mated to Dars2fl/fl mice. In addition to DARS2 KO mice, wild-type littermates 
(CkmmCre+/+, Dars2fl/fl or CkmmCre+/+, Dars2fl/+) resulting from this mating were used as 
controls, as from now referred to as WT mice. 
In order to obtain mice harbouring a heart and skeletal muscle-specific deletion of Dars2 
in addition to a whole body knock-out of Chop, several subsequent breedings were 
necessary: 
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First, Dars2fl/fl mice were inter-crossed with Chop-/- mice. Resulting animals heterozygous 
for both genetic loci were mated, to obtain Dars2fl/fl, Chop -/- mice. Secondly, CkmmCretg/+, 
Dars2fl/+, Chop-/- mice were generated by breeding Dars2fl/fl, Chop-/- mice with 
CkmmCretg/+, Dars2fl/fl mice. Resulting CkmmCretg/+, Dars2fl/+, Chop-/+ mice were again 
inter-crossed with Dars2fl/fl, Chop-/-. Finally, double transgenic Dars2fl/fl, Chop-/- mice were 
inter-crossed with triple transgenic CkmmCretg/+, Dars2fl/+, Chop-/- mice, resulting in 
animals devoid of transgenic Cre but deficient for CHOP (CkmmCre+/+, Dars2fl/+, Chop-/- 
or CkmmCre+/+, Dars2fl/fl, Chop-/-; as from now referred to as CHOP KO mice) as well as 
animals harbouring a heart and skeletal muscle-specific deletion of Dars2 in addition to 
a whole body knock-out of Chop (CkmmCretg/+, Dars2fl/fl, Chop-/-; as from now referred to 
as DKO mice).  
2.1.3 Phenotyping 
2.1.3.1 Sampling 
Immediately following the sacrifice of mice organ sampling was performed. Harvested 
organs were either snap-frozen in liquid nitrogen or embedded in Tissue-Tek (Sakura 
Finetek) and placed on dry ice for freezing. Snap-frozen or embeded organs were 
subsequently stored at -80°C. 
2.1.3.2 Body weight determination 
Body weight of individual animals was determined at p17 (±2). 
2.1.3.3 Blood glucose measurement 
Glucose levels in the blood were assessed with a reflectance meter (ACCU-CHEK 
AVIVA, Roche) using glucose strips and following the manufacturer’s instructions. Blood 
glucose levels of individual animals were determined at p17 (±2) from whole venous tail 
blood. Due to the critical health status of DKOL mice at this time point, blood glucose was 
only determined in the fed state.  
2.1.3.4 In vivo protein translation assessment 
Protein translation was determined using the nonradioactive technique called surface 
sensing of translation (SUnSET) described in (Goodman and Hornberger, 2013). This 
Materials and Methods  29 
assay is based on the incorporation of the structural analogue of tyrosyl-tRNA called 
puromycin in nascent polypeptide chains and subsequent detection of puromycylated 
proteins using an anti-puromycin-specific antibody.  
Briefly, mice were injected at the indicated time points intraperitoneally with 0.04 µmol of 
puromycin dissolved in PBS per g of body weight. 30 min after injection the animals were 
sacrificed and collected tissues snap-frozen in liquid nitrogen. Subsequently, protein 
lysates of the collected tissues were prepared as described in 2.4.1.1 and processed by 
SDS-PAGE and Western blot (2.4.2). The relative signal intensity of the anti-puromycin-
specific antibody is proportional to the relative protein synthesis rates at the time point of 
the puromycin injection. 
2.2 Cell Culture 
2.2.1 Maintenance of cultured cells 
Culture of immortalised mouse embryonic fibroblasts (MEFs) and fibroblasts was 
performed in a humidified atmosphere at 37°C and 5% CO2. The cell culture medium 
was composed of DMEM (4.5g/L glucose, GlutaMAX, sodium pyruvate; Gibco Life 
Technologies) supplemented with 10% 'Fetal Bovine Serum Premium, South American 
Origin' (Biowest) and Pen Strep (Gibco Life Technologies) and re-newed every second 
day. Upon conditions of mitochondrial dysfunction (induced either genetically or by 
treatment) the medium was additionally supplemented with 50µg/mL of uridine. At 90% 
confluency cells were split cell type-dependently in ratios ranging from 1:4 to 1:20. 
2.2.2 Cryopreservation 
Cryopreservation of cells was achieved by re-suspension of cells collected from a 90% 
confluent plate in 4mL freezing medium (cell culture medium supplemented with 10% 
fetal bovine serum and 10% DMSO). Subsequently, 1mL aliquots of the cells were stored 
at -80°C in a ‘Cryo 1°C Freezing Container’ (Nalgene) overnight, before being transferred 
to -145°C. For thawing, cryovials were rapidly warmed in a 37°C water bath. The liquid 
cell suspension was poured in 9mL of culture medium and pelleted to remove DMSO. 
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After re-suspension in 10mL culture medium, the cells were transferred to cell culture 
plates. 
2.2.3 Cellular treatments  
For induction of mitochondrial dysfunction by actinonin treatment, 80% confluent cells 
were treated for 48h with 100µM Actinonin (Sima-Aldrich). Inhibition of the ISR was 
achieved by 4h, 24h and 48h 1µM ISRIB (Sima-Aldrich) treatments of 90% confluent 
cells. Both compounds were solubilised in DMSO. Untreated cells were supplemented 
with corresponding amounts of the solvent. Treatments were renewed on a daily basis. 
2.2.4 Transfection and selection of stably-transfected cells 
Transfection of plasmids conferring hygromycin resistance was performed with 
Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions using the 
forward transfection procedure. 72h post transfection the culture medium was replaced 
by hygromycin-supplemented (100µg/mL) medium for negative selection of un-
transfected cells.  
2.3 Molecular biology 
2.3.1 Isolation of genomic DNA 
2.3.1.1 Isolation of crude DNA 
Crude DNA preparations were used for genotyping of animals or mouse embryonic 
fibroblasts (MEFs). Ear biopsies or cell pellets were lysed in 500µL of DNA lysis buffer 
(100mM Tris-HCl, 5mM EDTA, 200mM NaCl, 0.2% SDS (w/v), 0.2 mg/mL Proteinase K, 
pH 7.4) at 55°C, respectively. DNA of fully digested samples was precipitated with 500µL 
of 2-propanol (20min centrifugation at maximum speed) and washed once with 70% 
ethanol (15min centrifugation at maximum speed). The DNA pellet was subsequently 
resolved in 150µL dH2O and stored at 4°C. 
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2.3.1.2 Isolation of purified DNA 
DNA of high purity was required for quantification of mtDNA levels by qPCR. Therefore, 
approximately 1mm3 of cardiac tissue per sample was lysed in 600µL DNA lysis buffer 
(20mM Tris-HCl, 10mM EDTA, 100mM NaCl, 0.5% SDS (w/v), 0.2 mg/mL Proteinase K, 
pH 7.4) at 55°C. RNA was degraded by the addition of RNase A (100µg/mL) and 30min 
of incubation at 30°C. 600µL of a mixture of cold phenol:chloroform:isoamyl alcohol 
(25:24:1) was added. After centrifugation (10min at maximum speed), the aqueous layer 
was collected. DNA was precipitated by addition of 2-3 volumes of 100%, 1/10 volume 
of 3M NaOAc and incubation at -80°C for 30min. The DNA pellet obtained after 
centrifugation (30min, maximum speed, 4°C) was washed once with 500µL of 70% 
ethanol. Finally, the dry pellet was dissolved in 100µL ultra-pure H2O and stored at 4°C 
overnight for complete dissolving prior determination of the DNA concentration (see 
2.3.3). 
2.3.2 Isolation of total RNA 
For isolation of total RNA cell pellets were resuspended or approximately 25mg of tissue 
were homogenised in 1mL TRIzol reagent (Life Technologies) using a Precellys CK 14 
(Bertin Technologies) (5000rpm, 30sec). After 5min at RT, 200µL of chloroform were 
added and mixed vigorously for 15sec before a second incubation step at RT for 3min. 
Phase separation was completed by centrifugation (12.000g, 15min, 4°C). The aqueous 
upper phase was collected and containing RNA precipitated with 500µL 2-propanol 
(10min incubation at RT followed by 10min centrifugation at 12.000g and 4°C). The 
resulting RNA pellet was washed with 1mL of 75% ethanol (5min centrifugation at 7500g, 
4°C) and briefly dried before resuspension in 50µL ultra-pure H2O. After determination 
of RNA concentration (see 2.3.3), the residual DNA was digested by DNase I (New 
England Biolabs) treatment. The digestion mix (up to 10µg RNA, diluted 10X digestion 
buffer and 1µL DNase I in a total volume of 20µL) was incubated for 10min at 37°C. 
0.2µL of 0.5M EDTA were added to the reaction, to protect the RNA during the heat 
inactivation of DNaseI (75°C, 10min). After re-determination of RNA concentration, the 
samples were stored at -80°C. 
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2.3.3 Quantification of nucleic acids 
Nucleic acids were quantified using a NanoDrop ND-1000 UV-Vis spectrophotometer 
(Peqlab). Purity of DNA and RNA was estimated utilising the ratio of absorbance 
between 260nm (absorbance maximum of nucleic acids) and 280nm (absorbance 
maximum of proteins). A ratio of ~1.8 corresponds to “pure” DNA, whereas “pure” RNA 
has a ratio of ~2.0. 
2.3.4 Polymerase chain reaction (PCR) 
2.3.4.1 Genotyping PCR 
To determine the genotype of mutant mice or cells isolated from mutant mice embryos, 
PCR reactions with specific primers distinguishing between WT, floxed or KO alleles of 
the respective genes were performed. All genotyping reactions were performed with the 
DreamTaq polymerase (Thermo Fisher Scientific). 
PCR mix composition: 
 1µL   DNA 
0.5-1µL  per Primer (10µM) [2-4 primer per reaction, depending on the  
specific PCR] 
1µL  dNTP mix (1.25mM each) 
2µL  DreamTaq buffer (10X) 
0.05µL  DreamTaq polymerase 
Up to 20µL H2O 
 
Reaction-specific primers and conditions: 
 Dars2 PCR: Primer 1: 5' ATGAATTCTAGGCCAGCCAC 3' 
     Primer 2: 5' TGGCAATCTCTTAGGACTAAG 3' 
     V(primer)per reaction=0.8µL 
     TAnnealing=60°C 
     t Annealing=30sec 
     t Elongation=45sec 
Chop PCR: Primer 1: 5' ATGCCCTTACCTATCGTG 3' 
     Primer 2: 5' AACGCCAGGGTTTTCCCAGTCA 3' 
     Primer 3: 5' GCAGGGTCAAGAGTAGTG 3' 
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     V(primer)per reaction=1µL 
     TAnnealing=61°C 
     t Annealing=1min 
     t Elongation=30sec 
CkmmCre PCR: Primer 1: 5' GTGAAACAGCATTGCTGTCACTT 3' 
     Primer 2: 5' TAAGTCTGAACCCGGTCTGC 3' 
     Primer 3: 5' CAAATGTTGCTTGTCTGGTG 3' 
Primer 4: 5' GTCAGTCGAGTGCACAGTTT 3' 
     V(primer1&2)per reaction=1µL 
V(primer3&4)per reaction=0.5µL 
     TAnnealing=63°C 
     t Annealing=30sec 
     t Elongation=30sec 
 
PCR programme: 
1) Initial denaturation at 95°C for 5min 
For 35 cycles: 
2) Denaturation at 95°C for 30sec 
3) Annealing at 60 to 63°C for 30sec to 1min (see reaction-specific conditions) 
4) Elongation at 72°C for 30sec to 45sec  (see reaction-specific conditions) 
 
5) Final extension: 5min at 72°C 
6) Hold 4°C 
2.3.4.2 Reverse transcriptase PCR (RT-PCR) 
For cDNA synthesis from RNA utilising the ‘High capacity reverse transcription kit’ 
(Applied Biosystems) the following reaction mix was prepared: 
 2µL   RT buffer (10X) 
 0.8µL   dNTP mix (25X) 
 2µL   Random primer (10X) 
 1µL   Reverse transcriptase 
 2µg   RNA 
 Up to 20µL H2O 
PCR programme: 
1) Annealing 10min at 25°C 
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2) Elongation 120min at 37°C 
3) Denaturation 5sec at 85°C 
4) Hold 4°C 
Synthesised cDNA was stored at -20°C. 
2.3.4.3 Quantitative real-time PCR (qPCR) 
qPCR reactions were performed on 96 well and 384 well plates using the ‘Brilliant III 
Ultra-Fast SYBR Green qPCR Master Mix (Agilent Technologies) following the 
manufacturer’s instructions. Per reaction 50ng of cDNA were employed. The cycling 
reaction was performed in the ‘Applied Biosystems QuantStudio 7 Flex Real-Time PCR 
System’ (Fisher Scientific). Relative target gene expression was determined by 
normalisation to endogenous control genes (tbp or hprt, respectively) using the 
comparative (2-ΔΔCt). 
PCR programme: 
1) Initial denaturation at 95°C for 3min 
For 40 cycles: 
2) Denaturation at 95°C for 5sec 
3) Annealing and Elongation at 60 for 15sec  
Dissociation curve: 
4) Denaturation at 95°C for 15sec 
5) Annealing at 60°C for 1min 
6) Step-wise increase of temperature until 95°C (ramp time 20min) 
 
Table 2.1: Primers used for qPCR 
Transcript Forward Primer 5’-3’ Reverse Primer 5’-3’ 
afg3l2 GTTGATGGGCAATACGTCTGG  GACCCGGTTCTCCCCTTCT 
atf4 AACATCCAATCTGTCCCGG GTTCTCCAGCGACAAGGC 
bip GACTGCTGAGGCGTATTTGG ATCTTTGGTTGCTTGTCGCTGG 
cebpb CAACCTGGAGACGCAGCACAA TTGAACAAGTTCCGCAGGGTG 
chop TGCCTTTCACCTTGGAGACGG CGCAGGGTCAAGAGTAGTGAAGG  
clpp CAGTCTGAAAGCAACAAGAAGC  ACTGCATTGTGTCGTAGATGG 
cth GGGTTTTGAATACAGCCGC CTGTTGGTGCCTCCATACACT 
gadd34 GAGGGACGCCCACAACTTC TTACCAGAGACAGGGGTAGGT 
hprt GCCCCAAAATGGTTAAGGTT  TTGCGCTCATCTTAGGCTTT 
hsp60 GCCTTAATGCTTCAAGGTGTAGA  CCCCATCTTTTGTTACTTTGGGA 
lonp1 ATGACCGTCCCGGATGTGT CCTCCACGATCTTGATAAAGCG 
mthfd2 CCACTCCCAGAGCACATTGAT GTTGGAATGCCTGTTCGCTT 
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Transcript Forward Primer 5’-3’ Reverse Primer 5’-3’ 
mthsp70 ATGGCTGGAATGGCCTTAGC  ACCCAAATCAATACCAACCACTG 
pycr1 GATGCTCTGGCTGACGGTGGTGT GCTGGCTGGGATGCTGTTCTGAG 
shmt2 CCACCACCACTCACAAGACACTGCG TGTAGGGATGGGAACACAGCGAAGTTG 
tbp GGGAGAATCATGGACCAGAA TTGCTGCTGCTGTCTTTGTT 
yme1l1 ATTCTGCGGTAGACCCTGTC  CAACCACTTCCTGTAACTCTTGT 
 
2.3.4.4 mtDNA quantification 
Following DNA isolation as described in 2.3.1.2 mtDNA levels were determined by qPCR 
(Quiros et al., 2017). Relative mtDNA levels were estimated by normalisation of Nd1 
(mtDNA-encoded) to Hk2 (nDNA-encoded) DNA levels.  
 
Table 2.2: Primers used for mtDNA quantification 
Gene Forward Primer 5’-3’ Reverse Primer 5’-3’ 
Nd1 CTAGCAGAAACAAACCGGGC CCGGCTGCGTATTCTACGTT 
Hk2 GCCAGCCTCTCCTGATTTTAGTGT GGGAACACAAAAGACCTCTTCTGG 
2.3.5 Transformation of chemically compentent E. coli 
If not stated differently, transformations were performed with ‘Subcloning Efficiency 
DH5α Competent Cells’ (Thermo Fisher Scientific). A 50µL aliquot of competent cells 
was thawed on ice for 15min before adding 1-10ng of DNA in a volume of maximal 5µL. 
Following 30min of incubation on ice, the cells were subjected to a heat shock (20sec, 
42°C) and immediately put back on ice for 2min. After addition of 950µL of pre-warmed 
medium, cells were grown for 1h at 37°C and 800rpm. Finally, cells were pelleted (1min, 
1300rpm), resuspended in 50µL of medium and plated on selective LB agar plates. After 
incubation overnight at 37°C plates were stored at 4°C to prevent overgrowth of the 
colonies.  
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2.3.6 Preparative and analytical scale plasmid DNA purification 
from E. coli 
Small amounts of plasmid DNA were recovered from overnight liquid cultures (37°C, 
120rpm) of 4mL LB selection medium inoculated with a colony picked from an LB agar 
plate in the evening before. For plasmid preparation, the ‘ZymoPURE Plasmid Miniprep 
Kit’ (Zymo Research) was used according to the manufacturer’s instructions. 
Large amounts of plasmid DNA were recovered from overnight liquid cultures (37°C, 
120rpm) of 200mL LB selection medium inoculated in the evening before. Inoculation 
was performed with 500µL of a 4mL overnight pre-culture prepared the day before, as 
described above. For plasmid preparation, the ‘ZymoPURE II Plasmid Maxiprep Kit’ 
(Zymo Research) was used according to the manufacturer’s instructions. 
2.3.7 Agarose gel electrophoresis 
Size-dependent separation of DNA was achieved by agarose gel electrophoresis. 
Agarose concentration was adapted to the fragment size and ranged between 0.5% to 
2%. For the preparation of agarose gels, agarose was boiled in 0.5X TBE buffer. 
Subsequently, ethidium bromide (4µL per 100mL of agarose solution) was added, and 
the solution briefly stirred, before the agarose gel was poured into a gel chamber with 
slot combs. After completed polymerisation, the gel was transferred into an 
electrophoresis chamber and covered with 0.5X TBE. The ‘GeneRuler 1kb Plus DNA 
Ladder (Thermo Fisher Scientific) was used for size estimation of DNA fragments. DNA 
samples were diluted with an agarose gel loading buffer before loading into the gel 
pockets. Electrophoresis was performed at 80–150V until sufficient separation of the 
DNA fragments. For visualisation, the GelDoc system (BioRad) was utilised.  
2.3.8 DNA gel extraction  
Extraction of DNA fragments form agarose gels were performed with the ‘Zymoclean Gel 
DNA Recovery Kit’ (Zymo Research) according to the manufacturer’s instructions. 
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2.3.9 DNA sequencing 
For sequencing, plasmids were send to Eurofins were they were processed via Sanger 
sequencing. 
2.3.10 Q5 site directed mutagenesis 
The ‘Q5 Site-Directed Mutagenesis Kit’ (New England Biolabs) was used to introduce a 
point mutation (L120D) in the LIP plasmid provided by Maria Hatzoglou (Chiribau et al., 
2010). For primer design, the NEB online design software ‘NEBaseChanger’ was 
utilised. All three steps described in the protocol (exponential amplification, KLD reaction 
and transformation) were performed as indicated in the manual.  
Primer LIP L120D F: 5' GGTGGAGCAGACGTCGCGAGAG 3' 
Primer LIP L120D R: 5' TTCTTCTGCAGCCGCTCG 3' 
TAnnealing=65°C 
2.3.11 Northern blot analysis for mitochondrial mRNA 
quantification 
2µg of RNA supplemented with ‘RNA Sample Loading Buffer’ (Sigma-Aldrich) were 
heated for 10min at 65°C prior to loading on a 1.2% agarose-formaldehyde gel. 
Separation of RNA was performed for 2.5h at 130V in 1X MOPS running buffer. After 
visualisation of the gel with the GelDoc system (BioRad), an extensive washing step 
followed (3X 15min in nuclease-free H2O). Subsequently, the gel and the Hybond N+ 
membrane (GE Healthcare) were soaked in 20X SSC for 20min, before setting up the 
alkaline capillary transfer of the RNA to the membrane overnight. Crosslinking of the 
RNA was performed at 80°C for 15min. Mitochondrial probes (ND1, ND5, COX3, 16S) 
and the 18S nuclear probe (70ng each) were radioactively labelled (50µCi α32P-dCTP) 
utilising the ‘Random Primer DNA labelling Kit’ (Invitrogen). Following 1h of membrane 
pre-hybridisation at 65°C with ‘Rapid-Hyb Buffer’ (GE Healthcare) the labelled probe was 
added for 2h of hybridisation. Subsequently, three washing steps of 20min each were 
performed at 65°C (A: 2X SSC/ 0.1%SDS; B: 1X SSC/ 0.1%SDS; C: 0.5X SSC/ 
0.1%SDS). For detection of the radioactive signals, Amersham Hyperfilms MP (GE 
Healthcare) were exposed to the membrane. 18S rRNA levels served for normalisation 
of mitochondrial transcript levels. 
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2.4 Biochemistry 
2.4.1 Isolation of proteins 
2.4.1.1 Protein extraction from cardiac tissue 
Homogenisation of 25mg of cardiac tissue samples in 400µL cold organ lysis buffer 
(50mM HEPES pH 7.4, 50mM NaCl, 1% Triton X-100 (v/v), 0.1M NaF, 10mM EDTA, 
0.1% SDS (w/v), 10mM Na-orthovanadate, 2mM PMSF, 1X protease inhibitor cocktail 
(Sigma-Aldrich), 1X PhosSTOP phosphatase inhibitor cocktail (Roche)) was performed 
with the Precellys CK 14 (Bertin Technologies) (5000rpm, 30sec). Cleared protein 
lysates (45min, 13000rpm, 4°C) were transferred into fresh tubes. Subsequent 
determination of protein concentration was performed with Bradford reagent (Sigma-
Aldrich) according to the manufacturer’s instructions. Protein lysates were stored 
at -80°C. 
2.4.1.2 RIPA lysis of cultured cells 
Washed cell pellets were resuspended in 80-200µL cold RIPA buffer (150mM NaCl, 1% 
Triton X-100 (v/v), 0.5% Na-deoxycholate (w/v), 0.1% SDS (w/v), 50mM Tris-HCl pH 7.4, 
50mM NaF, 2mM EDTA) supplemented with 1X protease inhibitor cocktail (Sigma-
Aldrich) and 1X PhosSTOP phosphatase inhibitor cocktail (Roche). Next, cells were 
incubated 30min on ice with brief vortexing every 10min. Following 2X 45sec sonication 
the lysates were cleared (10min, 13000rpm, 4°C) and transferred into fresh tubes. 
Subsequent determination of protein concentration was performed with Bradford reagent 
(Sigma-Aldrich) according to the manufacturer’s instructions. Protein lysates were stored 
at -80°C. 
2.4.2 SDS polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western blot 
SDS-PAGE was conducted using the ‘Mini-PROTEAN Tetra Cell’ (BioRad) system as 
indicated by the manufacturer. Protein samples were dissolved in SDS-PAGE loading 
buffer (50mM Tris-HCl pH 6.8, 2% SDS (w/v), 10% Glycerol (v/v), 1% β-
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mercaptoethanol, 12.5 mM EDTA, 0.02% Bromophenol blue) prior boiling for 5min at 
95°C. Next, lysates were loaded next to a protein ladder (‘PageRuler Prestained Protein 
Ladder’, Thermo Fisher Scientific) on 8% to 15% acrylamide gels (stacking gel: 5% 
Acrylamide-bisacrylamide (37.5:1), 12.5 mM Tris-HCl, 0.1% SDS (w/v), 0.25% APS, 
0.25% TEMED, pH 6.8; separating gel: 8-15% Acrylamide-bisacrylamide (37.5:1), 
37.5mM Tris-HCl, 0.1% SDS (w/v), 0.1% APS, 0.1% TEMED, pH 8.8), depending on the 
required range of protein sizes to separate. To begin with, electrophoresis was 
performed at 80V for 15min in running buffer (25mM Tris-HCl, 250mM Glycine, 0.1% 
SDS (w/v), pH 8.3). Later, voltage was increased to 140V. Protein separation was 
stopped, as soon as the loading dye reached the end of the separating gel. 
For wet transfer, the ‘Criterion Blotter’ (BioRad) was used according to the 
manufacturer’s instructions. Transfer of proteins on a nitrocellulose membrane was 
conducted in transfer buffer (30mM Tris-HCl, 240mM Glycine, 0.037% SDS, 20% 
Methanol) at 400mA for 2h at 4°C. For a first evaluation of the transfer, shortly washed 
membranes (dH2O) were stained with Ponceau S solution (Sigma-Aldrich). Depending 
on the antibody requirements, de-staining and blocking of membranes was performed 
for 1h either in 5% milk-PBST or 3% BSA-TBST on a gently shaking platform. 
Subsequently, primary and secondary antibodies were incubated as indicated by the 
manufacturers. Inbetween primary and secondary antibody incubation, as well as prior 
detection, membranes were washed (3X, 5min) in PBST or TBST, respectively. For the 
visualisation of detected proteins, ECL solution (GE Healthcare) was applied to the 
membrane. Next, the membranes were exposed to ‘Super RX’ films (Fujifilm). The latter 
ones were developed using an automatic developer (Kodac) and scanned with a ‘V800 
Transparency Scanner’ (Epson) at 800dpi 16Bit colour depth. 
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Table 2.3: Antibodies, suppliers and catalogue numbers of antibodies used for Western 
blot 
Antibody Supplier Catalogue Number 
4EB-P1 CST 9644 
AFG3L2 Polyclonal antisera made by Prof. Dr. Elena I. Rugarli - 
AKT CST 9272 
AMPK CST 2532 
ASC Abcam ab175449 
ASNS Santa Cruz sc-365809 
ATF4 CST 11815 
ATP5A1 Abcam ab14748 
BECLIN-1 CST 3738 
BiP Santa Cruz sc-376768 
CEBPB Bioloegend 606203 
CHOP CST 2895S 
Cleaved Caspase 3 CST 9661S 
CLPP Sigma WH0008192M1 
COXI Molecular Probes 459600 
COXIV Molecular Probes A21348 
DARS2 Proteintech 13807-1-AP 
eIF2a Abcam ab26197 
GLUT-4 Millipore 07-1404 
HSC70 Santa Cruz sc-7298 
HSP60 ATCC HSP60 
IRE1a Santa Cruz sc-390960 
LC-3 CST 2775 
LONP1 Abcam ab103809 
MRPS12 Proteintech 15225-1-AP 
MTHFD2 Abcam ab56772 
mtHSP70 Abcam 82591 
mTOR CST 2972 
NDUFA9 Molecular Probes 459100 
NLRP3 CST 15101 
OXPHOS cocktail Abcam ab110413 
p- 4EB-P1 CST 2855 
p-AKT CST 4060 
p-EIF2a Abcam ab32157 
p-mTOR CST 2971 
p62 Abnova H00008878-M01 
p-AMPK CST 2535 
PARP CST 9542 
Puromycin Merck #MABE343 
PYCR1 Abcam ab94780 
SDHA Mitosciences MS204 
SDHB Abcam ab110413 
SHMT2 Abcam ab224428 
UQCRC1 Molecular Probes 459140 
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2.4.3 Isolation of cardiac mitochondria 
Freshly collected hearts were immediately transferred into 10mL of pre-chilled mito-
isolation buffer (MIB) (100mM Sucrose, 50mM KCl, 1mM EDTA, 20mM TES, 0.2% BSA 
free from fatty acids, pH adjusted to 7.2) supplemented with 1µg subtilisin (Sigma-
Aldrich) per mg of tissue. Approximately 20 long strokes of a Potter S (Sartorius) 
homogeniser at 1000rpm were required for homogenisation. After centrifugation (800g, 
5min, 4°C), the mitochondria-containing supernatant was transferred into a fresh tube. 
Pelleted mitochondria (8500g, 5min, 4°C) were resuspended in 30mL MIB and subjected 
to a third centrifugation step (700g, 5min, 4°C). Finally, mitochondria were pelted (8500g, 
5min, 4°C) and resuspended in 100µL MIP without BSA. Protein concentration of 
mitochondria was determined using Bradford reagent (Sigma-Aldrich) according to the 
manufacturer’s instructions. Mitochondria were either immediately used (respirometry or 
in organello translation) or snap-frozen and stored at -80°C. 
2.4.4 Mitochondrial respiration 
High-resolution respirometry utilising an Oxygraph-2k (OROBOROS Instruments) and a 
carbohydrate substrate uncoupler inhibitor titration (SUIT) protocol was conducted to 
determine mitochondrial oxygen consumption rates. First, the respiration medium 
(120mM Sucrose, 50mM KCl, 20mM Tris-HCl, 1mM EGTA, 4mM KH2PO4, 2mM MgCl2, 
0.1% BSA) was added to the oxygraph chamber and air equilibration was performed. 
Next, 25µg of freshly-isolated cardiac mitochondria were added. The respiration medium 
was supplemented with 2mM pyruvate, 0.8mM malate, 2mM glutamate and 2mM ADP 
to assess CI-dependent respiration. By providing 4mM of succinate, convergent CI and 
CII-dependent respiration was determined. Inhibition of CV by addition of 1.5 µg/mL of 
oligomycin allowed to evaluate the coupling efficiency. The maximal capacity of the 
electron transfer system (ETS) was assessed by titration of FCCP (0.5µM increments). 
Maximal capacity of the ETS of CII solely could be determined by inhibition of CI through 
addition of 0.5µM rotenone. Finally, inhibition of CIII by supplementation of 2.5µM 
antimycin A allowed the determination of the residual oxygen consumption (ROX). 
2.4.5 Blue native polyacrylamide gel electrophoresis (BN-PAGE) 
BN-PAGE was performed based on the ‘NativePage Novex Bis-Tris Gel System’ (Life 
Technologies) according to the manufacturer’s instructions. For analysis of mitochondrial 
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super-complexes, 10µg mitochondria were lysed with 4% of digitonin. Analysis of 
individual mitochondrial complexes was conducted post lysis of 10µg mitochondria in 1% 
DDM. After completion of lysis (15min on ice), lysates were cleared (30min, 13000rpm, 
4°C) and the resulting supernatant loaded on a 4-16% Bis-Tris gradient gel. 
Subsequently, proteins were transferred to an Amersham Hybond PVDF membrane (GE 
Healthcare) by Western blot (2.4.2). 
2.4.6 In organello translation 
De novo mitochondrial translation was assessed by incubation (1h, 37°C, on rotating 
wheel) of 1.5mg of freshly-isolated mitochondria in 1mL 35S-translation buffer (100mM 
Mannitol, 10mM Na-succinate, 80mM KCl, 5mM MgCl2, 1mM KH2PO4, 25mM HEPES 
pH 7.4, 5mM ATP, 200µM GTP, 6mM Creatine phosphate, 60µg/mL Creatine kinase, 
60µg/mL Cysteine, 60µg/mL tyrosine, 60µg/mL Amino acids [Ala, Arg, Asp, Asn, Glu, 
Gln, Gly, His, Ile, Leu, Lys, Phe, Pro, Ser, Thr, Trp, Val], 7µL/mL 35S-methionine). 
Subsequently, mitochondria were pelleted (12000g, 2min) and resuspended in 1mL non-
radioactive translation buffer containing methionine instead of 35S-methionine. Half of 
the sample ('pulse fraction') was pelleted again, resuspended in 100µL SDS-PAGE 
loading buffer (50mM Tris-HCl pH 6.8, 2% SDS (w/v), 10% Glycerol (v/v), 1% β-
mercaptoethanol, 12.5 mM EDTA, 0.02% Bromophenol blue) and lysed (30min, RT) 
before transfer at -20°C. For the 'cold chase' allowing to estimate the protein turnover, 
the remaining 500µL of resuspended mitochondria were incubated for 3h at 37°C on a 
rotating wheel. Subsequently, the 'chase fraction' was pelleted, resuspended in 100µL 
SDS-PAGE loading buffer and lysed as the 'pulse sample' before.  
Separation of mitochondrial proteins was achieved by SDS-PAGE. 10µL per sample 
were loaded on a 15cm long, 15% polyacrylamide gel and run in a 'SE600X Chroma 
Deluxe Dual Cooled Vertical Protein Electrophoresis Unit' (Hoefer) overnight at 80V 
continuously. After fixing (50% Methanol, 10% Acetic acid) for 30min, staining in 
Coomassie solution and de-staining (20% Methanol, 10% Acetic acid) of the 
polyacrylamide gel the latter one was placed on Whatman paper (GE Healthcare) and 
dried (2h, 80°C) in a gel dryer. For detection of radioactive signals of de novo synthetised 
proteins, Amersham Hyperfilms MP (GE Healthcare) were exposed to the membrane 
and developed using an automatic developer (Kodac). Digitalisation was performed 
using a  ‘V800 Transparency Scanner’ (Epson) at 800dpi 16Bit colour depth. The 
scanned gel was used as loading control. 
In organello translation experiments were performed together with Dr. Alexandra Kukat. 
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2.5 Histology 
2.5.1 Cryostat sections 
Tissue-Tek (Sakura)-embedded cardiac samples were sectioned utilising a 'CM1850 
cryostat' (Leica). Tissue sections were immediately transferred onto poly-L-lysine glass 
slides and stored at -20°C. 
2.5.2 Hematoxilin and eosin (H&E) staining 
H&E staining was performed on 7µm cryosections. Following 1min incubation in tap 
water, the sections were placed in Hematoxylin solution (Sigma-Aldrich) (4min) and tap 
water again (15min). Subsequently, the sections were placed in dH2O (1min), Eosin 
(Sigma-Aldrich) (1min) and washed several times with tap water. Next, dehydration was 
performed by incubation in 75% ethanol (1min), 96% ethanol (1min), 100% ethanol 
(1min) and xylene (1min). For mounting of cover-slips Entellan (Millipore) was used. 
Imaging was conducted using a ‘SCN400 Slide Scanner’ (Leica) at 40X magnification. 
2.5.3 COX/ SDH staining 
COX/SDH staining was performed on dried (10min, RT), 7µm cryosections surrounded 
with a 'Super PAP Pen' (Daido Sangyo). First, sections were incubated (40min, 37°C, 
humidified chamber) in COX solution (0.8mL Diaminobenzidine tetrahydrochloride, 
0.2mL Cytochrome c (500µM), a few grains of catalase). After three washing steps in tap 
water, SDH solution (0.8mL Nitroblue tetrazolium (1.875mM), 0.1mL Succinate (1.3M) 
0.1mL 2mM Phenazine methosulphate and 0.01mL Sodium azide (100mM)) was applied 
(12min, 37°C, humidified chamber). Subsequently, the sections were washed (3X, tap 
water), and dehydrated: 75% ethanol (2min), 95% ethanol (2min), 100% ethanol (10min). 
Finally, dried slides were mounted with Entellan (Millipore). Imaging was conducted 
using a ‘SCN400 Slide Scanner’ (Leica) at 40X magnification. 
 
Materials and Methods  44 
2.5.4 Transmission electron microscopy 
Acquisition of TEM pictures was largely performed by Beatrix Martiniy of the CECAD 
imaging facility. Tissue were dissected in 2 x 2 x 2mm cubes with a sharp razor blade 
and fixed in 2% glutaraldehyde / 2% formaldehyde in 0.1M cacodylate buffer (pH 7.3) for 
48h at 4°C. Afterwards, samples were rinsed in 0.1M cacodylate buffer (Applichem) and 
post-fixed with 2% osmiumtetroxid (Science Services) in 0.1M cacodylate buffer for 2h 
at 4°C. Samples were dehydrated through an ascending ethanol series (Applichem), 
transferred to propylene oxide (Merck) and embedded in epoxy resin (Sigma-Aldrich).  
Ultrathin sections (70nm) were cut with a diamond knife (Diatome) on an ultramicrotome 
(EM-UC6, Leica Microsystems) and placed on copper grids (Science Services, 
100mesh).  The sections were contrasted with 1.5% uranyl acetate (Plano) and lead 
citrate (Sigma-Aldrich).  
Images were acquired with a transmission electron microscope (JEM 2100 Plus, JEOL), 
a OneView 4K camera (Gatan) with DigitalMicrograph software at 80 KV at room 
temperature. 
2.6 Omic Analyses 
2.6.1 Label-free quantification of the cardiac proteome 
For whole-tissue proteomics protein lysates of cardiac tissue samples were prepared 
based on a finely ground tissue powder obtained by grinding the samples in liquid 
nitrogen. The ten-fold amount (v/w) of RIPA (150mM NaCl, 1% Triton X-100 (v/v), 0.5% 
Na-deoxycholate (w/v), 0.1% SDS (w/v), 50mM Tris-HCl pH 7.4, 50mM NaF, 2mM 
EDTA) supplemented with 1X protease inhibitor cocktail (Sigma-Aldrich) was added to 
the tissue powder, vortexed and passed several times through a cannula for lysis and 
chromatin shearing. After incubation (30min, 4°C, on a rotating wheel) lysates were 
cleared (15min, 4°C, full speed) and protein concentration was determined with Bradford 
reagent (Sigma-Aldrich) according to the manufacturer’s instructions.  
Next, 50µg protein per sample were precipitated with the four-fold volume of cold 100% 
acetone (60min, -80°C), pelleted (15min, 4°C, full speed) and washed twice with cold 
90% acetone (5min, 4°C, full speed). The air-dried pellet was subsequently resuspended 
in 300µL 8M urea buffer. 
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In solution digest was performed by addition of DTT to a final concentration of 5mM (1h, 
37°C), addition of chloracetamid to a final concentration of 40mM (20min, protect from 
light), addition of endoproteinase Lys-C at an enzyme-substrate ration of 1:75 (4h, 37°C) 
and dilution with 50mM TEAB to a urea concentration of 2M before adding trypsin at an 
enzyme-substrate ration of 1:75 (overnight, 37°C, protect from light). Digest was stopped 
with formic acid (1% final concentration). 
Digested protein lysates were loaded on SDB-RPS stage tips provided by the 
CECAD/CMMC proteomics core facility according to the standard procedure of the 
facility. The core facility further processed the samples using a ‘Q Exactive Plus Orbitrap’ 
(Thermo Fisher Scientific) coupled with an ‘EASY nLC LC’ (Thermo Fisher Scientific). 
Raw data were analysed with Maxquant (version 1.5.3.8). 
2.6.2 CHOP co-immunoprecipitation (co-IP) and subsequent 
mass-spectrometrical quantification of purified proteins 
For CHOP co-IP one heart per sample was homogenised in 500µL modified RIPA 
(150mM NaCl, 1% NP-40 (v/v), 0.25% Na-deoxycholate (w/v), 0.1% SDS (w/v), 50mM 
Tris-HCl pH 7.4) supplemented with 1X protease inhibitor cocktail (Sigma-Aldrich) using 
a Precellys CK 14 (Bertin Technologies) (5000rpm, 30sec) and lysed 20min on ice. 
Chromatin was sheared by sonication in a pre-cooled Bioruptor (Diagenode) (10 cycles: 
30sec ON, 30sec OFF). The cleared lysate (15min, 4°C, full speed) was transferred into 
a fresh tube, and protein concentration was determined with Bradford reagent (Sigma-
Aldrich) according to the manufacturer’s instructions. The protein lysate was incubated 
overnight with 5µL of CHOP antibody (#2895, CST) at 4°C on a rotating wheel.  
Precipitation was performed by incubation (1h, 4°C) of the lysate-antibody mixture with 
50µL equilibrated, magnetic ‘Dynabeads Protein G’ (Invitrogen). Following consecutive 
washing steps were performed: 1X with cold lysis buffer, 2X using cold wash buffer 1 
(50mM Tris-HCl pH 7.4, 150mM NaCl, 5% Glycerol (v/v), 0.05% NP-40), 2X utilising 
wash buffer 2 (50mM Tris-HCl pH 7.4). After the last washing step, the beads were 
resuspended in elution buffer (2M Urea, 50mM HEPES pH 8, 5mM DTT). 
On-bead digest was performed by addition of 50ng trypsin (30min, RT, gentle shaking) 
and subsequent addition of 50µL digestion buffer (2M urea, 50mM HEPES pH 8, 50mM 
Chloracetamid) (30min, RT, gentle shaking). The supernatant was transferred to a new 
tube, while the beads were resuspended once more in 50µL elution buffer. Finally, both 
supernatants were combined and supplemented with 50ng LysC and 100ng trypsin for 
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overnight digest (37°C, shaking at 1000rpm). The digest was stopped with formic acid 
(1% final concentration). 
Digested protein lysates were loaded on SDB-RPS stage tips provided by the 
CECAD/CMMC proteomics core facility according to the standard procedure of the 
facility. The core facility further processed the samples using a ‘Q Exactive Plus Orbitrap’ 
(Thermo Fisher Scientific) coupled with an ‘EASY nLC LC’ (Thermo Fisher Scientific). 
Raw data were analysed with Maxquant (version 1.5.3.8). 
2.6.3 RNA sequencing (RNAseq) of cardiac total mRNA 
RNA isolation for RNAseq was performed using the 'Direct-zol RNA MiniPrep Kit' (Zymo 
Research) according to the manufacturer’s instruction. Purified RNA was submitted to 
the Cologne Centre for Genomics for further processing. Libraries were prepared using 
the 'TruSeq mRNA Stranded Sample Preparation Kit' (Illumina) and validated on a tape 
station (Agilent). Equimolar amounts of libraries were pooled, quantified (Peqlab KAPA 
Library Quantification Kit, Applied Biosystems 7900HT Sequence Detection System) and 
finally sequenced on a 'HiSeq4000 sequencer' (Illumina). Subsequently, the RNAseq 
data set was analysed by the CECAD Bioinformatic facility utilising the QuickNGS 
pipeline (Wagle et al., 2015), ensembl version 93(mm10). 
2.6.4 Amino acid quantification 
Amino acid quantification was performed by Dr. Susanne Brodesser and Christina Lucas 
from the CECAD Lipidomics facility. Amino acid levels in mouse heart were determined 
by 'Liquid Chromatography coupled to Electrospray Ionisation Tandem Mass 
Spectrometry' (LC-ESI-MS/MS) using a 'QTRAP 6500 triple quadrupole/linear ion trap 
mass spectrometer' (SCIEX) coupled to a '1260 Infinity Binary LC System' (Agilent). 
Amino acids were derivatised with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate 
using the 'AccQ-Tag Ultra Derivatisation Kit' (Waters). 
2.6.5 Metabolomics 
Metabolomic analyses were performed by Dr. Susanne Brodesser and Christina Lucas 
from the CECAD Lipidomics facility. Levels of nucleotides and intermediates (organic 
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acids, sugar phosphates) of the glycolysis and the citric acid cycle in mouse heart were 
determined by 'Anion-Exchange Chromatography coupled to Electrospray Ionisation 
High-Resolution Mass Spectrometry' (IC-ESI-HRMS) using a 'Q Exactive HF 
quadrupole-orbitrap mass spectrometer' coupled to a 'Dionex Integrion RFIC system' 
(Thermo Scientific). 
2.7 Software 
'Adobe Photoshop' (Adobe) was used to adjust contrast of scanned films globally and to 
excise relevant areas for further processing. Densitometric analyses were performed 
with 'Image Studio Lite' (Licor). Figures and model illustrations were generated utilising 
'Adobe Illustrator' (Adobe). For model illustrations selected medical images licensed 
under a Creative Commons Attribution 3.0 Unported License from 'Servier Medical Art' 
(Servier) were used. 'Prism 8' (GraphPad) served to generate graphs, charts and 
statistical analyses. 
2.8 Nomenclature 
In general, genes and transcripts are italicised. For genes, only the first letter is written 
in uppercase, whereas transcripts are entirely written in lowercase. Protein names are 
not italicised and fully written in uppercase. 
2.9 Chemicals 
Name Supplier 
Acetic Acid AppliChem 
Acetone AppliChem 
Acetyl-L-Carnitine   hydrochloride Sigma Aldrich 
Acetyl-L-Cysteine Sigma Aldrich 
Adenine Sigma Aldrich 
Adenosin-Tri-Phosphate ATP Sigma Aldrich 
ADP Adenosine 5’-diphosphate sodium Salt Sigma Aldrich 
Agar bacteriology grade AppliChem 
Agarose ultra pure Invitrogen 
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Name Supplier 
Alanine (L-) Sigma Aldrich 
Aminobenzaldehyde Sigma Aldrich 
Ammonia Solution 25% AppliChem 
Ammoniumpersulfat APS Sigma Aldrich 
Ampicillin sodium salt AppliChem 
Antimycin A Sigma Aldrich 
Arginine mono-hydrochloride (L-) Sigma Aldrich 
Ascorbic Acid Sigma Aldrich Life Sc. 
Asparagine monohydrate (L-) Sigma Aldrich 
Aspartic Acid (L-) Sigma Aldrich 
Benzamidin-Hydrochloride AppliChem 
Bis Tris  Santa Cruz 
Blue Native Marker GE 
Boric acid Sigma Aldrich 
Bromophenol Blue MERCK 
BSA  (Albumin from bovine serum) fatty acid free Sigma Aldrich 
Calcium Carbonate AppliChem 
Calcium chloride dihydrate MERCK 
Carnithine hydrochloride  Sigma Aldrich Life Sc. 
Catalase, bovine liver Sigma Aldrich 
CCCP (Carbonyl cyanide 3-chloro-phenylhydrazon) Sigma Aldrich 
Chloro-D-Phenylalanine Sigma Aldrich 
Chloroform AppliChem 
Citrat Synthase Sigma Aldrich 
Coomassie Brilliant Blue G250 AppliChem 
Creatin Monohydrate Sigma Aldrich Life Sc. 
Creatine Phosphokinase Type III, bovine Sigma Aldrich 
Cyclohexamide Sigma Aldrich 
Cysteine hydrochloride monohydrate (L-) Sigma Aldrich 
Cytochrome c, bovine heart Sigma Aldrich 
DDM Dodecyl-β-maltosicyl Roth 
DEPC AppliChem 
Diethylamine Sigma Aldrich 
Digitonin (HP) MERCK 
Dimethyl malonate Sigma Aldrich 
DMSO Dimethylsulfoxide  Sigma Aldrich 
DTT Dithiothreitol Sigma Aldrich 
ECL Thermo 
EDTA  Ethylenediaminetetraacetic acid Sigma Aldrich 
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Name Supplier 
EGTA Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic 
acid  
Sigma Aldrich 
EtBr Sigma Aldrich 
Ethanol abs. AppliChem 
Ethylmethansulfonate Sigma Aldrich 
FCCP Sigma Aldrich 
Formaldehyde (mol. Biol grade) Sigma Aldrich 
Glucose AppliChem 
Glutamic Acid (L-) Sigma Aldrich 
Glutamine (L-) Sigma Aldrich 
Glutaraldehyde solution  Grade I 50% Sigma Aldrich 
Glycerol Sigma Aldrich 
Glycine Molecular Biology grade AppliChem 
Glycogen Roche 
GTP Guanosine 5’triphosphate sodium salt Sigma Aldrich 
Guanindine hydrochloride Sigma Aldrich 
HCl 37% VWR 
Heparin Sodium salt Sigma Aldrich Life Sc. 
HEPES-Molecular biology grade AppliChem 
Hexane Sigma Aldrich 
Histidine mono hydrochloride monohydrate (L-) Sigma Aldrich 
Hydrogen peroxid solution Sigma Aldrich 
Iso-Pentane Methylbutanol VWR 
Isobutylmethylxanthine Sigma Aldrich 
Isoleucine (L-) Sigma Aldrich 
Isopropanol Applichm 
Ketamin hydrochloride CIIIN Sigma Aldrich 
Ketoglutaric acid disodium Sigma Aldrichlt dihydrate Aldrich Chemistry 
Ketoglutaric acid potassium Sigma-Aldrichlt Sigma Aldrich 
L-Glutathion (reduced) Sigma Aldrich 
L(+)-lactic acid AppliChem 
LB Medium - powder acc to Miller  AppliChem 
LB Medium - powder according to Lennox AppliChem 
Leucine (L-) Sigma Aldrich 
Lithium acetoacetate Sigma Aldrich 
Lysine mono-hydrochloride (L-) Sigma Aldrich 
Magnesium chloride hexahydrate Fluka Analytical 
Magnesium sulfate anhydrate AppliChem 
Malic acid Sigma Aldrich 
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Name Supplier 
Mannitol Biochemica AppliChem 
Mercaptoethanol 98% Sigma Aldrich 
MES ROTH 
Methionine (L-) Sigma Aldrich 
Methylbutane Sigma Aldrich 
Milk powder AppliChem 
MOPS Mol Bio grade AppliChem 
Myxothiazol Sigma Aldrich 
N-Lauroylsarcosine Sodium Salt Sigma Aldrich Life Sc. 
Nicotinamid Sigma Aldrich Life Sc. 
Nitro Blue Tetrazolium Sigma Aldrich 
NP40 Nonidet P40 Biochemica AppliChem 
Oligomycin Sigma Aldrich 
Ornithine monohydrochloride Sigma Aldrich Life Sc. 
Oxaloacetic acid Sigma Aldrich 
Palmitic Acid Sigma Aldrich Life Sc. 
Paraquat Methylviologendichloride Sigma Aldrich 
PBS Buffer (10X Dulbecco's) Powder AppliChem 
PBS Tablets Calbiochem 
PEG Polyethylene glycol Sigma Aldrich Life Sc. 
Peptone from meat MERCK 
Periodic Acid Sigma Aldrich 
Phenol AppliChem 
Phenol/Chloroform/Isoamylalcohol Roth 
Phenylalanine (L-) Sigma Aldrich 
Phenylmethanesulfonylfluorid PMSF Sigma Aldrich 
PMSF AppliChem 
Poly-L-Lysine Sigma Aldrich 
Polyethylenimine Sigma Aldrich Life Sc. 
Potassium chloride AppliChem 
Potassium hydrogen phosphate MERCK 
Proline (L-) Sigma Aldrich 
Protein Standard Sigma Aldrich 
Puromycin Sigma Aldrich 
Retinoic Acid Sigma Aldrich 
RNase A AppliChem 
RNAse ZAP Sigma Aldrich 
Rotenone Calbiochem 
Rotiphorese Gel 40 (37.5:1) ROTH 
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Name Supplier 
SDS granules Sigma Aldrich Life Sc. 
Serine (L-) Sigma Aldrich 
Sodium 3-hydroxybutyrate Sigma Aldrich 
Sodium acetate solution (3M, pH 5,2) Molecular Biology grade AppliChem 
Sodium azide AppliChem 
Sodium chloride for molecular biology Sigma Aldrich Life Sc. 
Sodium deoxycholate AppliChem 
Sodium fluoride AppliChem 
Sodium Hydrogen Carbonate AppliChem 
Sodium hydroxide Sigma Aldrich 
Sodium Orthovanadate AppliChem 
Sodium Phosphate dibasic Sigma Aldrich Life Sc. 
Sodium Phosphate monobasic Sigma Aldrich 
Sodium pyruvate Sigma Aldrich 
Sodium succinate dibasic hexhydrate Sigma Aldrich 
Sodium tetraborate Sigma Aldrich 
Sodium Thiosulfate Sigma Aldrich Life Sc. 
Sodium- L- Lactate Sigma Aldrich 
Sorbitol AppliChem 
Succinic Acid Sigma Aldrich 
Sucrose Sigma Aldrich Life Sc. 
Sulfuric Acid Fluka 
Superoxide Dismutase Sigma Aldrich 
TCEP HCl Thermo 
TEMED Sigma Aldrich 
TES Buffer grade AppliChem 
Thapsigargin Sigma Aldrich 
Threonine (L-) Sigma Aldrich 
TMPD Tetramethyl-p-phenylenediamin Sigma Aldrich 
Tri-sodium citrate dihydrate AppliChem 
Tricine ROTH 
Triton X-100, molecular biology grade AppliChem 
Trizma Base Sigma Aldrich Life Sc. 
TrypanBlue Sigma Aldrich 
Trypsin from bovine pancreas VWR 
Tryptophan (L-) Sigma Aldrich 
Tween 20 VWR 
Tyrosine (L-) Sigma Aldrich 
Uracil Sigma Aldrich Life Sc. 
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Name Supplier 
Urea Fluka Analytical 
Uridine Sigma Aldrich Life Sc. 
Valine (L-) Sigma Aldrich 
Valinomycin Sigma Aldrich 
Xylazine Hydrochloride Sigma Aldrich 
Xylol ROTH 
Yeast extract granulate for Microbiology MERCK 
Zinc Sulfate Heptahydrate Aldrich 
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3 Results 
3.1.1 Generation of DARS2/CHOP double knock-out mice   
   
Initial studies on DARS2 KO mice (heart and skeletal muscle-specific deletion of the 
mitochondrial aspartyl-tRNA synthetase) revealed a trend towards up-regulation of the 
stress-responsive TFs ATF5 and CHOP already from one week of age on. The present 
study aims to investigate further the stress response triggered by mitochondrial 
dysfunction in DARS2 KO mice in general, and to understand the function of the TF 
CHOP, as known effector of the ISR and first UPRmt associated TF, in detail (Dogan et 
al., 2014; Horibe and Hoogenraad, 2007; Pakos-Zebrucka et al., 2016). For this purpose, 
DKO mice deficient for DARS2 (heart and skeletal muscle-specific) and CHOP (whole-
body) were generated. Detailed information regarding the used mouse strains, the 
breeding procedure and genotypes of the animals used are given under 2.1.2 and 
summarised in the scheme below (Figure 3.1):  
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Figure 3.1: Breeding scheme for generation of WT, DARS2 KO, CHOP KO and DKO mice. 
Note that deletion of Chop applies to the whole body whereas Dars2 deletion only concerns heart 
and skeletal muscle. Allele nomenclature: wild type (wt), transgene (tg), flowed (fl) and knock-out 
(ko). 
To generate the Chop deletion-comprising mouse line (breeding II Figure 3.1), the newly 
acquired mouse strain B6.129S(Cg)-Ddit3tm2.1Dron/J from the Jackson Laboratory was 
employed. Disruption of Chop in the animals used for this study was verified by PCR 
(Figure 3.2A), and RNAseq (Figure 3.2B). Further validation by Western blot on the 
protein level failed, as all tested CHOP-detecting antibody did not work (data not shown).  
 
Figure 3.2: Genotypic validation of WT, CHOP KO, DARS2 KO and DKO mice.  
(A) Genotyping agarose gel electrophoresis of WT, CHOP KO, DARS2 KO and DKO mice. PCR 
products were generated from DNA isolated from ear biopsies using gene-specific primer pairs 
for Chop, CkmmCre and Dars2. (B) Exemplary RNAseq data track visualisation of the chop 
mRNA by UCSC genome browser of one animal per genotype. RNAseq was performed on 
cardiac samples of animals at p17 (±2) (n=4). 
 
Chop 
CkmmCre 
Dars2 
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3.1.2 Phenotypic changes caused by deletion of Dars2 develop 
prematurely upon loss of Chop 
The dedicated aim of the present study was to decipher the role of the stress-responsive 
TF CHOP, which is up-regulated from early-on in DARS2 KO animals developing 
mitochondrial dysfunction later in life but also in the muscles of human patients came 
down with the mitochondrial disease of progressive external ophthalmoplegia (PEO) 
(Dogan et al., 2014; Forsstrom et al., 2019). Loss of aspartyl-tRNA synthetase DARS2 
in heart and skeletal muscle was characterised by progressively impaired mitochondrial 
translation and followed by reduced levels of fully assembled respiratory chain 
complexes I, IV and (to a lesser extent) III from the age of three weeks on. As a result of 
this, DARS2 KO animals displayed severe OXPHOS deficiency as well as a massively 
increased heart to body weight ratio, indicating strong cardiomyopathy at six weeks of 
age. Finally, those pathological changes entailed a drastic reduction of lifespan to only 
6-7 weeks. Up-regulated mRNA levels of stress-responsive TFs such as chop, atf4 and 
atf5 as well as increased protein levels of further stress-associated markers (e.g. p62, 
LONP1 or HSP60) were predominantly detected in hearts but not in skeletal muscle of 
DARS2 KO animals (Dogan et al., 2014). Due to the prominent stress response 
activation primarily observed in the heart, all analyses of the present study were 
performed exclusively on cardiac samples. 
To predict the impact of depleting CHOP in this system turned out to be difficult, as 
published studies revealed very context-specific beneficial or unfavourable effects of the 
TF in different disease models (Yang et al., 2017). It appeared very quickly that CHOP 
deficiency, contrarily to the situation in the WT background, entails deleterious 
consequences in the DARS2 KO background. The already considerably shortened 
lifespan of DARS2 KO mice was further reduced by more than 50% to less than three 
weeks. In contrast, CHOP KO animals did not display any physical or behavioural 
abnormalities up to an age of one year in accordance with information provided by the 
Jackson Laboratory (Figure 3.3A).  
The distribution of genotypes in the litters followed Mendel's laws (data not shown), and 
as no sex-specific differences were observed, male and female animals were analysed 
together. Aiming to distinguish between early initiated adaptations and late pathological 
changes, animals were analysed at following average time points: One week after birth 
(p6), two weeks after birth (p13) and after the visible manifestation of the phenotype (p17 
(±2)). Since the vast majority of analyses were performed on animals at p13 and p17 
(±2) constituting the 'early' and 'late' stage of the phenotype in DKO mice, the latter will 
be referred to as DKOE (p13) and DKOL (p17 (±2)), respectively.  
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Figure 3.3: Phenotypic characterisation of DKO animals.  
(A) Kaplan-Meyer survival curves for WT (n=36), CHOP KO (n=35), DARS2 KO (n=47) and DKO 
animals (n= 60). Lifespan of DKO in comparison to DARS2 KO mice is significantly decreased 
(****). Viability of CHOP KO mice was WT-like in 12-month follow-up. (B) Heart gross morphology. 
(C) Bodyweight (n=12-14). (D) Heart weight (n=10-14) and (E) heart-to-body weight ratio (n=10-
13) of animals at p17 (±2). Bars represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001). (F) Fold changes of the cardiac hypertrophy markers nppa and nppb 
obtained from the RNAseq data set of DARS2 KO and DKOL mice in comparison to WT mice at 
p17 (±2) (n=4). 
During the first two weeks of life, no obvious phenotypic differences between DKO mice 
and their respective controls were visible. However, shortly after this age, DKO mice 
appeared to develop high stress sensitivity. Simple handling of those animals to punch 
ear tags necessary for identification, caused several DKOs to die during the procedure. 
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Usually, this routine is performed when animals are older than two weeks of age. Shifting 
ear clipping to postnatal day 13 (p13) latest, however, prevented loss of animals due to 
stress induced by the procedure. At p17 (±2) a phenotype characterised by inactivity, 
bent posture and unsteady gait manifested. Once those symptoms appeared, most of 
the affected animals died within 24 hours, calling for close monitoring of the litters from 
the age of approximately two weeks on. During this terminal stage, DKOL mice display a 
markedly reduced body weight combined with a severe dilated cardiomyopathy shown 
by a highly significant increase of the heart to body weight ratio (Figure 3.3B-E). The 
significant increase of natriuretic peptide A and B transcript levels (nppa and nppb, 
respectively) provide further evidence for degeneration of the cardiac tissue (Figure 
3.3F). Strikingly, all previously mentioned morphological changes, namely reduced 
lifespan, decreased body weight and progressing degeneration of the heart recapitulate 
the DARS2 KO phenotype. However, at the age DKOL display the described changes, 
none of them manifested in DARS2 KO mice, yet. CHOP KO mice generally did not 
exhibit differences to WT animals. 
At the histological level first pathological changes at p17 (±2) not only appeared in DKOL 
but also in DARS2 KO samples. Hematoxylin and eosin (H&E) staining were without 
pathological findings. In contrast, cytochrome c oxidase/ succinate dehydrogenase 
(COX/ SDH) staining, visualising the functionality of the respiratory chain by the 
respective enzymatic activities, uncovered anomalies in DARS2 KO and DKOL mice. 
While DARS2 KOs presented first signs of COX deficiency, characterised by weakened 
brown staining, DKOL mice developed a deficiency for both, COX and SDH. As frequently 
observed in mito-deficient mutants (Trifunovic et al., 2004), transmission electron 
microscopic (TEM) pictures visualised a mosaic distribution of mitochondria with 
structural defects in DKOL mice. Structural defects ranged from loss of cristae to 
disturbed organellar integrity. Furthermore, the structural arrangement of sarcomeres 
was compromised (Figure 3.4). Collectively, the data clearly demonstrated that loss of 
CHOP in the context of disturbed mitochondrial proteostasis intensifies pathological 
changes in the heart. In comparison to DARS2 KO mice OXPHOS deficiency assessed 
by COX/SDH staining as well as degeneration of the cardiac tissue developed 
prematurely. 
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Figure 3.4: DARS2 KO and DKOL hearts display pathological changes.  
Histological, enzymatic and transmission electron microscopy (TEM)-based analyses of cardiac 
tissue sections (haematoxylin and eosin (H&E) and cytochrome c oxidase/ succinate 
dehydrogenase (COX/SDH) staining; scale bars: 50µm) (n=3) and biopsies (TEM, scale bars: 
2µm) (n=1) at p17 (±2).  
To perform an unbiased analysis of the consequences triggered by CHOP deficiency in 
the DARS2 KO background, whole tissue proteomics of mice at p6 and p17 (±2) were 
performed. While gene ontology enrichment analysis did not result in any significantly 
enriched terms at p6 (data not shown) the situation was different at p17 (±2). At that time, 
DKOL mice exhibit robust enrichment of many metabolically associated terms in contrast 
to the respective controls (WT, CHOP KO and DARS2 KO). Besides categories related 
to oxidative phosphorylation, biological processes concerning amino acid metabolism 
were immensely represented (Figure 3.5).  
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Figure 3.5: GO term analysis revealed strong enrichment of amino acid-related categories 
in DKOL mice.  
Gene enrichment analysis using gene ontology (GO) terms for biological pathways evaluating 
significant changes in the proteomic data set (FDR<0.05; Enrichment factor>1) of DKOL vs. WT 
mice at p17 (±2). CHOP KO and DARS2 KO in comparison to WT mice did not display any 
significantly enriched GO terms. 
With respect to the significant enrichment of amino acid metabolism-related GO terms in 
DKOL mice, amino acid levels were additionally quantified by mass-spectrometry (Figure 
3.6). Except for cysteine, all amino acids were successfully detected. In DARS2 KOs 
only two amino acids were changed: threonine (increased) and histidine (decreased). 
Consistent with the results from the proteomic analysis, 13 out of 19 amino acid species 
showed significant increases in DKOL mice. Serine, glutamine, glutamate and aspartate 
levels were not changed. Considering the different serine-related GO terms enriched in 
DKOL (Figure 3.5), the unaltered serine levels suggest an increased flux of serine into 
the one-carbon (1-C) cycle.  
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Figure 3.6: Metabolic alterations induced by loss of DARS2 and CHOP result in overall 
elevated amino acid levels in DKOL mice.  
Amino acid levels determined by liquid chromatography coupled to electrospray ionisation 
tandem mass spectrometry (n=4-5). Bars represent mean ± SD (One-way ANOVA, *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001). 
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Similar to the amino acid-related results, the proteomic data set revealed only a few 
significant changes of individual RC subunits in DARS2 KO mice. In DKOLs, the 
tendency towards reduced RC subunits was exacerbated with 43 significantly decreased 
RC subunits. No significant changes were observed in CHOP KO mice (Figure 3.7A). 
Surprisingly, super-complex (SC) assembly appeared to be affected in comparable 
proportions in DARS2 and DKOL mice, suggesting an impairment at the assembly level 
despite less pronounced reduction of individual RC subunits in DARS2 KOs (Figure 
3.7B). Northern blot analysis revealed significant increases of selected RC subunit-
encoding transcripts (cox3, nd1) in DKOL and DARS2 KO mice. Compared to DKOL 
mice, increases of cox3 and nd1 levels in DARS2 KOs occurred to a lesser extent. In 
addition, the 12S mito-ribosomal RNA was up-regulated in DKOL animals (Figure 3.7C, 
D). Based on those results and along with unaltered mtDNA levels (Figure 3.7E), 
potential causes of the strong alterations on the protein level in DKOL animals most likely 
originating from the post-transcriptional level.  
Results  62 
 
 
Figure 3.7: Lack of CHOP in DARS2-deficient hearts promotes loss of the respiratory chain. 
(A) Heatmap displaying the iBaq values of all significantly changed respiratory chain (RC) 
subunits (SUs) in the DKOL background (q<0.05, log2(FC)>|1|) along with the according iBaq 
values in WT, CHOP KO and DARS2 KO mice. iBaq values were determined by label-free 
quantitative proteomics of the heart (n=4). RC SUs with significant changes in the DARS2 KO 
background are labelled with an asterisk. No significant changes occurred in CHOP KO compared 
to WT mice. (B) BN-PAGE and subsequent Western blot analysis of OXPHOS complexes and 
super-complexes (SCs) in isolated mitochondria (n=3). Subunit-specific antibodies (left) were 
used to detect respective subunit-containing complexes and SCs (right). (C) Northern blot 
analysis and (D) relative quantification of mitochondrial transcript levels. mRNA levels were 
normalised to 18S rRNA. (E) Relative mtDNA levels determined by qPCR of isolated DNA using 
an Nd1-specific primer pair. Results were normalised to hexokinase-2 expression. No significant 
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changes were detected. Bars represent mean ± SD (One-way ANOVA, *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001). 
DARS2 deficiency results in a primary defect in mitochondrial translation, which is the 
expected leading cause for the observed perturbations of the mitochondrial proteome. 
However, the mitochondrial proteome of DKO mice showed larger changes as the one 
of DARS2 KO animals (Figure 3.7A). In order to assess mitochondrial translation in 
DARS2 KO and DKOL mice, in organello translation was performed with freshly isolated 
cardiac mitochondria. Although the overall synthesis rate of total mitochondrial proteins 
was not changed at p17 (±2) in DARS2 KO mice, individual proteins presented altered 
synthesis rates compared to CHOP KO and WT samples. Synthesis of 
mitochondria-encoded proteins was reduced, with the exception of five proteins (see 
bold labelling on the left side of Figure 3.8A) compensating on the level of overall 
synthesis rate (Figure 3.8A-C). Those proteins (namely ND2, ND1, ATP6, ATP8 and 
ND4L) contain low amount of aspartate residues, thus translation can occur more easily 
under conditions of a translation machinery devoid of aspartyl residues-charged tRNAs. 
Surprisingly, loss of CHOP in DARS2 KO animals additionally affected mitochondrial 
protein synthesis. The overall protein synthesis rate in DKOL mitochondria was reduced 
by 20% (Figure 3.8C). Whereas the five above-mentioned RC SUs with low aspartate 
levels displayed the same synthesis pattern in DKOL mitochondria, the reduction of the 
synthesis rate for all the other proteins was much stronger than in DARS2 KO mice 
(Figure 3.8A-B).  Subsequently, the bioenergetic consequences of reduced RC subunit 
availability (at least partially) caused by diminished mitochondrial translation rates were 
assessed by high-resolution respirometry following a SUIT protocol (Figure 3.8D) 
(Lemieux et al., 2011). Therefore, freshly isolated cardiac mitochondria were provided 
with pyruvate, glutamate and malate as well as succinate, feeding electrons in complex 
I and II, respectively. Oxygen consumption rates were recorded in parallel. Oxygen 
consumption is correlating with the proportion of on-going ADP phosphorylation, hence 
state 3 is also called the phosphorylating state. Coupling efficiency was monitored by 
addition of the complex V inhibitor oligomycin (state 4, also called the non-
phosphorylating state). To finally determine the maximum capacity of the electron 
transfer system (ETS) of complex I and II, mitochondria were uncoupled by FCCP 
(carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone) treatment. By additionally 
inhibiting complex I with rotenone, the maximum ETC capacity of complex II was 
determined. Complex I-mediated respiration as well as combined respiration of complex 
I and II proved to be significantly decreased in DKOL mice compared to WT, CHOP KO 
and DARS2 KO mice. Additionally, proton leak characterised by reduced state 4 
respiration was elevated in DKOL. In line with complex I-based state 3 respiration being 
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mainly affected in DKOL mice, the combined maximum capacity of the ETS for complex 
I and II was significantly reduced in those mice (Figure 3.8D).  
 
Figure 3.8: Mitochondrial translation defect in DKOL results in a respiratory defect at the 
organelle level.  
(A) In organello translation assay of cardiac mitochondria at p17 (±2). De novo protein synthesis 
was determined after one hour of 35S-methionine pulse labelling; protein turnover was assessed 
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after three hours of cold chase. Subsequently, isolated proteins were separated by SDS-PAGE. 
Individual proteins exhibiting increased synthesis rates in DKOL mice are labelled in bold. (B) 
Coomassie brilliant blue stained gels served as loading control for (A). (C) Relative protein 
synthesis and turnover rates calculated from the experiment shown in (A-B) and a second 
independent assay (n=3). (D) Oxygen consumption of intact cardiac mitochondria at p17 (±2) 
determined by oxygraph measurement. State 3: ADP-stimulated respiration of complex I (CI) and 
complex I and II (CI+CII) fed with the respective substrates (CI: pyruvate, malate, glutamate; CII: 
succinate). State 4: Determination of leak respiration by oligomycin-driven inhibition of CV. ETS: 
Maximum capacity of the ETS determined by titration with FCCP to uncouple mitochondria. 
Subsequent inhibition of CI by rotenone allowed determination of the maximal CII ETS capacity 
(n=3-4). (E) Cardiac ATP levels at p17 (±2) determined by metabolomic analyses: anion 
exchange chromatography followed by electrospray ionisation high-resolution mass spectrometry 
(n=8-9). Bars represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001). 
Finally, cardiac ATP levels were determined (Figure 3.8E). A possible trend towards 
decreased ATP levels in DKOL mice was detected by mass spectrometry, suggesting 
that the previously detected respiratory defect impacts on ATP availability in the heart. 
However, those results have to be interpreted with caution, as the analysis could not be 
performed under ideal conditions.  
Taken together, those results are raising novel issues. First, similar complex assembly 
defects in DARS2 KO and DKOL mice are not resulting in similar respiratory defects, as 
DARS2 KO respiration rates are WT-like. Notably, TEM pictures revealed local 
accumulations of mitochondria displaying severely compromised organellar structure in 
DKOL animals. Those defects most likely impact on the membrane potential and thereby 
negatively affect mitochondrial respiration. Second, mitochondrial translation is affected 
at a much earlier time point in DKO than in DARS2 KO mice in general, arguing for 
additional effects beyond loss of Dars2 impacting on translation.  
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To investigate if DARS2-deficiency, the resulting respiratory chain defects and possibly 
induced metabolic adaptations also affect the TCA cycle, TCA cycle intermediates were 
quantified by metabolomic analyses (Figure 3.9). The TCA cycle is not only required to 
feed the respiratory chain with NADH and FADH2, respectively, but also provides 
precursors for numerous biosynthetic pathways (Owen et al., 2002). The most prominent 
changes were detected for citrate. In DKOL mice, citrate levels show a four to five-fold 
increase in comparison to the other three genotypes. This phenotype was described 
before for patient cell lines harbouring mtDNA mutations (Chen et al., 2018). 
  
Figure 3.9: DKOL mice accumulate high levels of citrate in cardiac tissue. 
Levels of TCA cycle intermediates at p17 (±2) determined by metabolomic analyses: anion 
exchange chromatography followed by electrospray ionisation high-resolution mass spectrometry 
(n=7-9). Bars represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001). 
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3.1.3 Mitochondrial and cellular stress responses activated in 
DARS2 KO and DKOL mice 
As CHOP is a stress-responsive TF, it is essential to analyse how the deficiency of this 
TF influences the resulting mitochondrial and cellular stress-related pathways. Therefore 
unbiased techniques (proteomics, transcriptomics) were combined with targeted 
approaches in order to identify the major driving processes and monitor pathways with 
possible relevance at the same time. 
3.1.3.1 Omics analyses showcase transcriptional and translational 
changes of ATF4 targets as a central aspect of the response to 
mitochondrial dysfunction in DARS2 KO and DKO mice 
The global approach of omics analyses can facilitate the perception of a broader context, 
constituted of many single changes. Aiming to understand the on-going early changes 
in DARS2 KO mice at p17 (±2), the RNAseq data set was filtered, selecting only 
significantly changed transcripts (p<0.05; FC larger than 1.5 or smaller than -1.5) in 
DARS2 KO compared to WT mice. The respective FCs of selected transcripts for CHOP 
KO, DARS2 KO, and DKOL vs. WT mice were plotted on a heat map (Figure 3.10A). 
CHOP KO samples displayed no significant changes contrary to the transcript levels in 
DKOL samples, which were all (like the DARS2 KO samples) significantly changed. The 
spectrum of determined FCs in DARS2 KO mice was relatively narrow, ranging from -
4.7 to 4.32 vs. -2.3 to 240.47 in DKOL mice. Also, the predominant number of the selected 
transcripts in DARS2 KO and DKOL samples was up-regulated. 
Interestingly, the massive increase of FC range in DKOL mice was solely due to up-
regulation, as changes in down-regulated transcripts were in a similar range in 
DARS2 KO and DKOL animals. Hence, loss of Chop entails a general re-enforcement of 
transcriptional alterations already present in DARS2 KO mice. The transcriptional up-
regulation of transcripts suggests a repressive effect of CHOP (Figure 3.10A). For further 
analysis of the RNAseq data set, the Cytoscape plug-in iRegulon, utilising large motif 
and track collections to predict putative regulators of a selected gene list, was used 
(Janky et al., 2014). ATF4 was identified with a normalised enrichment score (NES) of 
18.73 as the presumed master regulator of the transcript list. For comparison: the 
second-best motive cluster obtained an NES of 5.29. According to this analysis, 41 of 
the 60 differentially expressed transcripts in DARS2 KO mice are ATF4 targets. 
Additionally, the transcription of the vast majority of those dedicated transcripts is further 
increased upon CHOP deficiency (Figure 3.10B). 
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Figure 3.10: RNAseq analysis suggests ATF4-like regulation of DARS2 KO and DKOL 
transcripts. 
 (A) Heat map displaying the relative FCs of all significantly changed transcripts in the DARS2 
KO background (p<0.05, FC>|1.5|) along with the according FCs in CHOP KO (no significant 
changes) and DKOL mice. FCs were determined by RNAseq of the hearts at p17 (±2) (n=4). (B) 
Heat map displaying the respective transcripts of (A) identified by cis-regulatory sequence 
analyses using iRegulon as potential ATF4 targets. 
Often enough, the central dogma of molecular biology is not applicable one-to-one, 
transcriptional changes not necessarily being followed by similar changes of the 
proteome. To understand if the observed enhanced ATF4-like regulation in DKOL 
compared to DARS2 KO animals on the transcript level is conveyed to the protein level 
as well, the proteomics data of DKOL and DARS2 KO samples were directly compared. 
Selecting only significantly increased proteins in DKOL vs. DARS2 KO samples (q<0.05, 
FC>2), a list of 62 proteins was generated. Further analysis of this list using iRegulon 
(Janky et al., 2014) affirmed a major proportion of ATF4 targets (33/62) among 
significantly increased proteins in the DKOL vs. DARS2 KO mice (Figure 3.11). 
Collectively, the omics analyses provide evidence for congruent changes in the 
transcriptome and translatome of DARS2 KO and DKOL mice. DKOL samples illustrated 
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a reinforced intensity of the detected changes in DARS2 KO mice. Furthermore, ATF4-
like regulation was identified as the most probable cause for the mentioned 
transcriptional and translational changes. 
 
Figure 3.11: Enhanced ATF4-like regulation of the DKOL proteome.  
Classification of significant changes (q<0.05, log2(FC)>|1|) in the DKOL vs. DARS2 KO proteomes 
determined by label-free quantitative proteomics of cardiac samples at p17 (±2) (n=4) by means 
of the Cytoscape plug-in iRegulon in ATF4 (violet) and non-ATF4 targets (blue). 
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3.1.3.2 ISR activation in DKOL exceeds the degree of activation in age-
matched DARS2 KO mice 
The omics analyses suggested a CHOP-dependent role in phenotype progression for 
ATF4. Since CHOP had been previously linked to both, the UPRmt and the ISR (Aldridge 
et al., 2007; Horibe and Hoogenraad, 2007; Michel et al., 2015; Restelli et al., 2018; 
Zhao et al., 2002), it seemed obvious to subject those stress responses to a general 
investigation. First analyses of commonly used UPRmt markers such as the mitochondrial 
proteases LONP1 (Lon protease homolog, mitochondrial), AFG3L2 (AFG3-like protein 
2) and CLPP (ATP-dependent Clp protease proteolytic subunit, mitochondrial) on the 
protein level did not reveal significant changes neither in DARS2 KO nor DKOL mice 
(Figure 3.12A, B).  
As mentioned in the introduction, the UPRmt concept harbours deficits regarding the 
precise definition of the pathway (1.2.1.2). Also, the method of choice to detect UPRmt 
activation is a matter of debate. As changes of chaperones - regularly present at high 
levels in the cell - are often barely visible on the protein level, the quantification of 
transcript levels was proposed as gold standard marker for UPRmt activation (Münch, 
2018). Although the biological significance of those changes are worthy of discussion, 
the transcript levels of three UPRmt-associated chaperones and proteases each are listed 
below (Table 3.1). Based on the debatable criteria proposed in the publication mentioned 
above, it could be reasoned that the UPRmt is activated in DKOL mice. 
Table 3.1: RNAseq data suggest activation of the UPRmt in DKOL mice.  
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
 DARS2 KO vs. WT DKOL vs. WT DKOL vs. DARS2 KO 
Transcript Fold 
change 
P-
value 
Fold 
change 
P-
value 
Fold 
change 
P-
value 
mtHsp70 1.31 **** 2.13 **** 1.58 **** 
hsp10 1.1 0.09 1.66 **** 1.49 **** 
hsp60 1.15 *** 1.17 ***   
lonp1 1.73 **** 2.57 **** 1.33 ** 
afg3l2 1.1 * 2.26 **** 2.04 **** 
yme1l1 -1.05 0.31 1.56 **** 1.63 **** 
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 Whereas ATF4 was not detectable under unstressed conditions in WT and CHOP KO 
samples, DKOL mice exhibited significantly increased ATF4 protein levels. Also, DARS2 
KO animals showed a trend towards augmented ATF4 protein levels. The spread of 
ATF4 protein levels most probably reflects differences in the phenotype progression of 
individual animals (Figure 3.12A, B). A direct measure for ISR activation is an increased 
proportion of phosphorylated eIF2α moieties. Both DARS2 KO and DKOL mice 
presented explicit activation of the ISR. DKOL animals, however, clearly exceeded the 
phosphorylated vs. un-phosphorylated eIF2α ratio of DARS2 KO mice (Figure 3.12C, D). 
Protein levels of the bona fide ATF4 targets ASNS (asparagine synthetase), MTHFD2 
(mitochondrial methylenetetrahydofolate dehydrogenase), SHMT2 (mitochondrial serine 
hydroxymethyltransferase) and PYCR1 (pyrroline-5-carboxylate reductase) were 
analysed, to assess whether increased ATF4 protein levels resulted into increased 
activation of ATF4 targets. A vast increase ranging from 10 to 275-fold of all four ATF4 
targets was detected in DKOL mice (Figure 3.12E).  
Collectively, the data provided minor evidence for the activation of the UPRmt in 
DARS2 KO and DKOL mice. Contrary to this, the ISR was doubtlessly activated in both 
DARS2-deficient mouse models. The extent of ISR activation, however, is amplified by 
a multiple of times upon CHOP deficiency.  
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Figure 3.12: Distinct ISR activation in DARS2 KO mice is tremendously enhanced upon 
loss of Chop.  
Western blot analysis of UPRmt markers (A), total and pSer51 eIF2α (C) and ATF4 downstream 
targets (E). HSC70 serves as loading control. (B, D, F) Quantification of Western blots shown in 
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(A, C, E). Experiments were performed on cardiac lysates of mice at p17 (±2). Bars represent 
mean ± SD (One-way ANOVA, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
3.1.3.3 The ISR is the earliest detected activated stress pathway in DKO 
animals 
It is commonly accepted, that during the terminal stage of a phenotype large variety of 
changes occur, complicating the task to separate cause and consequence. For this 
reason, we decided to analyse the animals not only around p17 (±2) during the terminal 
stage of DKOL mice, but also at one week of age (p6), far before the health status of 
DKO mice deteriorates. The corresponding proteomic data set provided us with a list of 
in total six significantly changed proteins in DKO compared to WT mice (Table 3.2).  
Table 3.2: Significantly changed proteins (q<0.05) determined by label-free quantitative 
proteomics of cardiac samples at p6 in DKO vs. WT mice.  
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s.: not significant 
 CHOP KO vs. WT DARS2 KO vs. WT DKO vs. WT 
Protein Fold 
change 
q-
value 
Fold 
change 
q-
value 
Fold 
change 
q-
value 
GBP5 1.84 n.s. 22.61 n.s. 21.51 * 
NUDT12 18.16 **** 19.59 n.s. 19.28 * 
TUBA1c 10.49 **** 12.57 n.s. 7.92 * 
EPPK1 1.10 n.s. -1.49 n.s. -5 * 
RPAP1 -1.96 n.s. -4.55 n.s. -11.11 **** 
ABLIM1 -2.94 n.s. -2.78 n.s. -11.11 * 
 
Out of those six candidates, GBP5 (Guanylate-binding protein 5) was the only protein 
striking out due to a possible link to mitochondrial dysfunction. GBP5 was previously 
shown to be an activator of the NLRP3 (NACHT, LRR and PYD domains-containing 
protein 3) inflammasome assembly in mammals (Shenoy et al., 2012). The link between 
innate immunity and mitochondria is known for a long time. In recent years the topic 
attracted notice in the scientific community since mtDNA was established as a cell-
intrinsic trigger of the anti-viral innate immune response (Oka et al., 2012; West et al., 
2015). NLRP3 inflammasome activation was assessed indirectly by caspase-1 and 
interleukin-1β cleavage, in order to investigate whether inflammasome activation is 
playing a role in DARS2 KO or DKO animals. However, in neither case significant 
changes were detected (data not shown). Furthermore, the protein levels of NLRP3 and 
ASC, an activating adapter for the inflammasome formation (He et al., 2016b), were not 
affected (Figure 3.13A).  In DARS2 KO mice no significant changes were detected.  
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Although, the RNAseq analysis around p6 did not reveal significant changes (data not 
shown) the mRNA levels of a few dedicated transcripts officiating as markers for the 
UPRmt or the ISR were tested (Figure 3.13B). Because the two ATF4 
targets Cth and Mthfd2 showed a high level of variation, observed strong tendencies 
(eight-fold and 14-fold, respectively) for up-regulation in DKO mice were not 
significant (Figure 3.13B). As the ISR signalling cascade starts with eIF2α 
phosphorylation resulting in increased atf4 translation and preceding transcriptional 
changes in the nucleus (Pakos-Zebrucka et al., 2016), phospho-eIF2α and ATF4 protein 
levels were analysed. Similarly to ATF4 target mRNA levels before, individual DKO 
animals exhibited increased levels of phosphorylated eIF2α and ATF4, showcasing 
differences in phenotype progression (Figure 3.13C-F). Taken together, analysis of one-
week-old animals provided first indications for an activated ISR in DKO mice. 
 
Figure 3.13: At p6 DKO animals provide first indications for ISR activation.  
(A) Western blot analysis and (B) relative protein levels of NLRP3, ASC and MRPS12. (C, D) 
Western blot analysis and (E, F) relative protein levels of total and pSer51 eIF2α as well as ATF4, 
respectively. HSC70 serves as loading control. Bars represent mean ± SD (One-way ANOVA, no 
significant changes detected). 
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3.1.3.4 UPRmt and ISR show different degrees of activation during the 
terminal stages of DARS2 KO and DKOL animals, respectively 
A direct comparison between the terminal stages of DKOL mice around p17 (±2) and 
DARS2 KO mice at six weeks of age could provide further insight into the relative degree 
of activation of UPRmt and ISR.  
 
Figure 3.14: DARS2 KO mice display upregulation of UPRmt markers at six weeks of age. 
(A) Western blot analysis and (B) relative protein levels of UPRmt markers. HSC70 serves as 
loading control. Bars represent mean ± SD, samples were normalised to WT mice of the 
respective age (2 weeks (p17±2): one-way ANOVA; 6 weeks: two-tailed t-test; *p<0.05, **p<0.01). 
Previous results demonstrated that UPRmt activation was not detectable on the protein 
level neither in DARS2 KO nor DKOL animals at p17 (±2) (3.1.3.2). In accordance with 
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previous work of the lab, up-regulation of the UPRmt markers LONP1, AFG3L2, HSP60 
and mtHSP70 but not CLPP were observed in DARS2 KO mice at six weeks of age 
(Dogan et al., 2014; Seiferling et al., 2016) (Figure 3.14). Based on those results a major 
role of the UPRmt in the accelerated deterioration of the health status of DARS2 KO mice 
induced by CHOP deficiency is improbable. 
Contrary to the UPRmt, first signs of ISR activation in individual DKO mice were already 
detected at p6 (3.1.3.3). At p17 (±2) the ISR was strongly activated in DKOL mice while 
individual DARS2 KO mice exhibited first signs of initial activation (3.1.3.2). At six weeks 
of age, DARS2 KO animals displayed robust ISR activation characterised by a 
significantly increased phospho-eIF2α to eIF2α ratio comparable to DKOL mice around 
p17 (±2) (Figure 3.15A, C). Moreover, increased ATF4 activity in DARS2 KO animals 
was determined by protein level quantification of the bona fide ATF4 targets SHMT2, 
ASNS and PYCR1  (Figure 3.15B, D). Taken together, the data suggest a time-
staggered activation of the ISR initiated around p6 in DKOL and around p17 (±2) in 
DARS2 KO mice. Direct comparison of the p-eIF2α to eIF2α ratios of DKOL and DARS2 
KO during the respective terminal stages (Figure 3.15C) might indicate a stronger 
activation of the stress pathway in DKOL mice. 
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Figure 3.15:  Loss of Chop precedes ISR activation caused by DARS2 deficiency from six 
to less than three weeks of age.  
Western blot analysis of total and pSer51 eIF2α (A) and ATF4 downstream targets (B). HSC70 
serves as loading control. (C, D) Quantification of Western blots shown in (A, B). Bars represent 
mean ± SD, samples were normalised to WT mice of the respective age (2 weeks (p17±2): one-
way ANOVA; 6 weeks: two-tailed t-test; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
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3.1.3.5 Activation of the ISR results in inhibition of cytoplasmic protein 
synthesis in DKOE mice 
The ISR pathway acts through two distinct effects: (i) preferential translation of stress-
responsive mRNAs like the atf4 transcript and (ii) global inhibition of CAP-dependent 
protein synthesis (Pakos-Zebrucka et al., 2016). Given the high relevance of the ISR for 
the mouse models in this study (3.1.3.1 - 3.1.3.4), relative protein synthesis rates were 
assessed (Figure 3.16). During the ISR a shift in translational programmes occurs, as 
the formation of the pre-initiation complex (PIC) for translation is inhibited by 
phosphorylation of eIF2α. The resulting inhibition of cytoplasmic protein synthesis is 
accomplished by eIF2α-independent translation of a specific subset of mRNAs, like 
the atf4 transcript (Guan et al., 2017; Krishnamoorthy et al., 2001; Pakos-Zebrucka et 
al., 2016). In vivo protein synthesis rates were determined by the SUnSET assay. This 
assay is based on intraperitoneal puromycin injection in mice and subsequent detection 
of puromycin incorporation in nascent protein chains by Western blot (Schmidt et al., 
2009). Cytoplasmic protein synthesis rates were equal among all four genotypes at one 
week of age (Figure 3.16A, C), in line with only mild changes on the molecular level in 
DKO mice at p6 (3.1.3.3).  
 
Figure 3.16: DKOE animals exhibit inhibition of protein synthesis and up-regulation of 
gadd34 mRNA levels, two hallmarks of the ISR.  
Western blot analysis of puromycin-injected animals at p6 (A) and p13 (±1) (B) for determination 
of relative protein synthesis rates (C, D). HSC70 serves as loading control.  
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However, around p13 a striking reduction down to 30% of residual protein synthesis was 
observed in DKOE mice (Figure 3.16B, D), indicating full ISR activation in DARS2/CHOP 
double-deficient animals at two weeks of age.  
3.1.3.6 Re-initiation of cytoplasmic protein synthesis in DKOL animals 
coincides with further reinforced pathological changes 
Previous findings revealed a reduction of global protein synthesis in DKOE mice to 30% 
of the WT level (3.1.3.5). This raised the question, how protein synthesis-deficient   DKOE 
mice can survive three to five more days before reaching the final stage of the phenotype. 
For this reason, the SUnSET assay (Schmidt et al., 2009) was repeated with animals of 
all genotypes at p17 (±2). Surprisingly, the inhibition of protein synthesis, a hallmark of 
the ISR, is entirely reversed in DKOL mice (Figure 3.17A, B). This finding implies that 
translation in DKOL animals was not limited to mainly stress-responsive mRNAs 
anymore. Whereas control mice exhibited no changes in the protein levels of ISR 
markers from p13 to p17 (±2) (data not shown), DKOE and DKOL mice did. A rising trend 
for phospho-eIF2α to eIF2α ratios, similar to ATF4 and ATF4 target protein levels (ASNS, 
SHMT2, PYCR1), was observed (Figure 3.17C-E). This suggests that stress-specific and 
standard protein syntheses are both simultaneously performed. In conclusion, several 
high-energy demanding processes such as re-initiation of protein synthesis and 
enhanced ATF4-driven amino acid synthesis (Figure 3.5 and Figure 3.6) concur with loss 
of mitochondrial respiration in the heart (Figure 3.8), an organ covering its high energy 
demand under normal conditions to 90% by oxidative phosphorylation (Mootha et al., 
1997). As a consequence, the heart of DKOL mice undergoes an energy crisis during 
which it is not surprising to observe systemic changes like hypoglycemia (Figure 3.17F) 
besides pathological changes in the organ itself (Figure 3.3, Figure 3.4).  
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Figure 3.17: In contrast to the current model of the ISR, protein synthesis in DKOL mice is 
re-initiated during the ISR.  
Western blot analysis of puromycin-injected animals at p17 (±2) to determine relative protein 
synthesis rates (B). (C) Western blot analysis and (D, E) relative protein levels of ISR markers. 
HSC70 serves as loading control. (F) Blood glucose levels determined in non-fasted animals. (C-
F) Direct comparison of early (DKOE) and late stage (DKOL) DKO mice.  Bars represent mean ± 
SD (One-way ANOVA; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
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In addition to the re-initiation of global protein synthesis and the deterioration of the 
health status, DKOL mice displayed further differences in comparison to DKOE animals. 
Also, on the level of mitochondrial translation (Figure 3.18A) and RC complex assembly 
(Figure 3.18B) a striking difference between early and late stage of the phenotype was 
observed. Whereas DKOE did not differ from WT animals, DKOL mice were characterised 
by loss of mitochondrial translation and RC complex assembly (Figure 3.18B), as already 
described earlier (Figure 3.8). It seems particularly conspicuous that DARS2 KO mice 
displaying first changes, e.g. at the level of RC complex assembly (Figure 3.18B) without 
a measurable impact on respiration (Figure 3.8A, D) exhibit stronger changes in 
comparison to WT than DKOE mice.  
Hence, although DARS2 KO animals display early changes on the molecular level 
delayed for a brief period by CHOP deficiency, DARS2 KO animals can maintain their 
state of health over an extended period, recognizable by a lifespan of six to seven weeks 
in contrast to less than three weeks for DKOL mice. 
 
Figure 3.18: Mitochondrial translation and RC complex assembly of DKOE mice is 
comparable to WT mice.  
(A) In organello translation assay of cardiac mitochondria. De novo protein synthesis was 
determined after one hour 35S-methinonine pulse labelling. Coomassie brilliant blue stained gel 
serves as loading control. DKO mice were littermates, phenotype progression however occurred 
faster in the DKOL animals. The observed results were reproduced in additional experiments 
resulting in a total number of replicates of 3 (n=3). (B) BN-PAGE and subsequent Western blot 
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analysis of OXPHOS complexes and super-complexes (SCs) in isolated mitochondria directly 
comparing early (DKOE) and late stage (DKOL) DKO mice (n=2-3). Subunit-specific antibodies 
(left) were used to detect respective subunit-containing complexes and super-complexes (right). 
3.1.3.7 Despite CHOP deficiency the negative feedback loop of the ISR is 
activated in DKOL mice  
The last uninvestigated ISR hallmark in the context of this work was the GADD34 
controlled negative feedback loop. GADD34 is essential for de-phosphorylation of eIF2a 
and results in de-activation of the ISR (Novoa et al., 2001; Novoa et al., 2003). 
Transcriptional activation of Gadd34 in the course of the ISR was shown to depend on 
CHOP (Marciniak et al., 2004). Therefore, it was surprising to detect the sharpest 
increase of gadd34 transcripts at p17 (±2) in DKOL mice. Since those mRNA levels 
ranged in a comparable order of magnitude as gadd34 levels in DARS2 KO mice at six 
weeks, an impairment of the ISR's negative feedback mechanism in DKO mice is 
implausible (Figure 3.19).  
Hence, the hallmarks of the ISR, namely (i) increased levels of phosphorylated eIF2α, 
(ii) ATF4 activation, (iii) inhibition of cytoplasmic protein synthesis and (iv) activation of 
the negative feedback loop, were fully recapitulated by DKO animals.   
 
Figure 3.19: CHOP deficiency in DARS2 KO mice does not affect the GADD34-mediated 
negative feedback loop of the ISR. 
(E) Assessment of relative gadd34 mRNA levels in 2 and 6 week old animals by qPCR. Bars 
represent mean ± SD, samples were normalised to WT mice of the respective age (2 weeks 
(p17±2): one-way ANOVA; 6 weeks: two-tailed t-test; *p<0.05, **p<0.01, ***p<0.001). 
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3.1.3.8 Assessment of further potentially relevant, stress-related pathways 
3.1.3.8.1 Alterations of downstream effectors of AMPK/ Akt/ mTOR 
signalling indicate metabolic adaptations to the modified energy 
status of DKOL hearts 
Metabolic pathways are characterised by a high degree of interdependence. As a 
metabolic organelle, mitochondria contribute to a variety of different pathways such as 
amino acid metabolism (Owen et al., 2002) or β-oxidation of fatty acids (Drysdale and 
Lardy, 1953). Therefore, impairing mitochondrial processes, in particular, is equivalent 
to interference with metabolism, in general. Moreover, it is a well-known phenomenon 
that, upon the development of cardiomyopathy, the heart is undergoing a switch of 
substrate preference. Fuel utilisation shifts from the predominant use of fatty acids, 
processed by fatty acid oxidation, to glucose, the fuel of choice of the foetal heart mainly 
relying on glycolysis (Lehman and Kelly, 2002). Three kinases deeply involved in 
regulation of metabolism are (i) AMPK (5'-AMP-activated protein kinase), the 'master 
regulator of metabolism', (ii) AKT (RAC-alpha serine/threonine-protein kinase), with 
major importance for the regulation of glucose metabolism, and (iii) mTOR (mammalian 
target of rapamycin, serine/threonine-protein kinase), triggering anabolism (mTORC1) 
or promoting cell survival and proliferation (mTORC2) (Saxton and Sabatini, 2017; 
Whiteman et al., 2002; Yuan et al., 2013).   
In order to evaluate possible altered activities, the phosphorylation status of AMPK at 
Thr172, AKT at Ser473 and mTOR at Ser2448 were analysed (Figure 3.20). 
Interestingly, none of the kinases exhibited a significantly changed phosphorylation 
status, except for p-AKT in CHOP KO animals (Figure 3.20A, B). Despite unaltered 
AMPK or AKT activity, glucose metabolism was demonstrably modified, as shown by 
increased protein levels of the primary mediator of insulin-stimulated glucose uptake in 
the heart: GLUT4 (Figure 3.20A, B). GLUT1 functionally complements GLUT4, the 
primary glucose transporter in the adult heart. The activity of the former one is mainly 
determined at the transcriptional level (Shao and Tian, 2015). Therefore, GLUT1-
encoding slc2a1 transcript levels in the RNAseq data set were compared: As for GLUT4 
on the protein level, slc2a1 transcript levels were significantly augmented (FC 5.15; 
p<10-4) in DKOL mice, whereas the transcript levels in the other genotypes remained 
unchanged.  
Concerning the recently introduced model of the integrated mitochondrial stress 
response (ISRmt) proposing mTORC1 complex-dependent ATF4 induction in a mouse 
model of mitochondrial myopathy (Nikkanen et al., 2016), the phosphorylated and total 
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protein levels of 4EBP1, a phosphorylation target of mTORC1, were assessed. 
DARS2 KO and DKOL mice showed increased total 4EBP1 protein levels complemented 
by increased p-4EBP1 levels in DKOL animals (Figure 3.20C, D). Furthermore, 
bioinformatic analyses, performed by our collaborators (Prof. Dr. Ivan Topisirovic, Prof. 
Dr. Ola Larsson and Christian Oertlin) using anota2seq (Oertlin et al., 2019), provided 
no evidence for considerably altered 4EBP1 activity. Therefore, increased mTORC1 
activity in DKOL samples is unlikely. However, these analyses suggested an ATF4-like 
regulation on the proteomic as well as on the transcriptomic level (data not shown).  
Generally, the presented data demonstrate a shift towards enhanced glucose 
metabolism in DKOL mice, indicating a switch to foetal-like cardiac metabolism, although 
they fail to provide robust evidence for increased activity of the mTORC1 complex. 
 
Figure 3.20: GLUT4, 4EBP1 and p-4EBP1 protein levels are increased in DKOL mice.  
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(A) Western blot analysis and (B) relative protein levels of pSer473 AKT, AKT, pThr172 AMPK, 
AMPK and GLUT4. (C) Western blot analysis and (D) relative protein levels of mTOR, pSer2448 
mTOR, 4EBP1 and pThr37/46 4EBP1. HSC70 serves as loading control. Experiments were 
performed on cardiac lysates of mice at p17 (±2). Bars represent mean ± SD (One-way ANOVA; 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
 
3.1.3.8.2 Increased p62 levels in DKOL suggest possible changes in 
autophagy 
Previous work of the lab on the DARS2 KO mouse model suggested reduced autophagy 
as one of the induced stress responses (Dogan et al., 2014). For this reason, the LC3B-
I to LC3B-II conversion as well as p62 levels were analysed (Figure 3.21). In contrast to 
the six week old DARS2 KO mice (Dogan et al., 2014), LC3-I to LC3-II conversion at p17 
(±2) was affected neither in DARS2 KO nor in DKOL mice. p62 protein levels, however, 
showed significant increases in DKOL samples (Figure 3.21), revealing a possible 
alteration of autophagy (Mizushima et al., 2010).   
 
Figure 3.21: DKOL mice exhibit increased p62 protein levels.  
(A) Western blot analysis and (B) relative protein levels of p62, LC3-I and LC3-II. HSC70 serves 
as loading control. Experiments were performed on cardiac lysates of mice at p17 (±2). Bars 
represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01). 
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3.1.3.8.3 Apoptosis is not increased in DKOL mice 
The pro-apoptotic role of CHOP during stress conditions such as microbial infection or 
ER-stress represents one of the best-studied functions of the transcription factor. CHOP-
dependent induction of apoptosis can occur via mitochondria-dependent, death receptor 
or other pathways (Hu et al., 2019). Furthermore, cardiomyocyte apoptosis represents a 
common feature of dilated cardiomyopathy pathology (Harvey and Leinwand, 2011). 
Cleaved caspase-3 protein levels were analysed in order to evaluate the potential 
relevance of apoptosis in DKOL animals. However, cleaved caspase-3 was neither 
detected in DKOL mice nor in the respective controls (data not shown). As the primary 
executioner caspase of the apoptotic pathway, cleaved caspase-3 induces PARP 
(protein poly-ADP-ribosyltransferase) cleavage, one of the hallmarks of apoptosis (Slee 
et al., 2001). To further confirm the negative cleaved caspase-3 signal, PARP cleavage 
was assessed. Again, no changes in DKOL samples in comparison to the respective 
controls were detected (Figure 3.22). One of the protein families that is transcriptionally 
regulated by CHOP is the BCL-2 family, comprising several pro- and anti-apoptotic 
proteins. The anti-apoptotic protein BCL-2, for instance, is negatively regulated by CHOP 
(Rodriguez et al., 2011). In DKOL mice BCL-2 protein levels were significantly increased 
(Figure 3.22). Taken together, the results provide no evidence for induction of apoptosis 
in any of the analysed samples, however they confirmed the proposed repressive effect 
of CHOP on Bcl-2, as BCL-2 protein levels were increased in DKOL mice. 
 
Figure 3.22: Neither DARS2 KO nor DKOL mice display signs of altered apoptotic cell death.  
(A) Western blot analysis and (B) relative protein levels of BCL-2 and PARP. (C) HSC70 serves 
as loading control. Experiments were performed on cardiac lysates of mice at p17 (±2). Bars 
represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01). 
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3.1.3.8.4 DKOL mice exhibit elevated ER stress-marker levels 
CHOP is known as one of the TFs activated downstream of the UPRER. Furthermore, 
increasing attention is attributed to mito-ER communication. For this reason, protein 
levels of the luminal ER chaperone BiP (binding-immunoglobulin protein) and one of the 
sensors of the UPRER, IRE1a (inositol-requiring protein 1), were assessed (Chakrabarti 
et al., 2011; Lopez-Crisosto et al., 2017). At p6, no changes were detected (data not 
shown). At p17 (±2), DKOL mice presented significantly increased BiP levels (Figure 
3.23). DARS2 KO, as well as selected DKOL mice, exhibited increased IRE1a levels 
(Figure 3.23). Furthermore, the RNAseq data revealed transcriptional activation of Atf6 
‒ one of the main TFs mediating the UPRER ‒ in DKOL mice (DARS2 KO vs. WT: FC 
1.33, p<10-4; DKOL vs. WT: FC 2.09, p<10-4). Collectively, those data indicate that the 
ER reacts in response to the perturbation of mitochondrial proteostasis induced by 
deletion of Dars2 and increases its luminal protein folding capacity by augmenting BiP 
levels of DKOL animals.  
 
Figure 3.23: DKOL mice increase protein folding capacity of the ER lumen by augmented 
BiP protein levels.  
(A) Western blot analysis and (B) relative protein levels of BiP and IRE1a. (C) HSC70 serves as 
loading control. Experiments were performed on cardiac lysates of mice at p17 (±2). Bars 
represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01). 
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3.1.4 C/EBPβ is the only identified transcription factor 
interacting with CHOP in DARS2 KO animals 
Since CHOP in DARS2 KO mice affects the activation of the ISR, but not the regulation 
of Gadd34 (3.1.3.1-3.1.3.7), alternative explanations for the detrimental consequences 
of CHOP-deficiency in DKO mice had to be identified. As a bZIP TF, dimerisation of 
CHOP is a prerequisite in order to bind DNA. Moreover, the DNA binding domain of 
CHOP is non-functional due to the substitution of several conserved aliphatic and basic 
residues of the C/EBP family of TFs. Thus CHOP requires a hetero-dimerisation partner 
that confers DNA binding (Ron and Habener, 1992). CHOP interacting proteins in the 
DARS2 KO vs. WT background were identified by co-immunoprecipitation and 
subsequent mass spectrometry (Table 3.3). Among the list of identified proteins, CHOP 
was expectably the most enriched one. The remaining group of six proteins contained 
only one more TF: C/EBPβ (Table 3.3).  
 
Table 3.3: Significantly enriched proteins (p<0.05, FC>2) isolated by CHOP co-
immunoprecipitation and identified by subsequent mass spectrometry. 
Protein names Gene names p-value FC 
CCAAT homologous protein 
CCAAT/enhancer-binding protein beta 
Chop 
Cebpb 
0.0262 
0.0064 
4.82 
4.31 
DnaJ homolog subfamily C member 11 Dnajc11 0.0194 3.25 
Lon protease homolog, mitochondrial Lonp1 0.0027 3.43 
E3 ubiquitin-protein ligase TRIM21 Trim21 0.0069 3.22 
Plasminogen activator inhibitor 1 RNA-binding 
protein 
Serbp1 0.0218 3.43 
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3.2 Investigating the mito-specific modulation of the 
ISR in vitro 
Previous in vivo experiments revealed an accelerated and intensified activation of the 
ISR in the context of mitochondrial dysfunction induced by deletion of Dars2 upon CHOP 
deficiency. In order to shed light on the molecular mechanism behind the observed over-
activation of the ISR in general, and ATF4 in particular, additional investigations were 
performed in vitro. 
3.2.1 Cellular models of mitochondrial dysfunction and 
physiological impact of CHOP upon ISR activation 
To facilitate mechanistic analyses of the earlier described effects of CHOP deficiency in 
DKO mice, several in vitro models, recapitulating the molecular in vivo phenotype as 
accurately as possible, were established. 
Among others, COX10-deficient fibroblasts obtained from the lab of Carlos T. Moraes 
were utilised. The loss of the assembly factor COX10 impedes complex IV assembly. 
Interestingly, those fibroblasts are not only complex IV but also complex I-deficient (Diaz 
et al., 2006). As expected in cells devoid of respiratory complexes I and IV, no 
respiration-related oxygen consumption by COX10 KO fibroblasts was recorded using 
Seahorse (data not shown). The ISR activation of COX10 KO fibroblasts, characterised 
by significant up-regulation of p-eIF2α, ATF4 and ATF4 downstream targets (MTHFD2, 
ASNS, SHMT2, PYCR1) (Figure 3.24A, B), was comparable to the situation in 
DARS2 KO and DKOL mice described before (Figure 3.15). Additionally, ISR inhibitor 
(ISRIB) treatments indisputably confirmed the ISR as the cause of ATF4 up-regulation. 
ISRIB treatments lead to a rapid decrease of ATF4 protein levels in cells displaying 
severe mitochondrial dysfunction. 4h treatment duration were sufficient to revert ATF4 
levels to the WT situation in COX10 KO fibroblast (data not shown). For visible effects 
on ATF4 downstream targets longer treatment durations were necessary. After 48h of 
ISRIB treatment, partial restoration of the WT situation was observed in COX10-deficient 
cells (Figure 3.24A, B). Several reasons for the discrepancy between the results of ATF4 
and ATF4 downstream targets should be considered. First, ATF4 protein levels need to 
be decreased in order to reduce the transcription of the respective target genes. Second, 
the already present mRNA moieties of ATF4 targets need to be degraded in order to 
prevent the synthesis of the respective proteins. Third, ATF4 is known for its extremely 
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short half-life that is characteristic for stress-responsive proteins (Dey et al., 2010). This 
short half-life might not apply to its respective downstream targets. 
In accordance with the published mechanism of ISR inhibition by ISRIB, based on the 
alleviation of eIF2B inhibition by phosphorylated eIF2α (Sidrauski et al., 2015), p-eIF2α 
levels were not affected by the inhibitor (Figure 3.24A).  
 
Figure 3.24: Mitochondrial dysfunction-induced ATF4 up-regulation is fully attributable to 
ISR activation.  
(A) Western blot analysis and (B) relative protein levels of ISR markers in immortalised COX10 
KO and control fibroblasts. (C) Western blot analysis and (D) relative protein levels of ATF4 in 
immortalised MEFs treated with DMSO (control, 48h), actinonin (48h) and/or ISRIB (4h). HSC70 
serves as loading control. Bars represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001). 
A second cell culture model further confirmed ISR-dependent ATF4 up-regulation. 48h 
of actinonin treatment robustly induced mitochondrial dysfunction in immortalised mouse 
embryonic fibroblasts (MEFs). Actinonin, a potent peptide deformylase inhibitor, 
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interferes with mitochondrial translation. Peptide deformylase is required for 
mitochondrial translation in order to remove the starter methionine's formyl group of the 
nascent polypeptide chain, when the latter one emerges from the exit tunnel of the 
mitoribosome (Chen et al., 2000). Additionally, actinonin was shown to deplete 
mitochondrial ribosomes, rRNAs and mRNAs as well as to block cell proliferation (Richter 
et al., 2013). As observed before in COX10-deficient cells, 4h of ISRIB treatment 
prevented up-regulation of ATF4 induced by 48h actinonin treatment in MEFs (Figure 
3.24C, D).  
In order to evaluate how well the selected in vitro treatment recapitulates the effects of 
CHOP-deficiency observed during mitochondrial dysfunction in vivo, CHOP KO MEFs 
were subjected to 48h of actinonin treatment (Figure 3.25A, B). In line with previous 
results (3.1.3.2, 3.1.3.3), ATF4 mRNA activation upon mitochondrial dysfunction ‒
detected at the transcript level here ‒ occured prematurely in CHOP-deficient cells 
(Figure 3.25A). Calling back to mind the chronology of the ISR, were preferential 
translation of atf4 mRNA precedes induction of ATF4 targets such as mthfd2 and atf4, it 
is not surprising to observe a simultaneous increase of those transcripts.  
Juxtaposition of actinonin-treated WT and CHOP KO MEFs facilitated the evaluation of 
physiologic effect of CHOP deficiency during mitochondrial dysfunction in vitro (Figure 
3.25B). The comparison of the linearised growth curves during the exponential growth 
phase of both cell lines revealed a much stronger negative effect on CHOP-deficient 
MEFs. As opposed to CHOP KO MEFs, growth rates of untreated and actinonin-treated 
WT MEFs did not differ significantly from each other.  
Most interestingly, ISRIB treatments partially rescued the negative effect induced by 
mitochondrial dysfunction in CHOP KO MEFs (p=0.056). In contrast to CHOP KO MEFs, 
a mild (though not significant) negative effect of ISRIB on the growth rates of actinonin-
treated WT MEFs was observed (Figure 3.25B).  
Taken together, the discussed in vitro studies showed, that mitochondrial dysfunction 
activates ATF4 up-regulation solely via the ISR. Furthermore, the premature activation 
of the stress response upon CHOP deficiency and the resulting negative effect on the 
physiological level observed in the DKOL mice were recapitulated in actinonin-treated 
CHOP KO MEFs. 
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Figure 3.25: Inhibition of the ISR induced by mitochondrial dysfunction is beneficial under 
conditions of CHOP deficiency.  
(A) Relative mRNA levels of ISR markers and cebpb in actinonin-treated (48h) CHOP KO MEFs 
and respective controls determined by qPCR. Samples were normalised to DMSO-treated WT 
MEFs. (B) Linearised growth curves of respective exponential growth phases of WT and CHOP 
KO MEFs under the specified conditions. Treatment durations correspond to respective growth 
times. Curves were determined using linear regression. Based on the calculated slopes for each 
condition Prism 7 software determined the probability of each possible pair of slopes being equal 
(n=3). Bars represent mean ± SD (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
3.2.2 CHOP deficiency modulates the protein levels of C/EBPβ 
isoforms 
As the transcriptomic analyses did not provide evidence for a CHOP-regulated sub-set 
of transcripts but rather indicated a general repressive effect on ISR target gene 
activation, possible interaction partners of CHOP had been determined. Strikingly, the 
only identified interacting TF in DARS2 KO hearts was C/EBPβ, which was the second 
most-enriched protein after CHOP in the co-immunoprecipitation assay (3.1.4). Since 
further analyses on tissue samples were not possible due to antibody issues, subsequent 
experiments were performed in vitro.  
The protein levels of the three C/EBPβ isoforms LAP* (liver activating protein*), LAP 
(liver activating protein) and LIP (liver inhibiting protein) were assessed in both cell 
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culture models introduced beforehand (Figure 3.26). Previous studies had shown, that 
the proportion of the short isoform LIP to the two longer isoforms LAP* and LAP 
modulates the cellular response to ER stress (Li et al., 2008). Similarly, the protein levels 
of the C/EBPβ isoforms explicitly responded to the increased mitochondrial stress level 
in COX10 KO fibroblasts. LAP* and LAP levels increased approximately two to three-
fold. LIP levels, however, increased up to eight-fold (Figure 3.26A, B). Additional 
experiments with other cellular models confirmed the general trends of the results as 
mentioned before. As one example of several, the response of actinonin-treated WT 
MEFs is shown below (Figure 3.26C, D). Most notably, LIP levels failed to increase in 
the CHOP-deficient background. Moreover, LAP* and LAP protein levels tend to be 
reduced in those cells, independent of the treatment. 
 
Figure 3.26: CHOP-deficient cells exhibit an altered response to mitochondrial dysfunction 
on the level of the C/EBPβ isoforms.  
Western blot analysis of the three CEBPβ isoforms LAP*, LAP and LIP in COX10 KO fibroblasts 
(A) and actinonin-treated (48h) CHOP KO MEFs (C) along with the respective controls. HSC70 
serves as loading control. (B, D) Quantification of Western blot analysis in (A) and (C). Bars 
represent mean ± SD (One-way ANOVA; *p<0.05, **p<0.01). 
Interestingly, a particular relationship, termed as a molecular symbiosis, between the 
TFs CHOP and LIP had been previously described in the context of ER stress. According 
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to the proposed model, CHOP ‒ preferentially interacting with the C/EBPβ isoform LIP ‒ 
requires LIP to enter the nucleus. In contrast to CHOP, LIP has not only a functional 
nuclear localisation sequence (NLS) but also a nuclear export signal (NES), which results 
in re-export of the TF and subsequent proteasomal degradation in the absence of CHOP. 
Therefore, upon induction of ER stress, increasing CHOP protein levels entail LIP 
accumulation too, as CHOP facilitates its nuclear retention (Chiribau et al., 2010).  
Taken together, it appeared that C/EBPβ levels alter upon mitochondrial dysfunction. 
Among all three isoforms, LIP exhibits the sharpest increase, which is impaired by loss 
of Chop. 
3.2.3 LIP and LAP act as functional antagonists for 
transcriptional regulation of Atf4  
The third alternative start codon of the C/EBPβ mRNA initiating translation of LIP is 
located after the sequence sections encoding the transactivation domains (TADs). 
Therefore, the short C/EBPβ isoform LIP harbours no TADs. This structural feature 
represents the main difference between LIP and the two longer isoforms LAP* and LAP. 
Contrary to LAP* or LAP, LIP primarily acts as a repressor and negatively impacts 
on Atf4 expression in the context of UV irradiation (Descombes and Schibler, 1991; Dey 
et al., 2012). In order to test whether the functional antagonism of LAP*/LAP and LIP 
also applies to the context of the ISR activation induced by mitochondrial dysfunction, 
several experiments in C/EBPβ KO MEFs complemented with either LAP or LIP were 
performed (Figure 3.27). C/EBPβ KO MEFs, as well as LIP and LAP-encoding plasmids, 
were kindly provided by Maria Hatzoglou (Chiribau et al., 2010). Since LAP* and LAP 
are functionally not different from each other, additional experiments comprising LAP* 
over-expression were not performed. 
Complementation of C/EBPβ KO MEFs with LAP or LIP was achieved by transfection. 
The hygromycin resistance-conferring plasmids, encoding the respective protein 
isoforms under control of the endogenous promoter, facilitated the subsequent 
hygromycin-based selection of stably transfected cells. As already suspected, the 
functional antagonism of LAP and LIP regarding the regulation of Atf4 expression in the 
context of mitochondrial dysfunction was confirmed. The increase of ATF4 protein levels 
in LAP expressing C/EBPβ KO MEFs was significantly higher than in C/EBPβ KO 
MEFs (Figure 3.27A, B). Furthermore, despite only feeble LIP expression in stably 
transfected C/EBPβ KO MEFs, presence of LIP tended to attenuate the increase of ATF4 
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protein levels in actinonin-treated cells (Figure 3.27C, D). However, the significance level 
was not reached under those conditions.  
 
Figure 3.27:  Nuclear retention of LIP represses ATF4 activation.  
(A) Western blot analysis and (B) relative protein levels of ATF4 and LAP in actinonin-treated 
(48h) C/EBPβ KO MEFs with or without stable over-expression of LAP along with the respective 
controls. (C) Western blot analysis and (D) relative protein levels of ATF4 and LIP in actinonin-
treated (48h) C/EBPβ KO MEFs with or without stable over-expression of LIP along with the 
respective controls. (E) Western blot analysis and (F) relative protein levels of ATF4 in actinonin-
treated (48h) CEBPβ KO MEFs with or without stable over-expression of the LIP L120D point 
mutant along with the respective controls. Bars represent mean ± SD (One-way ANOVA; *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001).     
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The molecular symbiosis between CHOP and LIP, as well as the results of LAP and LIP 
over-expression in actinonin-treated C/EBPβ KO MEFs (Figure 3.26A-D), imply 
insufficient nuclear retention of LIP as possible cause of excessive ATF4 up-regulation 
in the context of mitochondrial dysfunction upon CHOP deficiency. In order to test this 
hypothesis, the leucine amino acid residue located at position 120 in LIP, in the heart of 
the protein's NES (Williams et al., 1997), was mutated to aspartate to disrupt the NES. 
Strikingly, stable over-expression of LIP L120D in CHOP KO MEFs abolished increase 
of ATF4 protein levels by actinonin treatment (Figure 3.27E, F).  
Collectively the data suggest a major, CHOP-dependent role for LIP in regulation 
of Atf4 expression during mitochondrial dysfunction. 
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4 Discussion 
The knowledge of the close relation between mitochondrial with cellular, organ- or even 
organism-related homeostasis vigorously increased during the past decades. Numerous 
studies addressing mitochondrial function and dys-function but also the underlying 
mechanisms of primarily non-mitochondrial diseases and the ageing process contributed 
to the remarkable gain of knowledge. The central role of mitochondria in for instance (i) 
steering fuel utilisation for energy production, (ii) synthesis of nucleotides, amino acids, 
lipids and iron-sulphur clusters, but also (iii) cell-fate determining pathways like apoptosis 
emphasises the importance of mitochondria as metabolic and signalling hubs (Friedman 
and Nunnari, 2014; Galluzzi et al., 2018; Nunnari and Suomalainen, 2012; Schaefer et 
al., 2004; Wallace, 2005). As such, retrograde communication with the nucleus, 
facilitating concerted action in response to alterations ranging from the intra-organellar 
to the intra-organismal level, is of high importance. Understanding the underlying 
signalling pathways of those complex regulatory networks, e.g. induced by loss of 
mitochondrial homeostasis, can provide precious entry points for therapeutical 
approaches.  
The present study focused on one specific case of mito-nuclear communication: the 
induction of the stress-responsive TF CHOP upon mitochondrial dysfunction. CHOP was 
firstly described in the context of mitochondrial stress responses as a crucial component 
of the UPRmt ensuring the induction of mitochondrial chaperones and proteases in 
answer to disrupted proteostasis of the organelle (Aldridge et al., 2007; Martinus et al., 
1996; Zhao et al., 2002). Our studies revealed CHOP to be one of the first stress-related 
TFs up-regulated in the heart in response to mitochondrial dysfunction induced by heart 
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and skeletal muscle-specific deletion of Dars2, thereby suggesting a potential role in the 
early phase of the anterograde response (Dogan et al., 2014).  
For this study, a newly-generated double knock-out mouse model deficient for DARS2 
(heart and skeletal-muscle specific) and CHOP (whole-body) as well as several cell 
culture models were combined for reasons of mutual complementation in order to reach 
the previously defined objectives. 
4.1 DARS2 KO mice as an appropriate tool to 
investigate general stress responses induced by 
mitochondrial dysfunction 
Previous studies in the lab clearly defined the main characteristics of the cardiac 
phenotype in DARS2 KO animals: progressive development of OXPHOS deficiency and 
dilated cardiomyopathy resulting in a significantly reduced life expectancy of the mice to 
approximately seven weeks of age (Dogan et al., 2014). This pathology is prevalent for 
cardiac phenotypes of mitochondrial mutants and not a DARS2-specific phenomenon, 
as also mutations targeting other mitochondrial processes than translation show similar 
phenotypes. An excellent overview was given by Kühl and co-workers in a comparative 
study of five heart and skeletal muscle-specific mouse models targeting the 
mitochondrial replication (Twinkle KO), mtDNA maintenance (Tfam KO), mtDNA 
transcription (Polrmt KO), RNA stability/processing (Lrpprc KO) and the translation 
process (Mterf4 KO), respectively. The disruption of the before-mentioned processes 
central for mtDNA expression always resulted in OXPHOS deficiency, cardiomyopathy 
and early death at six to 21 weeks of age (Kuhl et al., 2017). 
On the molecular level, much attention was given to the remodelling of the serine 
biosynthetic and the 1-C pathway in response to mitochondrial dysfunction during the 
last years. The tight relationship between the function of the respiratory chain and serine 
synthesis as well as 1-C metabolism was investigated in a cell culture model with 
inducible expression of a dominant-negative mutant version of POLG. It was shown, that 
the increase of serine synthesis is impaired from the mitochondrial generation of formate 
through the 1-C cycle and that those metabolic alterations were mediated by the TF 
ATF4 (Bao et al., 2016). Similar rewiring of metabolism was reported for the 'Deletor' 
mouse, a model of slowly progressing mitochondrial myopathy. The accumulation of 
multiple mtDNA deletions in those animals lead to up-regulation of serine synthesis and 
impairment of folate-dependent biosynthetic pathways in the skeletal muscle (Nikkanen 
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et al., 2016). Also, the present study demonstrated markedly increased serine synthesis 
and remodelling of the 1-C cycle in hearts of DARS2 KO and DKO mice as well as in 
distinct cell culture models, underscoring the initiation of a response attributable to 
mitochondrial dysfunction in general, and not to DARS2 deficiency in particular.  
Further evidence supporting the notion of a general relevance of the observations made 
in DARS2 KO mice for mitochondrial stress responses are provided by the direct 
comparison of DARS2 KO and DKO mice. DKOL and DARS2 KO animals showed 
comparable OXPHOS assembly defects around p17. However, OXPHOS assembly 
defects at that age coincided with severe inhibition of mitochondrial translation and a 
respiratory defect only in DKOL and not in DARS2 KO mice. Hence, deletion of Dars2 
alone is not resulting in severe inhibition of mitochondrial translation at p17. The 
assembly defects accompanied by only mild translation defects in DARS2 KO mice 
rather suggest on-going protein synthesis enabled by misincorporation of amino acids 
substituting aspartate residues in newly synthesised proteins. The deletion of Chop in 
the DARS2 KO background revealed the existence of secondary responses modifying 
the mitochondrial translation process, in addition to the primary defect triggered by 
deletion of Dars2. Thus it appears essential for future projects to understand the 
mechanism delaying or alternatively causing accelerated loss of mitochondrial 
translation in DARS2 KO and DKO mice, respectively. Possible entry points to 
investigate causes of translational inhibition beyond DARS2 deficiency are (i) 
mitochondrial f-Met levels, that are potentially affected by the re-routing of the 1-C cycle, 
(ii) investigation of the driving forces leading to the structural defects observed on TEM 
pictures, and (iii) monitoring of mitochondrial protein import and its possible inhibition by 
accumulation of misfolded proteins in the mitochondrial matrix. 
4.2 CHOP deficiency results in severe deregulation of 
the ISR characterised by ATF4 over-activation 
CHOP is well-known for its apoptosis-related role within the ISR pathway that was 
extensively studied in the context of the UPRER, where the PERK-dependent branch of 
the stress response activates the ISR (Ron, 2002). Nevertheless, initiation of the ISR 
can occur in response to various types of stresses and by several cellular compartments 
(Pakos‐Zebrucka et al., 2016). Even though the upstream signalling events are still a 
matter of debate, mitochondrial dysfunction as a trigger of the ISR is commonly accepted 
in the field. For example, ISR activation was evidenced in mice with neuron-specific 
Discussion 100 
deletion of the mitochondrial fission protein DRP1. Interestingly, augmented ATF4 levels 
and increased p-eIF2α/eIF2α ratio used as a read-out for an activated ISR were also 
accompanied by increased chop mRNA levels (Restelli et al., 2018). Furthermore, the 
direct dependence of CHOP expression from the eIF2α/ATF4 axis in the context of 
mitochondrial dysfunction was shown in cell culture models with impaired mtDNA 
expression caused by mtDNA depletion or translational inhibition (Michel et al., 2015).  
Strikingly, transcriptomic and proteomic analyses provided strong evidence for CHOP as 
a regulator of the ISR. Deletion of Chop in the DARS2-deficient background resulted in 
a reinforced transcriptional signature of ATF4. Furthermore, transcriptional induction of 
ATF4 targets conveyed into similar changes in the proteomic data set. On the protein 
level, accentuated ISR in DKOL compared to DARS2 KO mice became apparent by a 
significantly increased proportion of phosphorylated eIF2α - representing the central hub 
of the ISR - and augmented ATF4 protein levels - the central TF of the ISR (Pakos-
Zebrucka et al., 2016). In summary, DKO mice exhibited a premature and strong 
activation of the ISR. The presented in vivo results provide solid evidence for a significant 
role of ATF4 in the response to mitochondrial stress and thereby further confirm 
published results acquired in several in vitro cell culture models of pharmacologically 
induced mitochondrial dysfunction (Quirós et al., 2017). 
4.3 First in vivo evidence for a translational switch from 
acute to chronic ISR 
Beside ATF4 activation, eIF2α phosphorylation also results in global inhibition of CAP-
dependent protein synthesis. In the field of mitochondrial dysfunction, inhibition of protein 
synthesis by the ISR is often assumed upon detection of ISR, but commonly not further 
explored. For the present project, inhibition of CAP-dependent protein synthesis was 
confirmed in DKOE mice at p13. This raised the question how the animals are able to 
survive for approximately four more days. Unexpectedly, protein synthesis of DKOL mice 
is not only partially, but fully restored around p17. Those surprising results are consistent 
with recent data published in a cell culture model of ER stress, revealing a translation 
initiation reprogramming during chronic ISR activation. According to the proposed model, 
two translational switches are induced subsequently: First, during the acute phase of the 
ISR, only stress-responsive mRNAs are translated. Second, upon persisting chronic ISR 
activation, global translation is re-initiated in an eIF4F-independent but eIF3-dependent 
manner, resulting in parallel execution of stress-specific and global translation. The 
Discussion 101 
second translational switch appeared to have beneficial effects within the studied in vitro 
model, preventing initiation of cell death (Guan et al., 2017). The present study in DKO 
mice provided first-time in vivo evidence for the switch from acute to chronic ISR along 
with the alterations on the level of cytoplasmic protein synthesis. Furthermore, the 
presented results demonstrate, that the model of the chronic ISR also applies to the 
context of mitochondrial dysfunction and is not limited to ER stress. 
Nevertheless, the execution of two translational programmes results in a significantly 
increased energy demand, protein synthesis being considered as one of the most energy 
consuming processes in the cell (Lane and Martin, 2010). With regard to the strong 
respiratory defect of the animal model used for the present study, initiation of chronic 
ISR most probably represents a further challenge to the animals’ energy resources. In 
addition, sudden re-initiation of global protein synthesis equates to increased ER stress 
due to a rapidly increasing amounts of proteins entering the ER for further processing. 
This configuration provides a potential explanation for the increase of ER stress markers 
observed during the terminal stage of DKOL mice.  
4.4 Putative signals upstream of eIF2α phosphorylation 
The study design of this project was mainly oriented towards downstream aspects of 
eIF2α phosphorylation. However, the upstream signalling events initiating the signalling 
pathway in the context of mitochondrial dysfunction remain an issue of great interest. 
eIF2α is known to be phosphorylated by four different kinases, that become activated by 
distinct types of stress: PKR, PERK, HRI and GCN2. The particular major activating 
stressors are dsRNA, ER stress, heme deficiency and amino acid deprivation (Donnelly 
et al., 2013). Except PERK, all kinases were previously proposed as potential inducers 
of the ISR in response to mitochondrial stress (Michel et al., 2015; Rath et al., 2012; 
Restelli et al., 2018; Taniuchi et al., 2016). Unfortunately, the wide range of models (from 
cell culture to mice), tissues (from intestinal epithelial cells to neurons) and methods used 
to investigate mitochondrial dysfunction in the mentioned publications (e.g. ΔOTC 
expression, DRP1 deletion, FCCP treatment) complicate the evaluation of these results.  
A recent publication examining endogenous intracellular dsRNAs interacting with PKR 
revealed dsRNAs of mitochondrial origin as the most strongly represented group. In 
addition, partial rescue of stress-induced eIF2α phosphorylation could be achieved by 
knock-down of polrmt (Kim et al., 2018). Considering the increase of selected 
mitochondrial transcripts, the gradual decline of the mitochondrial membrane potential 
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as well as the observed structural defects of mitochondria in DARS2 KO and DKO mice, 
a possible role for PKR should be assessed in future analyses. 
Increased BiP levels as a marker for ER stress were detected in both, DARS2 KO (data 
not shown) and DKOL mice during the respective terminal stages of the animals. 
Therefore, the involvement of PERK in sustaining ISR activation during the chronic 
phase of the ISR should be considered.  
Re-evaluation of the proteomics data provided indications for iron deficiency and 
enhancement of heme biosynthesis in DKOL mice. First, iron storage protein Ferritin H 
(FTH1) levels are significantly decreased in DKOL animals. Ferritin H is mainly regulated 
post-transcriptionally. Fth1 transcripts are actively recruited from monosomes to 
polysomes in the presence of iron (Rogers and Munro, 1987; Zähringer et al., 1976). 
Hence, decreased Ferritin H protein levels are most likely a result of decreased iron 
levels. Second, Ferrochelatase is significantly increased in DARS2 KO and DKOL mice. 
Ferrochelatase catalyses the last step of heme synthesis, incorporating a ferrous atom 
in protoporphyrinogen IX (Pelley, 2012). Those modifications point towards altered iron 
metabolism and are raising the possibility of ISR activation via the eIF2α kinase HRI. 
GCN2 is sensing amino acid deprivation through accumulation of uncharged tRNAs 
using a histidyl tRNA synthetase-domain (Vazquez de Aldana et al., 1994; Wek et al., 
1995). In this regard, the significantly decreased histidine levels in early-state DARS2 KO 
mice around p17 suggest GCN2 activation as a potential cause of early eIF2α 
phosphorylation. However, histidine levels of early-stage DKOE mice are not available, 
and no difference was detected in late-stage DKOL animals. Apart from decreased amino 
acid levels, increased tRNA levels could also result in GCN2 activation. Notably, 
increased ATF4 protein levels in the context of cancer were shown to be caused by the 
MYC-dependent increase of cytoplasmic tRNA levels leading to GCN2 activation 
(Tameire et al., 2019). Moreover, potential relevance of the TF MYC for mitochondrial 
stress responses was described for several mouse models of severe mitochondrial 
dysfunction (Kuhl et al., 2017). Interestingly, ATF4 and MYC share a considerable 
amount of transcriptional targets and were shown to co-occupy promoter regions of 
genes with functions in amino acid transport (Tameire et al., 2019). MYC promotes cell 
growth and proliferation by providing building blocks through increased anabolism and 
promotion of protein synthesis (Stine et al., 2015). Considering those findings, the 
transcriptional activation of Myc in DARS2 KO and DKO mice represents an important 
indication with a significance extending beyond the possible induction of GCN2 
activation. Hence, not only amino acid and cytoplasmic tRNA levels should be subject of 
further investigations to clarify a possible role of GCN2, but also the general role of MYC 
in the context of mitochondrial dysfunction needs to be analysed more precisely. 
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In conclusion, several models for eIF2α phosphorylation in DARS2 KO and DKO mice 
are conceivable, including the cooperation of two or more kinases. Assessment of the 
phosphorylation status of all four eIF2α kinases along with further analyses suggested 
above are required, in order to drive forward the understanding of the exact mechanisms 
upstream of eIF2α phosphorylation. 
4.5 CHOP is not required for in vivo activation of UPRmt 
markers  
Albeit the prominent ISR signature in DARS2 KO and DKO mice, the UPRmt, as the first 
CHOP-associated mito-specific stress response, had also to be taken into consideration. 
Inaugural in vitro studies demonstrated CHOP-dependent induction of a nuclear gene 
expression programme supposed to promote mitochondrial proteostasis by increased 
expression of mitochondrial chaperones and proteases (Zhao et al., 2002). Whereas 
partially only validated by reporter assays, proteins such as HSP60, HSP10 or YME1L1 
were subsequently employed as bona fide UPRmt markers (Aldridge et al., 2007; Zhao 
et al., 2002). Subsequent in vitro studies extended the list of mammalian UPRmt markers 
with e.g. mtHSP70 and LONP1 (Fiorese et al., 2016). It should be noted that those results 
were obtained solely by analyses performed on the transcript level. The mentioned study 
did not comment on CHOP, but proposed the TF ATF5 as mediator of the mammalian 
UPR mt, in analogy to ATFS-1 known from the C.elegans-specific pathway. However, 
these results not necessarily contradict the inaugural work based on CHOP, as CHOP 
is a known transcriptional regulator of ATF5 (Teske et al., 2013).  
With regard to the present study performed on DARS2 KO and DKO mice, CHOP does 
not seem to be essential for the transcriptional activation of UPRmt-associated genes. 
Transcriptional activation of mitochondrial chaperones and proteases related to the 
signalling pathway was not blocked in DKOL mice. On the contrary, UPRmt associated 
transcripts showed a significant increase in comparison to DARS2 KOs. However, the 
biological significance of this transcriptional activation, accepted as a gold standard for 
detection of UPRmt activation according to a recent review (Münch, 2018), remains 
disputable. In the present case, those transcriptional changes did not implicate elevated 
protein levels of the respective mitochondrial chaperones and proteases in DKOL mice. 
Considering the late-onset increase of respective UPRmt markers in DARS2 KO mice on 
the protein level (detectable only at six weeks of age) and in accordance with the 
observations made in the Deletor mouse introduced earlier (Forsstrom et al., 2019), the 
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data suggest a subordinate role for the UPRmt in the mentioned in vivo models. The 
biologically relevant induction of mitochondrial chaperones and proteases on the protein 
level arises late in the chronology of pathological changes. This leads to the question, to 
what extent mitochondrial homeostasis can be improved at this advanced stage of 
mitochondrial dysfunction. Moreover, the concept of the UPRmt would benefit from further 
consolidation in general, as the widely used UPRmt markers certainly require a more 
profound validation. 
4.6 Mitochondrial deficiency induced by loss of Dars2 
entails considerable changes in cardiac 
metabolism that occur prematurely upon CHOP 
deficiency 
4.6.1 General pathological changes associated with 
mitochondrial dysfunction in the myocardium 
According to the resting metabolic rates determined for major organs in humans, both 
heart and kidney display the highest resting energy expenditure (Elia, 1992; Wang et al., 
2010). Interference with cardiac mitochondrial energy production frequently results in 
activation of adaptive but also maladaptive alterations of the organ’s energy metabolism. 
Development of cardiomyopathy, for instance, is commonly observed under the 
described conditions (Kelly and Strauss, 1994). Hence, cardiomyopathy developed by 
DARS2 KO and DKOL mice was not surprising. However, it is interesting to note that 
DKO mice exhibited premature development of cardiac pathologies in comparison to 
DARS2 KO mice. Considering the coinciding onset of cardiomyopathy with the transition 
from the acute to the chronic stage of the ISR, a possible involvement of the ISR in the 
disease progression needs to be taken into account. 
From a metabolic point of view, DKO mice display the classical switch from energy 
production mainly based on fatty acid oxidation to a foetal-like metabolic profile relying 
primarily on glucose utilisation. Significantly increased nppa and nppb levels detected in 
DKOL mice provide further evidence for the re-expression of the foetal gene program 
(Ellen Kreipke et al., 2016; Lehman and Kelly, 2002; Ritterhoff and Tian, 2017). Also, a 
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trend towards reduced ATP levels in DKOL mice was detected. According to the “energy 
starvation” hypothesis of heart failure, suboptimal ATP supply predisposes for the 
contractile dysfunction observed during heart failure (Katz, 1998). In the heart, CK 
(creatine kinase) represents a spatial and temporal ATP buffer, generating high cytosolic 
ATP concentrations at the site of consumption out of phospho-creatine and ADP. It has 
been shown previously, that ATP flux through CK in hearts of patients with mild-to-
moderate chronic heart failure is reduced already before a significant reduction of ATP 
levels is detectable. Furthermore, evidence for a deficit in energy supply of failing human 
hearts was provided (Weiss et al., 2005). Hence, the detection of a trend towards 
diminished ATP concentration in the hearts of DKOL mice might suggest a progressed 
state of heart failure.  
Besides contractile dysfunction as discussed above, also ventricular arrhythmias are 
tightly associated with heart failure (Packer, 1985). Strikingly, single cardiomyocytes with 
severe mitochondrial dysfunction are sufficient to promote cardiac arrhythmia. Using the 
K320E-TwinkleMyo mouse exhibiting accelerated accumulation of mtDNA deletions it was 
shown, that already 0.6% of COX-negative cardiomyocytes result in spontaneous 
ventricular premature contractions and atrioventricular blocks (Baris et al., 2015). 
Considering the severe impairment of ETC function in both, DARS2 KO and DKO mice, 
the occurrence of cardiac arrhythmias in those animals further contributing to the 
pathology seem likely.  
Furthermore, alarming citrate levels were detected in hearts of DKOL mice. As compared 
to WT samples, a 5.6-fold increase of the metabolite had been determined. It was 
previously shown in patient cells harbouring mtDNA mutations, that upon severe 
OXPHOS impairment glutamine metabolism is altered and feeds the reductive TCA 
cycle, resulting in increased citrate synthesis (Chen et al., 2018). Increased intracellular 
citrate levels can engender intracellular acidosis, leading to hypocalcemia caused by 
reduced availability of Ca2+. Importantly, cardiac contraction is induced by Ca2+-release 
from the sarcoplasmic reticulum. Ca2+-release occurs in close proximity to mitochondria. 
As a result of increased Ca2+ uptake by mitochondria during this phase, the TCA cycle 
and the ETC are transiently activated, inducing increased ATP production. Therefore, 
reduced Ca2+ availability caused by citrate-driven metabolic acidosis contributes to 
reduced contractility of the heart. The excitation of muscle fibres is damped, and ATP 
production-coupling in mitochondria with the muscle contraction provided by Ca2+ is 
impaired (Orchard and Kentish, 1990; Poole-Wilson, 1982; Porter et al., 2011). 
Therefore, increased citrate levels negatively impact on cardiac physiology of DKOL mice 
via impairment of the excitation-contraction-metabolism coupling.  Furthermore, 
additional effects of elevated citrate levels on regulation of metabolic enzymes or 
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chromatin dynamics by acetylation have to be taken into consideration (Wellen et al., 
2009; Zhao et al., 2010). 
4.6.2 ATF4-specific metabolic alterations induced by the 
activation of the ISR 
Induction of anabolic programmes by ATF4 activation becomes evident on closer 
inspection of transcriptional ATF4 targets. In DKO mice, re-inforced increases of amino 
acid transporters (e.g. SLC38A2, SLC7A5), amino acid metabolic enzymes (e.g. ASNS, 
PHGDH) and tRNA synthetases (e.g. GARS, NARS) determined in DARS2 KO mice 
were ascertained on the mRNA and protein level. Mass spectrometric analyses of amino 
acid levels in cardiac samples further confirmed the observed trend, as 15 out of 19 
recorded amino acids showed significant increases in DKOL mice. However, this overall 
increase is most probably not entirely attributable to ATF4-related changes, as also 
branched-chain amino acids (BCAAs: Ile, Leu and Val) were affected and BCAA 
catabolism is known to be impaired during cardiac dysfunction and hypertrophy 
(Ritterhoff and Tian, 2017). The metabolic rewiring caused by the transition of acute to 
chronic ISR in general, and activation of ATF4 in particular, results in the induction of 
anabolic pathways and thus a significantly increased energy demand in hearts of DKOL 
mice.   
As a regulator of growth and metabolism, mTORC1 is controlled by an extensive variety 
of signals such as cellular energy levels (via AMPK) or nutrients (especially amino acids) 
(Goberdhan et al., 2016). Therefore, generally increased amino acid levels in DKOL mice 
provide a possible explanation for the minor signs of mTORC1 activation detected in the 
animals. Nevertheless, the data indicate that mTORC1 activation plays a subordinate 
role in our model of mitochondrial dysfunction and rather represents a consequence than 
the cause of ATF4 activation. 
This conclusion is of particular interest, as an inverse relationship between mTORC1 
and ATF4 was shown in the Deletor mouse. Strikingly, treatment of Deletor mice with 
rapamycin, an inhibitor of mTORC1, resulted in decreased atf4 mRNA levels and were 
accompanied by arrested disease progression (Khan et al., 2017). Control of ATF4 by 
mTORC1 was shown to occur on the post-transcriptional level by regulation of mRNA 
stability and translation (Park et al., 2017). As a whole, the described findings summarise 
the mutual interference between ISR and mTORC1 via amino acid and atf4 transcript 
levels (Papadopoli et al., 2019). Moreover, these insights highlight the necessity to 
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understand the upstream events of ISR in DARS2 KO and DKO mice as well as 
mTORC1 activation in Deletor mice, respectively.   
Intriguingly, bringing the most recent publication of the Deletor mouse model into 
accordance with the findings mentioned above is challenging. First, atf4 transcript levels 
in Deletor mice are unchanged up to the age of 22 months (Forsstrom et al., 2019), 
contrary to the previous paper reporting significant changes on the mRNA as well as on 
the protein level (Khan et al., 2017). Instead, a significant contribution of ATF3 and ATF5 
to the progression of the integrated mitochondrial stress response (ISRmt) proposed by 
the Suomalainen laboratory earlier, was suggested (Forsstrom et al., 2019; Suomalainen 
and Battersby, 2017). Second, mTORC1, previously classified upstream of ATF4 and 
FGF21 activation (Khan et al., 2017), is not considered as the regulator of the ISRmt 
anymore. Conversely, an FGF21-dependent regulation of the ISRmt was proposed 
(Forsstrom et al., 2019). Interestingly, actinonin-treated murine myoblasts displayed an 
ATF4-dependent, but ATF3 and ATF5-independent ISRmt. The post-mitotic nature of the 
analysed skeletal muscle samples issued from Deletor mice versus the proliferative 
nature of the myoblast cell line was proposed as a possible explanation for the described 
differences between the two model systems (Forsstrom et al., 2019). Due to insights 
gained from analyses performed on DKO mice, this explanation might be questioned. 
Analyses of DKO mice were also performed on a post-mitotic tissue, the murine heart. 
Possible alternative explanations might include the severity of the disease, tissue-
specific effects or the age and therefore the developmental state at which the disease 
peaks. 
4.7 The interplay between LIP and CHOP is essential for 
adjusted transcriptional regulation of Atf4 during 
severe mitochondrial dysfunction 
Net transcription of a specific gene represents the result of complex signal integration 
taking place at several regulatory levels, including the activity of activating or repressing 
TFs on the promoter level. Therefore, increased Atf4 transcription upon loss of Chop 
might result from augmented activation, decreased repression or a combinatory effect of 
both.  
Interestingly, C/EBPβ was identified as CHOP interactor in DARS2 KO hearts. Like 
CHOP, C/EBPβ is a pleiotropic TF contributing among other things to regulation of 
hematopoiesis as well as homeostasis of several tissues such as bone, skin or fat (Begay 
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et al., 2018). C/EBPβ is primarily regulated on the translational level. One of its 
peculiarities is the sequence of three consecutive in-frame start codons on the protein-
coding mRNA, giving rise to the three C/EBPβ protein isoforms LAP* (liver activating 
protein*, 38 kDa, full lengh), LAP (liver activating protein, 35 kDa) and LIP (liver inhibitory 
protein, 20 kDa, devoid of the TADs present in LAP* and LAP) (Descombes and Schibler, 
1991). Both longer isoforms and LIP are characterised by an antagonistic relationship, 
as the names already indicate. In many cases target genes (e.g. Mafb, coding for a TF 
involved in osteoclastogenesis) are positively regulated by LAP*/LAP, whereas LIP 
binding represses the respective locus. As the DBD is identical in all three isoforms, the 
regulation occurs via the modulation of the LAP*/LAP vs. LIP ratio (Smink et al., 2009; 
Tsukada et al., 2011).  
Based on in vitro analyses assessing (i) the response of all three C/EBPβ isoforms LAP*, 
LAP and LIP to mitochondrial dysfunction, and (ii) the impact of individual isoforms on 
Atf4 expression the following mechanism underlying ISR over-activation in DKO mice is 
proposed:  
Loss of CHOP impairs the increase of the C/EBPβ isoform LIP, normally occurring upon 
mitochondrial dysfunction. CHOP was previously shown to prevent the re-export of LIP 
from the nucleus in the context of ER stress, thereby preventing cytoplasmic degradation 
of LIP (Chiribau et al., 2010).  
Additionally, nuclear retention of LIP via mutation of the NES (LIP L120D) abolished the 
increase of ATF4 protein levels upon actinonin treatment in CHOP-deficient MEFs. 
Those results are in line with an earlier report studying the causes of variable ATF4 
expression in response to eIF2α phosphorylation upon distinct stress conditions such as 
ER stress or UV irradiation. It was shown, that UV irradiation LIP-dependently represses 
Atf4 transcription. Furthermore, evidence for beneficial effects of eIF2α phosphorylation 
as well as enhanced cell survival due to repression of Atf4 during UV irradiation were 
provided (Dey et al., 2012).  
Taken together, CHOP-mediated nuclear retention of LIP upon mitochondrial 
dysfunction represents a novel regulating screw in the context of the mito-specific 
modulation of the ISR, contributing to the adjustment of Atf4 expression executed by the 
repressive impact of LIP on the Atf4 promoter (Figure 4.1).  
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Figure 4.1: Model of CHOP-mediated nuclear retention of LIP, exerting repressive effects 
on the Atf4 promoter. 
Increased CHOP protein levels triggered by mitochondrial dysfunction-related ISR activation 
facilitate nuclear retention of LIP. The latter TF negatively affects Atf4 transcription. In the absence 
of CHOP, LIP re-export and subsequent proteasomal degradation abrogate the repressive effect 
of LIP on the Atf4 promoter, resulting in increased Atf4 expression. 
However, further investigations are necessary to provide deeper mechanistic details on 
the LIP-mediated repression of Atf4. Owing to the characteristics of the C/EBP family of 
TFs (Tsukada et al., 2011), pre-formed LIP-containing dimers binding to the Atf4 
promoter as well as the replacement of a single subunit within a promoter-bound dimer 
by LIP need to be considered. Also, LIP-containing dimers might be of homo- or hetero-
dimeric nature. On the one hand, transcriptional inhibition could be achieved by binding 
of TF dimers fully devoid of TADs (e.g. LIP homodimers or LIP-CHOP heterodimers, 
respectively). However, experiments in CHOP KO MEFs revealed, that CHOP is 
dispensable for repression of Atf4 transcription. On the other hand, mechanisms 
including the replacement of the activating C/EBPβ isoforms LAP* or LAP by LIP in Atf4 
promoter-binding dimers should be taken into consideration, too. The presence of LIP in 
the respective dimers would thereby revert the LAP*/LAP-mediated positive effect on 
transcription. The determination of the dimer composition upon mitochondrial 
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dysfunction during future investigations will certainly advance the understanding of 
underlying mechanistic details. Moreover, direct comparison of LIP dimer composition 
during mitochondrial dysfunction and UV irradiation could provide further insights into 
stress-specific fine-tuning of the ISR in response to different types of stress. 
4.8 Summary 
In consideration of beforehand discussed accumulated pathological developments 
caused by mitochondrial dysfunction and resulting metabolic alterations in DKO mice, 
heart failure appears as the most plausible cause of death. Significant changes 
contributing to pathology are summarised below (Figure 4.2). 
 
Figure 4.2: Events contributing DKO mice pathology. 
Referring to the earlier defined research aims for this study investigating the role of 
CHOP in the context of mitochondrial dysfunction, following insights were gained: 
First, deletion of Chop has detrimental effects in conditions of severe mitochondrial 
dysfunction as shown by animal (DARS2/CHOP DKO mice) or cell culture-based 
experiments (actinonin-treated CHOP KO MEFs), resulting in significantly shortened life 
expectancy or reduced growth rates, respectively. 
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Second, under the given circumstances CHOP modulates the progression of the ISR, a 
stress pathway induced in many models of mitochondrial dysfunction (Arnould et al., 
2015; Dogan et al., 2014; Forsstrom et al., 2019; Kuhl et al., 2017; Quirós et al., 2017). 
Third, CHOP negatively regulates transcriptional activation of Atf4 via the nuclear 
retention of the inhibitory C/EBPβ isoform LIP, thereby adding a supplementary 
regulatory layer to the ISR. 
This study provided evidence for the deleterious consequences of ISR deregulation 
resulting in ATF4 over-activation. The discussed findings give rise to further questions 
concerning (i) the benefit of the ISR, (ii) specific conditions impairing a beneficial 
equilibrium between activation and inhibition of the stress response and (iii) about ATF4 
as a potential therapeutic target for pathological developments triggered by inappropriate 
ISR activation. Obviously, the respective answers strongly depend on the specific 
situation, determined for instance by the nature and severity of the ISR initiating stress 
or the affected tissue. Therefore, the coordinated efforts of many researchers are 
required in the future in order to recognise the greater picture. 
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